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SUMMARY
 
 
Summary 
Epigenetic mechanisms, including DNA methylation and histone modifications, control gene 
expression by modulating chromatin structure. DNA methylation is involved in genomic 
imprinting, X-chromosome inactivation and long-term transcriptional repression. DNA 
methylation patterns are established by de novo DNA methyltransferases Dnmt3a and 
Dnmt3b, and are propagated by the maintenance DNA methyltransferase Dnmt1.  
In the present study, I aimed to identify novel interacting proteins and to characterize their 
functions in the regulation of Dnmt1 activity. For this purpose, I generated an ES cell line 
stably expressing GFP-Dnmt1. Using an immunoprecipitation approach in combination with 
mass spectrometry, I identified an ubiquitin specific protease Usp7 as a novel interaction 
partner. Interestingly, I could also show that Usp7 interacts with Uhrf1, a crucial cofactor of 
Dnmt1. To elucidate the role of Usp7 in the regulation of Dnmt1 in vivo, I established an 
ubiquitination and a protein stability assay. With these assays, I could show that Uhrf1 
mediates the ubiquitination of Dnmt1 as well as its autoubiquitination, whereas Usp7 
stabilizes Dnmt1 by removal of the ubiquitin chain from the modified Dnmt1. Taken together, 
Uhrf1 and Usp7 coordinately control the Dnmt1 abundance during the cell cycle. 
Genetic ablation of uhrf1 was reported to result in global hypomethylation in ES cells (ESCs) 
which is similar to that observed in dnmt1-/- ESCs. Uhrf1 is supposed to recruit Dnmt1 to 
hemimethylated CpG sites. To investigate the mechanism of Dnmt1 recruitment by Uhrf1, the 
domains involved in the interaction between Dnmt1 and Uhrf1 were mapped. Basing on the 
mapping result, several specific mutants of Dnmt1 and Uhrf1 were generated. Using a 
functional rescue approach, I could show that the interaction of Dnmt1 with Uhrf1 is 
necessary but not sufficient for the maintenance of DNA methylation. This observations lead 
to propose that Uhrf1 modulates the chromatin accessibility for recruiting Dnmt1 to substrate 
sites in vivo. To test this hypothesis, I established an in vitro DNA methylation assay to 
analyze Dnmt1 activity on chromatin substrates in the presence or absence of Uhrf1. A 
deletion mutant of Dnmt1 which lacks amino acids essential for the interaction with Uhrf1 is 
enzymatically active in vitro. Interestingly, this mutant is unable to methylate naked 
hemimethylated substrates when cell extracts were added to the methylation reaction. These 
results suggest that activation and inhibition of Dnmt1 occur in vivo and that Uhrf1 likely has 
multiple functions in the maintenance of DNA methylation. 
In conclusion, this work provides novel insights into the mechanisms of Dnmt1 regulation by 
the interacting proteins Uhrf1 and Usp7. 
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SUMMARY
 
 
Zusammenfassung 
(Translation with the help of Zijing Gong, Zhuo Li, Daniel Smeets, Katharina Thanisch, 
Katrin Schneider, Andrea Rottach, Carina Frauer, Susanne Breitsameter) 
 
Epigenetische Mechanismen, wie DNA-Methylierung oder postranslationale Modifikation 
von Histonen, kontrollieren Genexpression durch Veränderung der Chromatinstruktur. Die 
DNA-Methylierung spielt eine fundamentale Rolle in biologischen Schlüsselprozessen wie 
dem genomischen Imprinting, der X-Chromosomeninaktivierung und der langfristigen 
transkriptionellen Genrepression. Die Etablierung neuer Methylierungsmuster erfolgt durch 
die de novo DNA-Methyltransferasen Dnmt3a und Dnmt3b, während die maintenance DNA-
Methyltransferase Dnmt1 diese Muster über sukzessive Zellteilungen hinaus erhält. Intra- 
und intermolekulare Wechselwirkungen gewährleisten hierbei eine strenge Regulation der 
Dnmt1-Aktivität. 
Im Rahmen der vorliegenden Studie sollten neue mit Dnmt1 wechselwirkende Proteine 
identifiziert und bezüglich ihres Einflusses auf die Dnmt1-Aktivität untersucht werden. Dazu 
wurde eine embryonale Stammzelllinie (ES-Zellen) hergestellt, welche stabil GFP-Dnmt1 
exprimiert. Durch eine mit Massenspektrometrie kombinierte Immunpräzipitation konnte 
Usp7 als neuer Interaktionspartner von Dnmt1 und dessen Kofaktor Uhrf1 identifiziert 
werden. Ubiquitinierungs- und Proteinstabilitäts-Tests in lebenden Zellen ergaben, dass Uhrf1 
sowohl die Ubiquitinierung von Dnmt1 als auch seine Autoubiquitinierung vermittelt, 
während Usp7 Dnmt1-Proteine durch Entfernung von Ubiquitinresten stabilisiert. Die 
koordinierte Aktivität von Uhrf1 und Usp7 reguliert die Stabilität von Dnmt1 durch 
Ubiquitinierung beziehungsweise Deubiquitinierung, wodurch die Abundanz von Dnmt1-
Molekülen während des Zellzyklus kontrolliert wird.   
Interessanterweise zeigen dnmt1 und uhrf1 defiziente ES-Zellen gleichermaßen den Phänotyp 
einer genomischen Hypomethylierung. Darüber hinaus zeigt Dnmt1 eine diffuse Verteilung 
im Kern von uhrf1-/- ES-Zellen, was auf eine Rolle von Uhrf1 bei der Rekrutierung von 
Dnmt1 zu hemimethylierten CpG-Stellen hinweist. Zum näheren Verständnis des 
Mechanismus der Dnmt1-Rekrutierung durch Uhrf1, wurden daher die interagierenden 
Domänen ermittelt und eingegrenzt. Mittels spezifischer Dnmt1- und Uhrf1-Mutanten konnte 
die Rolle der Uhrf1-Dnmt1 Wechselwirkung für den Erhalt der DNA-Methylierung als 
notwendig, jedoch nicht ausreichend charakterisiert werden. Basierend auf diesen 
Ergebnissen postulieren wir, dass Uhrf1 die Zugänglichkeit des Chromatins in vivo moduliert 
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und die Rekrutierung von Dnmt1 zu hemimethylierter DNA ermöglicht. Mittels eines dafür 
entwickelten in-vitro DNA-Methylierungstests sollte die Aktivität von Dnmt1 an einer 
künstlich hergestellten Chromatinmatrix bestimmt werden, um diese Hypothese zu testen. 
Interessanterweise ist eine mutierte Form von Dnmt1, der die für die Wechselwirkung mit 
Uhrf1 entscheidenden Aninosäuren fehlt, in Gegenwart von Zellextrakten nicht in der Lage, 
die nackte hemimethylierte DNA zu methylieren, obwohl das isolierte Enzym aktiv ist. Diese 
Ergebnisse deuteten darauf hin, dass in vivo sowohl eine Aktivierung als auch eine Inhibition 
von Dnmt1 stattfindet und Uhrf1 verschiedene Funktionen bei der Erhaltung der DNA-
Methylierung durch Dnmt1 hat.  
Die vorliegende Studie trägt zum Verständnis der Regulationsmechanismen von Dnmt1 durch 
die Interaktionspartner Uhrf1 und Usp7 bei. 
 
 
INTRODUCTION
 
 
1. Introduction 
1.1. DNA methylation in eukaryotic cells 
In addition to the well known four bases, the genome of higher eukaryotes contains 
methylated cytosine residues, which predominately occur in the context of CpG dinucleotide 
sites. The CpG sites are distributed throughout the genome and highly concentrated at gene 
bodies, repetitive elements and promoter regions, so called as CpG island. Approximately 60-
80% of CpG dinucleotides are methylated in mouse and human (Ehrlich et al., 1982; 
Gruenbaum et al., 1981). Cytosine methylation in DNA is established and maintained by a 
family of DNA methyltransferases (Dnmts), the de novo methyltransferases Dnmt3a and 3b 
and the maintenance methyltransferase Dnmt1. In the complex reaction, the target cytosine is 
flipped out of the DNA double helix and forms a covalent complex with the DNA 
methyltransferase through its C6 position. After transfer of a methyl group from the donor of 
S-Adenosyl-L-Methionine (AdoMet) to the C5 position of the nucleobase, the enzyme is 
released by β-elimination.  
DNA methylation is an important epigenetic modification that in general provides long-term 
gene silencing (Bird, 2002). DNA methylation was implicated in numerous biological 
processes, including genomic imprinting, X chromosome inactivation and transposon 
silencing. DNA methylation controls gene expression in a direct and an indirect manner. The 
direct transcriptional repression mediated by DNA methylation is achieved by preventing 
transcriptional factors binding to their recognition sites. Most mammalian transcription 
factors are sensitive to CpG methylation in their recognition sequence, such as c-Myc, E2F 
and NF-kB (Prendergast et al., 1991; Di Fiore et al., 1999; Bednarik et al., 1991). The indirect 
mechanism of transcriptional repression involves methylation readers, the methyl CpG 
binding proteins (MBDs) or the SRA proteins (Uhrf1/2), which induce the formation of silent 
chromatin (Fuks, 2005; Fatemi and Wade, 2006; Bostick et al., 2007; Papait et al., 2007; 
Sharif et al., 2007).  
Additionally, DNA methylation was shown to cooperate with dynamic histone modifications 
including methylation, ubiquitination, acetylation and phosphorylation, to regulate the 
expression of individual genes. 
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1.1.1. DNA methyltransferases 
Dnmt3 family 
Dnmt3a and 3b are two closely related de novo methyltransferases (Fig. 1) and responsible 
for generating DNA methylation patterns during gametogenesis and early embryonic 
development (Okano et al., 1999; Kaneda et al., 2004). They are highly conserved and have a 
similar organization with a C-terminal catalytic domain and an N-terminal regulatory domain. 
The catalytic domain takes a folding similar to bacterial DNA methyltransferases. In the 
regulatory domain, a proline-tryptophan-proline motif (PWWP) is involved in functional 
specialization of these enzymes. The PWWP domain was shown to bind the trimethylated 
histone H3K36 and target Dnmt3a and 3b to pericentromeric heterochromatin (Ge et al., 2004; 
Dhayalan et al., 2010). A crystal structure suggested that the PWWP domain of Dnmt3b can 
bind to DNA as well through its basic surface (Qiu et al., 2002). Hence, the methylation of 
major satellite repeats was abolished by disruption of the PWWP domain (Chen et al., 2004).  
 
Figure 1. Schematic representation of the domain structure of the Dnmt3 family and the subcellular 
localization mediated by its individual regulatory subdomains. 
Dnmt3 family harbors a conserved catalytic domain and a regulatory domain. The PWWP domain of Dnmt3a 
and 3b can recognize trimethylated histone H3K36 and target the proteins to heterochromatin (Ge et al., 2004; 
Dhayalan et al., 2010). The image shows the cellular localization of endogenous Dnmt3a stained by using an 
anti-Dnmt3a antibody. In addition, the functional PHD finger in the regulatory domain can bind to the N-
terminal histone H3 only when lysine 4 was unmethylated (Jia et al., 2007; Otani et al., 2009). 
 
Another functional domain in the N-terminal part is the plant homeodomain (PHD) finger，
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which mediates the interactions with transcriptional repressors, histone deacetylases and 
histone methyltransferases (HMTs). As readers of histone modifications, the PHD fingers of 
Dnmt3a and 3b specifically recognize unmethylated histone H3K4 and might link DNA 
methylation and histone modifications (Otani et al., 2009). 
Dnmt3a and dnmt3b are highly expressed in undifferentiated embryonic stem cells (ESCs) 
but down-regulated in differentiated somatic cells (Okano et al., 1998b) suggesting that 
Dnmt3a and 3b are highly active in ESCs and early embryos. Mice lacking dnmt3a died at 
about four weeks of age, indicating that Dnmt3a is not required for early development and 
may methylate a set of sequences critical for postnatal development. Dnmt3a specifically 
mediates the methylation of imprinted genes in germ cells. Dnmt3a conditional mutant 
females in germ line lack methylation of allele-specific expression at maternally imprinting 
genes, whereas the mutant males show hypomethylation at two of three paternally imprinting 
genes (Kaneda et al., 2004). Unlike dnmt3a null mice, ablation of dnmt3b is embryonic lethal 
at embryonic days E14.5-18.5, implicating that Dnmt3b plays an important role during early 
development. DNMT3b specifically methylates the centromeric minor satellite repeats in 
ESCs and is involved in a human immunodeficiency, centromeric instability, facial anomalies 
(ICF) syndrome, which is caused by mutations in the C-terminal domain of DNMT3b (Xu et 
al., 1999; Hansen et al., 1999). Loss of DNMT3b activity in ICF syndrome leads to a 
reduction of DNA methylation only at specific repeated sequences and CpG islands in the 
inactive X chromosome in females. In addition, Dnmt3a and 3b form a hetero-complex in 
vivo to mediate the silencing of transcription factors oct4 and nanog during ESCs 
differentiation (Li et al., 2007). 
The third member of Dnmt3 family is Dnmt3L, which is essential for the methylation of 
maternally imprinted genes (Hata et al., 2002; Bourc’his et al., 2001). Structurally, Dnmt3L 
only possesses a short N-terminal regulatory domain and a catalytic domain (Fig.1). Due to 
the lack of several conserved residues required for methyltransferase activity, Dnmt3L is not 
able to catalyze methyl group transfer. However, Dnmt3L interacts and colocalizes with 
Dnmt3a and 3b during early embryonic development and stimulates their activity (Hata et al., 
2002; Xie et al., 2006). Additionally, Dnmt3a and 3b coordinately regulate Dnmt3L 
expression by methylating the promoter of dnmt3l (Hu et al., 2008). Crystallographic studies 
revealed that Dnmt3L recognizes the N-terminal tail of histone H3 only when lysine 4 is 
unmethylated and induces de novo DNA methylation by recruitment and activation of 
Dnmt3a2, a variant of Dnmt3a (Jia et al., 2007). Dnmt3l knockout mice failed to establish the 
maternal methylation imprints in oocytes, but DNA methylation of most sequences is not 
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affected, suggesting that other mechanisms may exist to regulate the activity of Dnmt3a and 
3b (Bourc’his et al., 2001; Ooi et al., 2007).   
Dnmt2 
Dnmt2 is a relatively small protein and lacks the N-terminal regulatory domain present in 
Dnmt1 and Dnmt3 families. Dnmt2 was discovered by Okano et al in 1998, but no 
methyltransferase activity towards DNA was detected (Okano et al., 1998). However, a 
crystal structure of human DNMT2 complex containing S-adenosyl-L-homocysteine 
(AdoHcy) showed that Dnmt2 possesses DNA-binding property (Dong et al., 2001) and 
might have very weak DNA methyltransferase activity (Hermann et al., 2004). Most 
importantly, Dnmt2 was shown to methylate aspartic acid transfer RNA (tRNAasp; Goll et al., 
2006). Therefore it is controversial question whether Dnmt2 has DNA methyltransferase 
activity. 
Dnmt1 
Dnmt1 is the first discovered mammalian DNA methyltransferase and responsible for 
inheritance of DNA methylation patterns after DNA replication (Bestor et al., 1988). 
Although homozygous ESCs lacking dnmt1 show a four-fold reduction in global DNA 
methylation, the mutant cells are viable and have no obvious abnormalities with growth rate 
and morphology (Li et al., 1992; Lei et al., 1996), suggesting that DNA methylation is not 
required for self proliferation of ESCs. However, dnmt1 null embryos showed a delayed 
development and died at mid-gestation stage, implicating that DNA methylation is 
indispensable for early embryonic development. 
Dnmt1 is a relatively large protein comprising an N-terminal regulatory domain in addition to 
the C-terminal catalytic domain, which contains all the conserved motifs for DNA 
methyltransferase activity. The N-terminal domain constitutes two thirds of the molecule, 
which contains different functional subdomains: a proliferating cell nuclear antigen (PCNA) 
binding domain (PBD), a heterochromatin targeting sequence (TS), a CXXC-type zinc finger 
domain and two Bromo-Adjacent Homology domains (BAH1 and BAH2, Fig. 2). The N-
terminal domain of Dnmt1 is linked to the catalytic domain by seven glycine-lysine repeats, 
(KG)7. PCNA targets Dnmt1 to replication sites in vivo through the interaction with the PBD 
domain (Chuang et al., 1997; Leonhardt et al., 1992). Dnmt1 is recruited to DNA repair sites 
by PCNA to restore DNA methylation patterns (Mortusewicz et al., 2005). The TS domain is 
required for recruitment of Dnmt1 to pericentric heterochromatin in late S phase and G2 
phase (Easwaran et al., 2004) and mediates dimerization of Dnmt1 (Fellinger et al., 2009). 
Recently, the TS domain was reported to play a role in autoinhibition of Dnmt1 activity by 
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virtue of binding DNA (Syeda et al., 2011; Takeshita et al., 2011). The BAH domain might be 
involved in protein-protein interaction. Under the control of the N-terminal regulatory 
domain, Dnmt1 shows a preferential binding for hemimethylated DNA in contrast to Dnmt3 
enzymes. 
 
Figure 2. Schematic representation of the domain structure of Dnmt1 and subcellular localization 
mediated by its individual regulatory subdomains during the cell cycle 
Dnmt1 comprises a regulatory domain and a catalytic domain. The regulatory domain harbors several functional 
subdomains: PBD (proliferating cell nuclear antigen binding domain); TS domain (the targeting sequences); 
ZnF domain (CXXC type zinc finger) and BAH domains (bromo-adjacent homology domains). The PBD-
mediated interaction with PCNA targets Dnmt1 to the replication machinery during S phase while the TS 
domain targets Dnmt1 to pericentric heterochromatin during late S and G2 phases. Images show the localization 
of GFP-Dnmt1 during S and G2 phase. The ZnF preferentially binds to unmethylated CpG (Frauer et al., 2009). 
The methylation activity of Dnmt1 is regulated by the N-terminal regulatory domain. 
 
Dnmt1 is ubiquitously expressed and it has different translational start points that lead to 
different splice variants. In somatic cells, mouse Dnmt1 comprises 1620 amino acids. A short 
isoform of Dnmt1, which lacks the first 118 amino acids of the somatic form, is specifically 
expressed during oocytes growth and maturation, and also during preimplantation 
development (Carlson et al., 1992; Gaudet et al., 1998; Hirasawa et al., 2008; Howell et al., 
2001). The oocyte specific variant of Dnmt1 (Dnmt1o) was shown to transiently translocate 
from cytoplasm to nucleus at the 8-cell stage during early embryonic development (Carlson 
et al., 1992; Cardoso and Leonhardt, 1999), where it maintains genomic imprinting. Dnmt1o 
protein is more stable than the somatic form Dnmt1 (Ding and Chaillet, 2002), possibly due 
to lacking the first 118 amino acids, which are suggested to comprise ubiquitination sites 
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(Agoston et al., 2005).  
1.1.2. Dynamics of DNA methylation 
DNA methylation is a stable but not irreversible epigenetic mark. Although the molecular 
mechanism of DNA demethylation is poorly understood and the enzymes are so far not 
identified, DNA methylation reprogramming was already observed during early mammalian 
embryogenesis and gametogenesis (Mayer et al., 2000; Monk et al., 1987). The first phase of 
methylation reprogramming occurs within 4-8 hours after fertilization, in which methylation 
patterns in the paternal genome are erased except for imprinted loci and repetitive elements. 
After implantation, DNA methylation patterns are reestablished by Dnmt3a and 3b. Most 
previous studies suggest that the genome wide demethylation observed after fertilization 
occurs actively, implicating the presence of demethylating enzymes that can actively remove 
either the methyl group from the methylated cytosine or the whole nucleotide. The second 
phase of demethylation occurs before implantation and is replication-dependent process, that 
is, by the lack of maintenance DNA methyltransferase following DNA replication and cell 
division (Morgan et al., 2005). Consistent with this observation, it was reported that the 
maternally contributed maintenance methyltransferase Dnmt1 is excluded from nucleus 
during early embryonic development (Carlson et al., 1992; Cardoso and Leonhardt, 1999).  
Concerning the mechanism of demethylation, several mechanisms suggested: (1) direct 
removal of the methyl group from 5-methylcytosine (5mC), (2) direct removal of 5mC by a 
glycosylase, followed by DNA repair machinery to replace 5mC with cytosine, (3) 
deamination of 5mC to thymine, subsequent removal and repair. The deamination of 5mC 
catalyzed by the cytidine deaminase family (Activation Induced deaminase and Apolipo-
protein B RNA-editing catalytic component-1) is the first step for DNA demethylation, in 
which an intermediate G:T mismatch is generated. Subsequently, the enzymes responsible for 
DNA repair are recruited to the mismatch sites. DNA demethylation through DNA repair 
mechanisms was first described in mammalian cells by Jost et al, who reported an enzymatic 
system which replace 5mC by cytosine (Jean Pierre Jost, 1993). Later, thymine DNA 
glycosylase (TDG) was proposed as the enzyme responsible for replacing the mismatch 
nucleotide with cytosine (Zhu et al., 2000). Moreover, Dnmt3a and 3b were found to directly 
participate in active demethylation of 5mC through deamination and interaction with TDG 
(Li and Zhou et al., 2007; Metivier et al., 2008). This interaction between DNA 
methyltransferases and TDG can stimulate glycosylase activity. It is surprising that Dnmt3a 
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and 3b possess two opposite enzymatic activities. Gadd45 (growth arrest and DNA damage 
inducible protein 45α) protein family is also involved in DNA demethylation by inducing the 
nuclear excision repair system (Rai et al., 2008; Jirichy and Menigatti, 2008; Schmitz et al., 
2009; Barreto et al., 2007).  
Recently, it was reported that the mammalian genome contains a novel modification, 5-
hydroxymethylcytosine (5hmC) (Tahiliani et al., 2009), which results from oxidation of 5mC 
by Tet proteins. 5hmC is supposed to be an intermediate in the DNA demethylation process, 
which may directly be dealkylated resulting in cytosine (Guo et al., 2009; Liutkeviciute et al., 
2009). Additionally, by tracking the paternal DNA methylation state in live zygotes that were 
treated with siRNA (Okada et al., 2010), the elongator complex component Elp3 (or KAT9) 
was supposed to participate in paternal genomic DNA demethylation.  
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1.2. Regulation of Dnmt1 
The maintenance of DNA methylation is a complex process, including the recognition of 
hemimethylated DNA substrate, binding of methyl group donor, formation of a covalent 
complex, transfer of a methyl group to cytosine and release from the covalent complex. The 
characterization of Dnmt1 and the identification of its functional regulators were the major 
area of study in the past two decade.  
1.2.1. Characterization and functional analysis of Dnmt1 
According to bioinformatic analysis, Dnmt1 was proposed to have evolved by fusion of two 
or more ancestral genes for controlling DNA methyltransferase activity (Margot et al., 2000). 
Whereas the purified C-terminal domain of Dnmt3a and 3b still possess the ability to transfer 
methyl group to DNA substrate, the isolated C-terminal domain of Dnmt1 is not sufficient for 
enzymatic activity (Fig. 3a), neither alone nor in combination with other single domains 
(Fatemi et al., 2001). Using deletion analysis, a large part of the N-terminal domain (NTD) 
was reported to be required for enzymatic activity of Dnmt1 (Zimmermann et al., 1997; 
Aubol et al., 2003; Araujo et al., 2001; Margot et al., 2000). These results suggest that the 
enzymatic activity of Dnmt1 is under control of the N-terminal regulatory domain of the 
enzyme. 
In contrast to prokaryotic DNA methyltransferases, Dnmt1 shows a preferential binding for 
the DNA substrates containing hemimethylated CpG sites under the regulation of the NTD. 
The preference rate was investigated by different groups with variable results ranging from 2 
to 200 fold (Fatemi et al., 2001; Jeltsch et al., 2006), depending on the DNA template and 
conditions used in the assay. Recently, a novel non-radioactive assay for DNA 
methyltransferase activity and DNA binding was developed and showed an averaged 
preference rate of 15-fold for hemimethylated DNA (Frauer et al., 2009). Interestingly, the 
preferential binding of bacterial DNA methyltransferase HhaI for hemimethylated DNA was 
increased to 2.5-fold by fusing NTD of Dnmt1 (Pradhan et al., 2000). However, the binding 
affinity is not comparable with Dnmt1, suggesting that the region responsible for substrate 
recognition might reside not only in the regulatory domain, but also in the catalytic domain. 
14 
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Figure 3. Regulation of Dnmt1 activity by its N-terminal regulatory domain 
a) Isolated catalytic domain of Dnmt1 cannot methylate DNA substrates containing the hemimethylated CpG 
sites. b) Dnmt1 possesses a preferential binding and activity for the hemimethylated DNA under control of the 
N-terminal regulatory domain. In addition, Dnmt1 shows the methylation activity toward unmethylated DNA by 
activation of fully methylated DNA. c) The linker between the CXXC and BAH1 domains could hold the 
unmethylated DNA away from catalytic center to prevent de novo methyltransferase activity of Dnmt1. It can 
also be speculated that an unknown protein might reposition the linker to release the autoinhibition.  
 
In addition to methylate hemimethylated DNA, Dnmt1 has de novo methyltransferase activity 
in vitro (Gowher et al. 2005). Dnmt1 mediates de novo methylation of CpG islands in human 
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cells and is proposed to be responsible for erroneous hypermethylation in cancer cells (Jair et 
al., 2006). Regarding whether Dnmt1 could methylate unmethylated DNA, Bestor et al 
initially showed that the cleavage between N- and C-terminal domains caused a large 
stimulation of the initial velocity of methylation on unmethylated DNA without changing 
methylating rate of hemimethylated DNA, demonstrating that the NTD may be an intrinsic 
inhibitor of de novo methylation activity of Dnmt1 (Timothy H. Bestor, 1992). Furthermore, 
an allosteric activation mechanism to control de novo methyltransferase activity of Dnmt1 
was suggested (Fig. 3b; Fatemi et al., 2001), in which Dnmt1 is stimulated to methylate 
unmodified cytosine by binding fully methylated DNA. The allosteric activation of Dnmt1 is 
mediated by its CXXC domain, suggesting that the binding of methylated DNA triggers a 
conformational change resulting in access of Dnmt1 to unmethylated DNA (Fatemi et al., 
2001). Furthermore, the CXXC domain was observed to directly interact with the catalytic 
domain and might be act as an intrinsic inhibitor for controlling de novo methyltransferase 
activity of Dnmt1. However, complementation of dnmt1-./- ESCs with Dnmt1∆CXXC argues 
against the speculation that the CXXC domain function in restraining Dnmt1 
methyltransferase activity on unmethylated DNA (Frauer et al., 2011; Song et al., 2010). A 
crystallographic study of Dnmt1-DNA complex revealed that Dnmt1 binds unmethylated 
DNA by the CXXC domain, but the linker between the CXXC and BAH1 domain blocks the 
catalytic center of the C-terminal domain and inhibits de novo methylation activity (Fig. 3c; 
Song et al., 2010). In addition, the loop of the BAH2 domain interacts with the target 
recognition domain (TRD), positioning the TRD in a retracted position and preventing it from 
access to DNA major groove (Song et al., 2010). Basing on the crystal structure studies, it can 
be speculated that the linker between the CXXC and BAH1 domains might be repositioned 
by potential interaction partners, which activate the de novo methylation activity of Dnmt1. 
1.2.2. Regulation by posttranslational modifications 
Posttranslational modifications often modulate the functions of target proteins by affecting 
their activity, localization, turnover and interactions with other proteins. So far most of the 
usual modifications were discovered on Dnmt1, including phosphorylation, methylation, 
acetylation, sumoylation and ubiquitination (Fig. 4a). 
Dnmt1 can be phosphorylated at Ser140, Ser146 and Ser515 (Sugiyama et al., 2010; Goyal et 
al., 2007; Esteve et al., 2010). Phosphorylation of Dnmt1 at Ser515 is required for the 
intramolecular interaction between the N and C-terminal domains, which is essential for 
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enzymatic activity. In contrast to the modification of Ser515, phosphorylation of Dnmt1 at 
Ser146 by casein kinase 1δ/ε was reported to decrease DNA binding affinity. Recently, also 
sumoylation of human DNMT1 was observed (Lee et al., 2009). Sumoylated DNMT1 shows 
a stronger catalytic activity on genomic DNA compared with unmodified form in vitro. 
Interestingly, the posttranslational modifications were shown to regulate Dnmt1 function in a 
cross talk manner during the cell cycle. One example is the control of DNMT1 abundance by 
a cross talk of methylation and phosphorylation during S phase and G2 phase (Fig. 4b). 
DNMT1 associates with a histone methyltransferase SET7, which catalyzes the addition of a 
methyl group to Lys142 (Esteve et al., 2010; Esteve et al., 2009). Methylation at Lys142 
controls DNMT1 stability through an ubiquitination-dependent pathway. Furthermore, 
Ser143 of DNMT1 was identified to be phosphorylated by AKT1 kinase (Esteve et al., 2010). 
The methylation of Lys142 and phosphorylation of Ser143 exist in a mutually exclusive 
manner, and show different patterns during the cell cycle. Lys142 methylation enriches in the 
late S and G2 phases, whereas phosphorylated DNMT1 peaks in early and mid S phases. 
These results suggest that DNMT1 is stabilized by phosphorylation during early and mid S 
phase so that it can follow the fast DNA replication. After cells enter late S phase, DNMT1 
degradation is activated by methylation of Lys142. These results reveal a dynamic regulation 
of DNMT1 protein level during the cell cycle, which is mediated by a cross-talk of 
methylation and phosphorylation. In addition, Dnmt1 was also observed to interact with a 
histone demethylase Lsd1, which catalyze the removal of a methyl group from Lys1096 and 
stabilize Dnmt1 (Wang et al., 2009).  
In addition, a mechanism for controlling DNMT1 function by a cross talk of acetylation and 
ubiquitination was reported. DNMT1 stability is regulated by acetylation and ubiquitination 
during the cell cycle, which is mediated by the coordinated action of several DNMT1-
associated proteins (Du et al., 2010; Bronner et al., 2011). 
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Figure 4. Dnmt1 abundance regulated by posttranslational modifications during the cell cycle 
a) Posttranslational modifications of Dnmt1. Dnmt1 was shown to be modified by phosphorylation at lysine 140 
(correspond to Lys143 in human DNMT1) and Lys515, by methylation at Lys139 (correspond to Lys142) and 
Lys1096.  In addition, Dnmt1 was also reported to be modified by acetylation, sumoylation and ubiquitination. 
The acetylation, sumoylation and ubiquitination sites are so far not mapped, but were narrowed down to some 
regions of Dnmt1. 
b) Dnmt1 may coordinately be controlled by Akt1, Usp7 and HDAC1 during early and mid S phases to get a 
stable form of phosphorylated Dnmt1. When cells enter late S phase, Dnmt1 in turn strongly interacts with 
Uhrf1, Tip60 and Set7/9 to activate its degradation through an ubiquitination pathway.  
 
During early and mid S phase, DNMT1 shows strong interaction with histone deacetylase 1 
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(HDAC1) and the deubiquitinase HAUSP (herpes virus-associated ubiquitin-specific 
protease), which catalyze the removal of acetyl and ubiquitin groups from DNMT1, 
respectively, and stabilize DNMT1. In late S phase, the E3 ligase UHRF1 and 
acetyltransferase (HAT) Tip60 interact with DNMT1 counteracting the effect of HDAC1 and 
HAUSP, marking DNMT1 for proteasomal degradation. In addition, the expression analysis 
of Tip60 and HDAC1, as well as UHRF1 and HAUSP during the cell cycle, suggest that 
DNMT1 might be initially acetylated, subsequently triggering the degradation of DNMT1 
through the ubiquitin pathway (Du et al., 2010). 
 
1.2.3. Regulation of Dnmt1 by interacting factors 
Dnmt1 has been extensively characterized for two decades. Several proteins were covered to 
associate with Dnmt1 and regulate its catalytic activity, substrate specificity and sequence 
targeting (Table 1). Interacting proteins link Dnmt1 to diverse biological pathways, like the 
cell cycle regulation, tumorigenesis, DNA repair and chromatin structure, implicating Dnmt1 
might possess more functions in addition to DNA methylation. The identification and 
characterization of such these interacting factors will help to better understand the mechanism 
of maintenance of DNA methylation.  
PCNA  
Dnmt1 was first shown to associate with the replication machinery, coupling maintenance of 
genomic DNA methylation to DNA replication (Leonhardt et al., 1992). Later, a direct 
interaction between Dnmt1 and the replication processivity factor of proliferating cell nuclear 
antigen (PCNA) was observed and the interaction was mapped to the N-terminal part of 
Dnmt1, amino acids 163 to 174 (PBD domain, Chuang et al., 1997). PCNA is a cofactor of 
DNA polymerase delta and as a homotrimer it contributes to increase the processivity of 
leading strand synthesis during DNA replication (Bravo et al., 1987; Kelman and O'Donnell, 
1995; Wyman and Botchan, 1995). DNA replication is highly processive taking about 0.035 
second per nucleotide (Jackson et al., 1998), whereas the purified recombinant Dnmt1 show 
low turnover rates about 70-450 second per methyl group transfer by in vitro steady-state 
kinetic analysis (Pradhan et al., 1999). It is believed that the transient interaction of Dnmt1 
with PCNA may enhance DNA methylation efficiency so that Dnmt1 can follow the fast and 
processive DNA replication machinery. However, the PBD-mediated association with the 
replication machinery is not strictly required for maintaining DNA methylation by Dnmt1 
(Schermelleh et al., 2007; Spada et al., 2007). 
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Table 1 Dnmt1 interacting proteins and their proposed functions 
Interacting proteins Proposed Functions Reference 
Transcriptional repressors 
DMAP1 
Involved in transcription 
repression and activation 
Component of the NuA4 
histone acetyltransferase 
(HAT) complex 
Rountree et al. 2000; Xin et al. 
2004; Muromoto et al., 2004 
PML-RAR 
Transcriptional regulator of 
retinoic acid (RA) target 
genes; induces gene 
hypermethylation and 
silencing by recruiting 
Dnmt1 
Di Croce et al., 2002 
HESX1 
Required for normal 
forebrain and pituitary 
development in human 
Sajedi et al., 2008 
mSin3a 
A core component of a large 
multiprotein co-repressor 
complex
Xin et al. 2004; Kimura et al., 
2003 
Chromatin modifiers 
HDAC1/2 Histone deacetylases 
Fuks et al., 2000; Xin et al. 
2004; Eden et al., 1998; Jung 
et al., 2007 
Lsd1 Histone demethylase  Wang et al., 2008 
Suv39H1 H3K9me2/3 methyltransferase Fuks et al., 2003 
G9a H3K9me1/2 methyltransferase 
Estève et al., 2006; Kim et al., 
2009; Tachibana et al 2002; 
Peters et al., 2003 
Ezh2 H3K27me3/2 methyltransferase 
Taghavi et al., 2006; Vire et 
al., 2006; Wu et al., 2008; 
Shen et al., 2008 
(Methyl) CpG  binding proteins 
MeCP2 Methylated CpG binding protein 
Hiromichi Kimura and Kunio 
Shiota, 2003 
MBD2/MBD3 Methylated CpG binding protein Tatematsu et al., 2000 
Uhrf1/2 Hemi-methylated CpG binding protein 
Bostick et al., 2007; Sharif et 
al., 2007; Arita et al., 2008; 
Awakumov et al., 2008; Qian 
et al., 2008 
CFP1 
a component of Setd1A and 
Setd1B histone H3K4 
methyltransferase complex; 
unmethylated CpG binding 
protein 
Butler et al., 2008 
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Table 1 Dnmt1 interacting proteins and their proposed functions 
Interacting proteins Proposed Functions Reference 
Tumor suppressors 
p53 Tumor suppressor in many 
tumor types 
Esteve et al., 2005 
hNaa10p Tumor suppressor Stimulate Dnmt1 activity Lee et al., 2010 
BRCA1 Breast cancer-associated gene 1 Shukla et al., 2010 
DNA methyltransferases 
Dnmt3a De novo DNA methylation Fatemi et al., 2002; Kim et al., 2002 
Dnmt3b De novo DNA  methylation Rhee et al., 2002; Kim et al., 2002 
Chromatin binding proteins 
HP1 Heterochromatin binding protein 
Fuks et al., 2003; Smallwood 
et al., 2007 
Cell cycle regulators and DNA replication factors 
PCNA 
Targeting Dnmt1 to replication 
foci 
Associate with p21 
Chuang et al., 1997; 
Leonhardt et al., 1992 
pRb1/2 Cell cycle regulator Jung et al., 2007; Robertson et al., 2000 
E2F 
Transcription factor 
Plays a role in controlling cell 
cycle entry 
Jung et al., 2007; McCabe et 
al., 2006; Robertson et al., 
2000 
Chromatin remodeling factors 
Lsh Chromatin remodeling Myant and Stancheva, 2008 
hSNF2H/Tip5 Chromatin remodeling Zhou and Grummt, 2005 
Others 
PARP1 poly ADP-ribose polymerase 1 Reale et al., 2005; Zampieri et al., 2009 
p23 Chaperone Zhang and Verdine, 1996 
Annexin V Anticoagulant protein Ohsawa et al., 1996 
Daxx Suppression of B cell development and apoptosis Muromoto et al., 2004 
Akt1 Protein phosphorylation Esteve et al., 2010 
 
In addition, PCNA also plays a central role in DNA repair. PCNA serves as a loading 
platform for enzymes involved in DNA synthesis and chromatin assembly. In response to 
DNA damage, PCNA targets Dnmt1 to DNA damage sites for restoration of DNA 
methylation (Mortusewicz et al., 2005).  
Histone methyltransferases: G9a, Ezh2 and Suv39H1  
Mammalian heterochromatin binding protein 1 (HP1) and the major euchromatic histone 
methyltransferase G9a were identified as the proteins interacting with Dnmt1 (Jacobs et al., 
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2002; Tachibana et al 2002; Peters et al., 2003). G9a is responsible for mono- and 
dimethylation of histone H3K9. G9a null ESCs reveal DNA hypomethylation at specific loci 
(Ikegami et al. 2007). Moreover, DNA methylation requires the lysine methyltransferase G9a 
but not its catalytic activity (Dong et al., 2008). The members of HP1 family were shown to 
directly interact with Dnmt1. This interaction results in a functional stimulation of Dnmt1 
methyltransferase activity (Swallwood et al., 2007). Therefore, HP1 could be an adaptor to 
mediate communication between histone and DNA methyltransferases. In the pathway of 
G9a-HP1-Dnmt1, G9a might create a binding platform by methylation of histone H3K9 for 
HP1 α, β and γ, subsequently HP1 proteins are recruited, resulting in an increased DNA 
methylation by stimulation of Dnmt1 activity (Esteve et al., 2006). Dnmt1, G9a and HP1 
form a potential positive feedback loop and functionally interacts each other to coordinate 
gene silencing (Fig. 5a and 5b). 
Polycomb group (PcG)-mediated gene silencing is one of the two major epigenetic repression 
systems. The PcG protein Ezh2, a histone methyltransferase responsible for the methylation 
of histone H3K27, was shown to physically interact with all of the Dnmts. A remarkable 
reduction of DNA methylation at a number of CpG sites within the MYT1 and WNT1 
promoters was observed by depletion of ezh2, suggesting that Ezh2 directly controls DNA 
methylation. The binding of Ezh2 promotes the association of Dnmts with chromatin 
templates. These results suggest a model in which PcG proteins recruit Dnmts to setup DNA 
methylation marks and subsequently recruit PcG proteins to maintain chromatin repression 
state (Vire et al., 2006; Wu et al., 2008; Shen et al., 2008).  
In addition to association with G9a and Ezh2, also Suv39H1 interacts with Dnmt1 and HP1, 
forming a functional complex that mediates gene silencing (Fuks et al., 2003). Suv39H1, HP1 
and Dnmt1 might form a positive feedback loop to repress gene expression. 
HDCA1/2 
Several transcriptional repressive complexes, including the methylated CpG binding proteins 
(MBDs) and the histone deacetylases (HDACs), are involved in DNA methylation. Since an 
interaction between Dnmt1 and MeCP2 was observed, Dnmt1 may play more roles in gene 
silencing in addition to its capacity to methylate hemimethylated CpG sites. A correlation 
between histone hypoacetylation and DNA hypermethylation at transcriptional inactive 
regions was reported (Eden et al., 1998), suggesting that DNA methylation contributes to 
gene repression by inducing decreased levels of chromatin acetylation. 
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Figure 5. The proposed function of Dnmt1 interacting proteins in DNA methylation and the maintenance 
and spread of chromatin structure 
a) Histone methyltransferases G9a and Ezh2 in G9a-HP1-Dnmt1 and Ezh2-HP1-Dnmt1 complexes, respectively, 
might establish methylation of histone H3K9 and H3K27 to maintain and spread higher order chromatin 
structure. b) The methylation marks setup by G9a and Ezh2 recruit chromatin binding proteins like Uhrf1 to 
target site and modulate the accessibility of chromatin for MBD proteins and DNA methyltransferases. c) 
During DNA replication, PCNA, MeCP2 and Uhrf1 are supposed to play a role in recruiting Dnmt1 to the 
replication fork in order to methylate the newly synthesized hemimethylated CpG site. d) After DNA replication, 
HDAC proteins could join the Dnmt1-Uhrf1 complex to spread the repressive chromatin states together with the 
histone methyltransferases, G9a and Ezh2. 
 
 
Indeed, Dnmt1 directly interacts with HDAC1/2 (Fuks et al., 2000; Robertson et al., 2000; 
Rountree et al., 2000). A complex containing Dnmt1, HDCA2 and a Dnmt1 association 
protein DMAP1 was shown to localize at replication foci (Rountree et al., 2000). Whereas 
DMAP1 associates with Dnmt1 throughout S phase, HDCA2 only joins the complex in late S 
phase at heterochromatin regions, which might promote local chromatin condensation by 
establishing a hypoacetylation status of heterochromatin after DNA replication (Fuks et al., 
2000). These observations lead to a speculation that at least two transcriptional repressive 
complexes might exist. In early S phase, when the euchromatin is duplicated, Dnmt1 is 
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targeted to replication foci by PCNA and forms a transcriptional repressive complex with 
DMAP1 (Fig. 5c). HDCA2 is recruited to this complex when cells enter to late S phase (Fig. 
5d), when the heterochromatic regions containing highly methylated DNA and 
hypoacetylated histones are replicated. The selective interaction of DNMT1 with HDAC2 
during S phase may be critical for maintaining these two epigenetically distinct compartments 
of the genome (Rountree et al., 2000). 
Chromatin binding proteins: MBDs and Uhrf1/2 
MBD proteins possess DNA binding affinity, specifically for fully methylated CpG 
dinucleotides (Jorgensen et al., 2004). MBDs contribute to transcriptional gene repression 
and organization of chromatin via association with HDACs (Wade, 2001). Moreover, MeCP2 
is supposed to function in recruiting Dnmt1 to its target sites (Hiromichi Kimura and Kunio 
Shiota, 2003). MeCP2 associates with Dnmt1 through its transcription repressor domain 
(TRD), which is also required for recruitment of HDACs via a co-repressor mSin3a. 
Therefore, HDAC proteins are excluded from the Dnmt1-MeCP2 complex. Considering these 
observations, it is proposed that DNA methylation might be sequential process to mediate 
transcriptional repression. MeCP2 may contribute to DNA methylation by recruiting Dnmt1 
to target sites (Kimura et al., 2003). Subsequently HDACs accumulate at heterochromatin to 
maintain and spread the silent chromatin state by deacetylating histones.  
Uhrf1, also known as ICBP90 in human or Np95 in mouse, was reported in DNA-Dnmt1 
complex. It interacts and colocalizes with Dnmt1 throughout S phase. Uhrf1 shows a weak 
preferential binding for hemimethylated CpG sites, which is mediated by its SRA domain. In 
addition, the tandem Tudor domain of Uhrf1 was shown to bind repressive chromatin mark, 
histone H3K9me3, possibly linking DNA methylation and histone modification (Rottach et 
al., 2009). Deletion of uhrf1 leads to genomic hypomethylation in ESCs and embryos 
(Uemura et al., 2000; Bostick et al., 2007; Papait et al., 2007; Sharif et al., 2007; Achour et 
al., 2008), suggesting that Uhrf1 is an essential cofactor of Dnmt1. After Dnmt1 transferring 
methyl group to cytosine, Uhrf1 might also recruit histone modifiers such as HDAC1 (Unoki 
et al., 2004), the histone methyltransferase G9a and de novo DNA methyltransferases Dnmt3a 
and 3b. 
De novo methyltransferase: Dnmt3a and 3b 
In general Dnmt3a and 3b are de novo methyltransferases which is required for establishment 
of DNA methylation patterns during early embryonic development, whereas Dnmt1 is 
responsible for maintaining DNA methylation patterns after replication. However, this 
categorical distinction does not precisely reflect their biological function, since human 
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DNMT1 was shown to form a complex with de novo methyltransferase DNMT3a and 
DNMT3b to regulate gene expression (Kim et al., 2002). In addition, Dnmt3a and 3b are 
required for proper maintenance of DNA methylation in somatic and ESCs (Liang et al., 2002; 
Chen et al., 2003; Dodge et al., 2005). The maintenance methyltransferase Dnmt1 was also 
observed to participate in de novo DNA methylation through cooperation with de novo 
methyltransferases, either Dnmt3a or Dnmt3b. Dnmt1 activity is enhanced on DNA template 
that is pre-incubated with Dnmt3a in vitro, suggesting that pre-existing methylated DNA 
might activate de novo activity of Dnmt1 (Fatemi et al., 2002). Besides DNMT3a, DNMT1 
was also reported to cooperate with DNMT3b for silencing genes in human cancer cells 
(Rhee et al., 2002). 
 
Recently, a crystal structure of a Dnmt1 fragment reveals that the TS domain inserts into the 
catalytic center of C-terminal domain, suggesting that it could mediate the autoinhibition of 
Dnmt1 (Syeda et al., 2011; Takeshita et al., 2011). Therefore, it is likely that Dnmt1 is 
activated by releasing the autoinhibition by either allosteric conformational changes or 
functional interacting proteins. 
Many Dnmt1 interacting proteins were reported so far, which link DNA methylation and 
chromatin structure. However, additional interacting proteins may exist that reveal novel 
functions in regulation of Dnmt1. Although it is proposed that DNMT1 and DNMT3s 
cooperate to mediate gene silencing in human tumor cells, it remain elusive whether Dnmt1 
possesses de novo methyltransferase activity. Likely, the characterization of new proteins 
interacting with Dnmt1 will shed light on the mechanism of aberrant hypermethylation in 
tumor cells. 
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1.3. Ubiquitination and De-ubiquitination 
Ubiquitin is a small protein with 76 amino acids and highly conserved in all eukaryotes. 
Ubiquitin conjugation to substrate proteins is a highly ordered process (Fig. 6), in which at 
least three enzymes: an ATP-dependent ubiquitin-activating enzyme (E1); an intermediate 
ubiquitin-conjugating enzymes (E2) and a terminal ubiquitin ligase (E3) are required (Fang et 
al., 2004; Pickart et al., 2004; Raymod J. Deshaies and Claudio A.P. Joazeiro, 2009). In some 
cases, ubiquitin elongation factors, also named as E4 enzymes, are involved in the formation 
of multiubiquitin chains (Koegl et al., 1999). Ubiquitin is activated and transferred to the 
cysteine residue in an E1 active site, which requires ATP as an energy source. Then the 
ubiquitin peptide is passed on to the second enzyme, E2. Generally the E2 enzyme interacts 
with a specific E3 partner, which transfers the ubiquitin to target protein by generating an 
isopeptide bond between a lysine of substrate and the C-terminal glycine of ubiquitin. E2 
enzymes share many conserved residues in their catalytic domain, whereas E3 ubiquitin 
ligases only share a few conserved motifs. Therefore, the substrate specificity of 
ubiquitination is mainly determined by the E3 ligase, although E2 enzymes can also play a 
role in substrate selection (Laney et al., 1999). There are two main classes of E3 ligases, the 
proteins with the E6-AP carboxyl terminus (HECT domain) (Huibregtse et al., 1995) and 
proteins with a really interesting new gene (Ring) finger domain (Jackson et al., 2000). E3 
ligases can modify target proteins by mono-ubiquitination via Lys6, Lys11, Lys29, Lys48 and 
Lys63 residues of ubiquitin. In general, Lys48-linked polyubiquitination marks protein for 
degradation by 26S proteasome (Baumeister et al., 1998), whereas Lys63-linked 
monoubiquitination serves as signal in intracellular trafficking, DNA repair and signal 
transduction pathways (Hicke L et al., 2005). 
Ubiquitination is a highly dynamic process and can be reversed by removal of the ubiquitin 
moiety from ubiquitin-conjugated proteins by deubiquitylating enzymes (DUBs). DUBs 
constitute a super family comprising at least five major classes based on sequence and 
structural similarity: the ubiquitin-specific protease (USP, UBP), ubiquitin C-terminal 
hydrolase (UCH), ovarian tumor (OTU), Machado-Joseph disease (MJD), and the jab1/MPN 
domain-associated metalloisopepetidase (JAMM) class. The USP, UCH, OUT and MJD 
families are cysteine peptidases, while the JAMM family is zinc metalloisopeptidases. In 
addition to the function of processing ubiquitin precursors, the major role of DUBs is to 
remove the ubiquitin chain from ubiquitin-conjugated proteins, leading to protein 
26 
 
INTRODUCTION
 
 
stabilization by rescue them from proteasomal degradation (Wilkinson et al.; 1997). Several 
previous studies showed that DUBs participate in the control of histone ubiquitination, which 
is involved in numerous biological important pathways, including cell growth, development, 
chromatin structure and transcriptional regulation (Kim et al., 2003; DiAntonio et al., 2001). 
   
 
Figure 6. Ubiquitin pathway and its proposed functions 
Ubiquitin (ub) is activated by E1 enzyme in the presence of ATP to form a high-energy of ub-adenylate, 
followed by transfer of ub to the catalytic cysteine of the E1. The ub is then transferred to the E2 conjugating 
enzyme via a transthiolation reaction. The ub is ligated to a substrate with the aid of an E3 ligase enzyme. The 
DUBs (deubiquitination enzymes) can remove ub from substrates (Kerscher et al. 2006). Ubiquitination is 
involved in numerous biological important pathways, including cell growth, development and transcriptional 
regulation. 
 
The E1, E2, E3, 26S proteasome and DUBs form a complex ubiquitin proteasomal network 
to balance protein abundance in the cells. Proteins are tagged by a polyubiquitin chain via E1, 
E2 and E3, and subsequently are recognized and degraded by the 26S proteasome. DUBs can 
remove the ubiquitin chains to prevent degradation. The ubiquitin proteasome pathway is a 
major system responsible for removing intracellular proteins, especially mis-folded proteins 
in eukaryotes. 
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1.3.1. Uhrf1, a Ring-type E3 ligase for ubiquitination 
As mentioned above, Uhrf1 is a crucial cofactor of Dnmt1 for maintenance of DNA 
methylation (Bostick et al., 2007; Sharif et al., 2007). Uhrf1 harbors a Ring domain at its C-
terminal part. In vitro, Uhrf1 endows an ubiquitin E3 ligase activity, which is required for the 
growth regulation of tumor cells (Jenkinis et al., 2005). In addition, Uhrf1 is an E3 ubiquitin 
ligase for histone core particles in vitro (Citterio et al., 2004), although the functional role of 
this biochemical activity is still unclear. Recently, Uhrf1 was also shown to mediate the 
ubiquitination of Dnmt1, controlling Dnmt1 stability in coordination with acetylase Tip60 
and histone deacetylase HDAC1 (Du et al., 2010; Achour et al., 2009).  
In addition, a PHD finger of Cys4-His-Cys3 motif (four cysteines, one histidine and three 
cysteines) resides between the tandem Tudor and SRA domains. Generally, the PHD fingers 
comprise approximately 50-80 amino acids and present in more than 100 human proteins. 
Crystal structures reveal that the PHD fingers resemble similar to the Ring fingers, which 
typically have a C3HC4 motif and like the PHD fingers coordinate two zinc ions. The crucial 
difference between PHD and Ring fingers is in their surface areas. The Ring domain contains 
a conserved alpha-helix for E2 enzymes binding, which is absent from the PHD finger. 
However, the PHD fingers of MEKK and MIR were shown to function as ubiquitin E3 
ligases (Lu et al., 2002). Later, structural analysis showed that the zinc finger of MIR looks 
like a Ring rather than a PHD finger and that the PHD finger of MEKK was misclassified as 
the PHD finger (Coscoy et al., 2003). Therefore it is still not fully understood whether the 
PHD finger can also mediate ubiquitination. 
The biological function of PHD fingers was extensively investigated in previous studies. 
Basing on the binding specificity for histone modifications, the PHD finger family can be 
divided into several subgroups. The PHD finger of Dnmt3L was shown to mediate the protein 
binding to unmethylated H3K4 (Jia et al., 2007). In contrast, the PHD finger of nucleosome 
remodeling factor (NURF) can specifically recognize trimethylated histone H3K4 (Wysocka 
et al., 2006) and target the NURF complex to Hox gene promoters during development to 
activate transcription. The PHD finger of ICBP90 was shown to preferentially bind 
trimethylated H3K9 (Karagianni et al., 2008). However, we observed that the PHD finger of 
Uhrf1 does not possess a preferential binding for a peptide containing H3K9me3, but it can 
stimulate the binding affinity of H3K9me3 by the Tudor domain (Pichler et al., 2011). 
Interestingly, Papait et al observed that the PHD domain of Uhrf1 has a function in large-
scale reorganization of pericentric heterochromatin (Papait et al., 2008).  
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1.3.2. Usp7, a ubiquitin specific protease 
Ubiquitin specific protease 7 (Usp7) is one of the deubiquitylating enzymes (DUB) and 
belongs to the ubiquitin-specific protease (USP or UBP) family. It was originally identified as 
protein interacting with the ICP0 of herpes simplex virus, so also named Herpes virus-
associated ubiquitin-specific protease (Hausp) (Everett et al., 1997; Holowaty et al., 2003). 
Usp7 plays an important role in the regulation of stress response pathways, epigenetic 
silencing and the progress of infections by DNA viruses (Fig. 7) (van der Horst et al., 2006; 
van der Knaap et al., 2005; Khoronenkova et al., 2010).  
 
 
Figure 7. Proteins directly and functionally interact with Usp7 
Usp7 interacts with various proteins involved in diverse pathway, like the p53-Mdm2 pathway and gene 
silencing. 
(ICP0: Everett et al., 1997; Holowaty et al., 2003; EBNA1: Holowaty et al., 2003; Foxo4: Van der Horst et al., 
2006; GMP: van der Knaap et al., 2005; p53: Li et al., 2002; Mdm2: Meulmeester et al., 2005; Tang et al., 2010; 
TSPYL5: Epping et al., 2011; Ring1B: de Bie P et al., 2010) 
 
Usp7 comprises 1103 amino acids harboring a catalytic domain, a N- and a C-terminal 
domain. Basing on the bioinformatic analysis, four ubiquitin-like domains reside in the C-
terminal part (Fig. 8; Zhu et al., 2007), which are supposed to mediate protein-protein 
interactions. The C-terminal domain of Usp7 is required for interaction with a regulatory 
protein ICP0, which plays a critical role in the replication-latency balance of herpes simplex 
virus (Everett et al., 1997; Holowaty et al., 2003; Daubeuf et al., 2009). A NMR structure of 
the first Ubl domain was solved (PDB 2KVR), showing a folding similar to ubiquitin-like 
domains. In addition, the C-terminal domain of Usp7 is critical for deubiquitination activity 
(Ma et al., 2010). Usp7 also binds to another viral protein, the EBNA1 protein of Epstein-
Barr virus (EBV), through the N-terminal tumor necrosis factor-receptor associated factor 
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(TRAF)-like domain (Holowaty et al., 2003). To better understand the molecular basis for the 
interaction between Usp7 and its substrates, several crystal structures containing the TRAF 
domain and EBNA1 peptides were solved (Saridakis et al., 2005). The TRAF domain uses an 
eight-stranded beta sandwich fold to create a surface groove, which provides a docking site 
for EBNA1 peptides (PDB 2FOJ).  
Using an affinity purification approach, Usp7 was co-precipitated with p53 (Li et al., 2002). 
Usp7 directly binds to p53 through its TRAF-like domain, suggesting that Usp7 has an 
important role in p53 pathway. Over-expression of Usp7 stabilizes p53 and induces p53-
dependent growth repression and apoptosis. The ablation of usp7 expression was reported to 
have an opposite effect on the protein stability of p53. In addition to p53, other members of 
regulatory proteins in p53-Mdm2 pathway were also reported to interact with Usp7, such as 
Mdm2, MDMX and DAXX (Meulmeester et al., 2005; Tang et al., 2010), suggesting a 
central role of Usp7 in p53-Mdm2 pathway. 
 
 
Figure 8. Schematic representation of Usp7 and solved structures 
Usp7 comprises 1103 amino acids, harboring a tumor necrosis factor-receptor associated factor (TRAF)-like 
domain, a catalytic domain and four ubiquitin like domains (Ub). The crystal structure of TRAF-like domain 
was solved (PBD 2FOJ). The structures of the N-terminal domain comprising both TRAF and catalytic domain 
(PDB 2F1Z) and the first ubiquitin-like domain (PDB 2KVR) are also available in the PDB database. 
 
Besides the regulation of protein stability, Usp7 is also involved in the modulation of 
chromatin structure and gene silencing. Usp7 binds to heterochromatin in Drosophila, 
catalyzing the removal of ubiquitin from monoubiquitinated histone H2B, which is important 
for the epigenetic silencing of homeotic genes. Moreover, the deubiquitination reaction of 
H2B is greatly stimulated through the association of Usp7 with Guanosine 5’-monophosphate 
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synthetase (GMP) (van der Knaap et al., 2005). Recently, Usp7 was reported to associate with 
DNA containing hemimethylated CpG sites by a novel SILAC-based DNA-protein 
interaction screening approach (Mittler et al., 2009). With this screening system, they 
confirmed that two hemimethylated CpG binding proteins Uhrf1 and Dnmt1 were co-
precipitated with a DNA probe. Besides these two methylated CpG binding proteins, Usp7 
was identified in the bound fraction, suggesting that Usp7 might be a component of Dnmt1-
Uhrf1 complexes.  
To elucidate the physiological functions of Usp7 in vivo, Kon et al generated the usp7 
knockout mice (Kon et al., 2010). Mice lacking usp7 show an interesting phenotype with 
early embryonic lethality between embryonic days 6.5 (E6.5) and E7.5, implicating that Usp7 
is essential for early embryonic development in mice. The usp7 knockout embryos exhibit no 
recognizable structures and ESCs are greatly reduced in numbers compared with the wild 
type embryos. These findings suggest that embryonic lethality is caused by abnormal 
proliferation and developmental arrest. 
1.3.3. Transcriptional regulation by ubiquitination and deubiquitination 
In eukaryotic cells, gene expression is modulated at different levels from the transcription 
step to posttranslational modification. Ubiquitination participates in the transcriptional 
regulation either through proteasome dependent or proteasome independent mechanism, 
which involves the modulation of gene expression by histone ubiquitination. 
Although transcriptional regulation and ubiquitin-mediated proteolysis are in general two 
distinct biological processes, several studies have directly connected these two events in the 
control of gene expression (Li et al., 2007; Xu et al., 2004; Liao et al., 2010; Zhang et al., 
2003). Ubiquitin was shown to control messenger RNA synthesis, a process that depends on 
RNA polymerase II and transcription factors. For example, the large subunit of RNA 
polymerase II Rpb1 is ubiquitinated by a HECT domain ubiquitin E3 ligase Wwp2 and 
subsequently degraded by the 26S proteasome (Li et al., 2007). Furthermore, Wwp2 was also 
reported to promote degradation of the transcription factor Oct4 and play a role in controlling 
the pluripotence of human ESCs (Xu et al., 2004; Liao et al., 2010).  
In addition to acetylation, methylation and phosphorylation, histones can also be modified by 
ubiquitination. Previous studies were reported that all the core histones can be the substrate of 
ubiquitination. Ubiquitinated H2A was the first identified (Goldknopt et al., 1975). Later the 
ubiquitination site of H2A was mapped to a highly conserved residue lysine 119 (Nickel BE 
31 
 
INTRODUCTION
 
 
et al., 1989). Furthermore, H2B was also reported to be modified by the addition of ubiquitin 
to its C-terminal region at lysine 120 (both in mammals and S. cerevisiae) (West et al., 1980; 
Thorne et al., 1987). The enzymes responsible for ubiquitination of histone H2B were first 
identified in S. cerevisiae: Rad6 (E2) and Bre1 (E3) (Robzyk et al., 2000; Hwang et al., 2003; 
Wood et al., 2003). In S. cerevisiae, the H2B ubiquitination can be reversed by 
deubiquitinases Ubp8 and Ubp10. In addition to histone H2A and H2B, ubiquitination of 
histone H3 was also observed (Chen et al., 1998; Dover et al., 2002; Liu et al., 2005; Wang et 
al., 2006), but it is not as prevalent as the ubiquitination of H2A and H2B. The ubiquitination 
sites of histone H3 are so far not determined. 
Evidence from previous studies suggests that histone ubiquitination may contribute to gene 
activation (Shema et al., 2008; Espinosa, 2008). For example, Henry et al showed that the 
ubiquitin E3 ligase Bre1 and the deubiquitinase Ubp8, which are the subunits of the 
coactivator complex SAGA, mediate the ubiquitination and deubiquitination of H2B that 
contributing to transcriptional control in yeast (Fig. 9a, Henry et al., 2003). Moreover, the 
ubiquitin conjugation enzyme Rad6 and E3 ligase Bre1 were shown to associate with the 
transcription elongation complex in yeast cells (Xiao et al., 2005). The methylation levels of 
histone H3K4 and H3K36, which correlate with transcriptional active chromatin, are altered 
in yeast mutant with disrupted ubiquitination or deubiquitination of H2B. Furthermore, the 
Rad6 protein, which is a major E2 for the monoubiquitination of H2B in yeast, was shown to 
play an important role in transcriptional activation (Kao et al., 2004). To investigate the 
biological functions of H2B monoubiquitination, Minsky et al generated an antibody specific 
for ubiquitinated H2B and mapped the global distribution of H2B monoubiquitination in the 
genome. Using chromatin immunoprecipitation experiments on human cells, followed by 
microarray analysis they showed the ubiquitinated H2B preferentially associates with the 
highly expressed genes in transcribed regions (Minsky et al., 2008), suggesting that H2B 
ubiquitination correlates with transcriptionally active chromatin. 
Although most studies suggest a positive correlation between transcription and histone 
ubiquitination, an opposite effect was also pointed out. Ring1A and Ring1B are two 
components of polycomb repressive complex 1 (PRC1) and contribute to the ubiquitination 
of H2A in vivo (Wang et al., 2004; de Napoles et al., 2004). 
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Figure 9. Proposed mechanisms of transcriptional regulation by histone ubiquitination 
a) Ubiquitination of H2B mediated by a E3 ligase Bre1, a subunit of SAGA complex, might serve a signal for 
RNA polymerase II binding and activate gene transcription. b) Ring1A, a subunit of polycomb complex 1, 
catalyzes H2A monoubiquitination and cooperates with repressive polycomb complex 1 to mediate gene 
silencing. c) Ubiquitination of histone H2B mediated by ubiquitin-conjugation enzyme Rad6 may be a signal for 
recruiting Set1 and Dot1, the histone H3K4 and H3K79 methyltransferases respectively, to chromatin (Sun and 
Allis, 2002; Nakanishi et al., 2009). In yeast, the methylation of histone H3K4 might recruit other transcription 
factors and in turn regulate gene silencing. COMPASS means the Complex Proteins Associated with Set1.  
 
Ring1B null ESCs reveal a global reduction of the ubiquitinated H2A. Additionally, Ring1B 
is thought to recruit PRC1 proteins to the X chromosome and mediate its silencing in female 
mammals (Fig. 9b; Fang et al., 2004). Ring1A associates with another component of PRC1 
Bmi-1 to positively regulate the ubiquitination of H2A (Cao et al., 2005). A significant 
reduction of H2A ubiquitination and up-regulation of the Hox13 gene were observed by 
deletion of Bmi-1. These results suggest that the ubiquitination of H2A participates in PcG-
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dependent gene silencing pathways. 
Concerning the mechanism how histone ubiquitination and deubiquitination affect 
transcription, a possible explanation is that the ubiquitination of histone influences higher 
order chromatin structure, and in turn affect gene transcription. However, since ubiquitin is 
about half of the size of core histones, it likely sticks out of the nucleosome core particle. 
Thus, a reasonable speculation is that the ubiquitination state of histones may serve as a 
binding site for other factors and in turn modulate gene activation or repression (Sridhar et al., 
2007). A connection between the ubiquitination of histone H2B and the methylation of 
histone H3K4 and H3K79 was reported (Fig. 9c; Sun and Allis, 2002; Nakanishi et al., 2009), 
that implicates a regulatory pathway wherein Rad6-mediated H2B ubiquitination regulates 
Set1-catalyzed H3K4 methylation and Dot1-mediated H3K79 methylation and subsequently 
regulates gene silencing. In this pathway, the ubiquitination of H2B (Lys123) is prerequisite 
for the methylation of H3K4, as the H3K4 methylation is abolished when lysine 123 is 
mutated to arginine, whereas the ubiquitination of H2B is not affected when lysine 4 of H3 is 
mutated to arginine. However, an opposite evidence was shown that methylation of H3K4 
and H3K79 is not strictly dependent on the ubiquitination of histone H2B (Lys123; Foster et 
al., 2009). In addition to the cross-talk between the ubiquitination of H2B and the 
methylation of histone H3K4, H2A deubiquitination mediated by deubiquitinase Ubp-M, is 
critically involved in the cell cycle progression and gene expression through communication 
with phosphorylation of histone H3S10 (Joo et al., 2007) 
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1.4. Aims of the work 
Dnmt1 has been extensively studied over the past two decades. However, it is still not fully 
understood how Dnmt1 is regulated by intra- and intermolecular interactions. Therefore, the 
main objective of this PhD thesis was to identify and study the regulation of Dnmt1 by novel 
interactions. For this purpose, an ES cell line stably expressing GFP-Dnmt1 was generated 
and used to identify potential interacting proteins of Dnmt1. Additionally, the essential 
cofactor Uhrf1 was supposed to recruit Dnmt1 to DNA target sites. Basing on this 
observation, I was interested in understanding the mechanism of Dnmt1 recruitment by Uhrf1. 
To clarify this question, several mutants of Uhrf1 were generated and used to functionally 
characterize the domains involved in recruiting Dnmt1 to hemimethylated CpG sites.  
Besides the intermolecular interactions, we were also interested in characterizing the 
regulation of Dnmt1 by intra-molecular interactions. In particular, we aimed to understand 
the role of CXXC domain in the regulation of Dnmt1. This highly conserved CXXC zinc 
finger domain is also present in the histone methyltransferase MLL and the methyl-CpG 
binding protein MBD1. Since the CXXC zinc finger of MLL and MBD1 was shown to 
preferentially bind unmethylated DNA. Thus, it is likely that the CXXC domain of Dnmt1 
has a function in the discrimination of hemimethylated CpG sites generated after DNA 
replication. 
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2. Results 
 
 
 
 
 
 
 
 
 
 
2.1. USP7 AND UHRF1 CONTROL UBIQUITINATION AND STABILITY 
OF THE MAINTENANCE DNA METHYLTRANSFERASE DNMT1 
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Usp7 and Uhrf1 Control Ubiquitination and Stability of
the Maintenance DNA Methyltransferase Dnmt1
Weihua Qin, Heinrich Leonhardt,* and Fabio Spada*
Department of Biology II, Center for Integrated Protein Science Munich (CIPSM),
Ludwig Maximilians University Munich, Großhaderner Str. 2, 82152 Planegg-Martinsried, Germany
ABSTRACT
In mammals Dnmt1 is the DNAmethyltransferase chieﬂy responsible for maintaining genomic methylation patterns through DNA replication
cycles, but how its maintenance activity is controlled is still not well understood. Interestingly, Uhrf1, a crucial cofactor for maintenance of
DNA methylation by Dnmt1, is endowed with E3 ubiquitin ligase activity. Here, we show that both Dnmt1 and Uhrf1 coprecipitate with
ubiquitin speciﬁc peptidase 7 (Usp7), a de-ubiquitinating enzyme. Overexpression of Uhrf1 and Usp7 resulted in opposite changes in the
ubiquitination status and stability of Dnmt1. Our ﬁndings suggest that, by balancing Dnmt1 ubiquitination, Usp7 and Uhrf1 ﬁne tune Dnmt1
stability. J. Cell. Biochem. 112: 439–444, 2011.  2010 Wiley-Liss, Inc.
KEY WORDS: HAUSP; NP95; PROTEIN STABILITY; UBIQUITINATION; DNA METHYLATION
B y affecting transcriptional activity DNA methylation playskey roles in development and differentiation, genomic
imprinting, X chromosome inactivation and genome stability
[Bird, 2002]. In higher eukaryotes only the C5 position of cytosine
is enzymatically methylated and this is mostly, but not exclusively,
in the context of CpG dinucleotides. A family of mammalian
cytosine-C5 DNA methyltransferases (Dnmts) establishes and
maintains genomic patterns of cytosine methylation [Goll and
Bestor, 2005; Spada et al., 2006]. The best characterized roles for
these enzymes are establishment of DNA methylation patterns
during gametogenesis and development by Dnmt3a and 3b and
maintenance of genomic methylation after replication by Dnmt1
[Leonhardt et al., 1992; Li et al., 1992; Lei et al., 1996; Okano et al.,
1999].
Dnmt1 is a relatively large protein with an N-terminal regulatory
region spanning two thirds of the molecule and a C-terminal
catalytic domain connected by seven lysyl–glycyl dipeptide repeats
referred to as (KG)7 linker [Margot et al., 2000]. The N-terminal
region comprises a proliferating cell nuclear antigen (PCNA) binding
domain (PBD), a heterochromatin targeting sequence (TS), a CXXC-
type zinc ﬁnger domain and two bromo-adjacent homology
domains (BAH1 and 2). PCNA targets Dnmt1 to replication and
DNA repair sites in vivo to restore DNA methylation during the
respective processes [Leonhardt et al., 1992; Chuang et al., 1997;
Easwaran et al., 2004; Mortusewicz et al., 2005]. The methylation
efﬁciency is enhanced by the association of Dnmt1 with the
replication machinery, but this association is not strictly necessary
to maintain genomic methylation [Schermelleh et al., 2007; Spada
et al., 2007]. The TS domain has been shown to mediate recruitment
of Dnmt1 to pericentric heterochromatin from the ensuing of its
replication during mid S phase through G2 phase [Easwaran et al.,
2004]. The N-terminal region of Dnmt1 is subject to various types
of post-translational modiﬁcation (PTM), several of which were
involved in the control of Dnmt1 stability. It has been proposed
that the phosphatidylinositol 3-kinase/protein kinase B pathway
targets Dnmt1 and increases its stability [Sun et al., 2007]. The
methylation state of several lysine residues of Dnmt1 was reported
to be controlled by histone methyltransferase SET7 and histone
demethylase LSD1, the methylated state being prone to proteosomal
degradation [Esteve et al., 2009; Wang et al., 2009]. Finally, Dnmt1
protein stability was shown to be controlled also by ubiquitin
mediated proteosomal degradation, although the enzymes control-
ling the ubiquitination state of Dnmt1 have not been reported
[Agoston et al., 2005].
Usp7 (also known as Hausp) belongs to the ubiquitin speciﬁc
peptidase class of deubiquitinating enzymes (DUBs). Genetic
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ablation of Usp7 in mice results in arrest of embryonic development
shortly after implantation (E6.5–7.5) [Kon et al., 2010]. The best
characterized function of Usp7 is the modulation of the p53-Mdm2
pathway as Usp7 deubiquitinates and stabilizes both p53 and Mdm2
[Li et al., 2002, 2004; Meulmeester et al., 2005]. Usp7 was also found
to affect transcriptional activity by removing monoubiquitin from
both the transcription factor FoxO4 and histone H2B. Deubiquitina-
tion of FoxO4 by Usp7 reduced its activity as a transcription factor,
while deubiquitination of H2B by a Usp7-GMP synthetase complex
enhanced both Polycomb-mediated silencing and transcriptional
activation by EBNA1 [van der et al., 2005; van der Horst et al., 2006;
Sarkari et al., 2009].
In the present study we identiﬁed Usp7 as an interacting partner of
Dnmt1 and Uhrf1. We show that, while Uhrf1 promotes ubiquitination
of Dnmt1 and decreases its stability, Usp7 mediates deubiquitination
of both Uhrf1 and Dnmt1 and increases Dnmt1 stability.
MATERIALS AND METHODS
EXPRESSION CONSTRUCTS
Expression constructs for GFP-Dnmt1 (wt, full length), GFP-
Dnmt1D1-171, GFP-Dnmt11-309, GFP-Dnmt11-1111, GFP-Dnmt1310-
629, GFP-Dnmt1630-1111, GFP-Dnmt11124-1620 and HA-ubiquitin
were described previously [Easwaran et al., 2004; Pohl and Jentsch,
2008; Fellinger et al., 2009]. Expression constructs for GFP-
Dnmt1D459-501 and GFP-Dnmt1D651-698 were derived from GFP-
Dnmt1 by overlap extension PCR. To generate the Ch-Usp7
construct the Usp7 coding sequence was ampliﬁed using cDNA
from mouse E14 ESCs as template and subcloned into the pCAG-
Cherry-IB vector [Meilinger et al., 2009]. Expression constructs for
Cherry fusions of the various Usp7 fragments were cloned into
pCAG-Cherry-IB vector by PCR ampliﬁcation. The Ch-Usp7C224S
construct was derived from Ch-Usp7 by overlap extension PCR.
The GFP-Uhrf1 construct was described previously [Meilinger et al.,
2009]. The Uhrf1-Ch construct was derived from the GFP-Uhrf1
construct by standard subcloning procedures. All constructs were
veriﬁed by DNA sequencing.
CELL CULTURE AND TRANSFECTION
HEK293T, BHK, and ESCs were cultured and transfected as described
[Meilinger et al., 2009; Szwagierczak et al., 2010]. The dnmt1/
ESCs used in this study are homozygous for the c null allele [Lei
et al., 1996] For stable complementation with GFP-Dnmt1
transfected dnmt1/ ESCs were selected with 10mg/ml of
blasticidin (PAA) and individual clones were picked manually
and expanded. For the in vivo ubiquitination assay, transfected
HEK293T cells were incubated with medium supplemented with
2mMN-ethylmaleimide (NEM; Sigma) for 30min before harvesting.
For cycloheximide treatment transfected cells were incubated in
medium containing 10mg/ml cycloheximide (Sigma) and harvested
at the indicated time points.
MASS SPECTROMETRY
In-gel digests were performed according to standard protocols.
Brieﬂy, after washing the excised gel slices proteins were reduced by
adding 10mM DTT prior to alkylation with 55mM iodoacetamide.
After washing and shrinking of the gel pieces with 100% acetonitrile,
trypsin (Sequencing Grade Modiﬁed, Promega) was added and
proteins were digested overnight in 40mM ammoniumbicarbonate
at 378C. For protein identiﬁcation 10ml of each sample were ﬁrst
puriﬁed and concentrated on a C18 reversed phase pipette tip
(ZipTip, Millipore). Peptides were eluted with 1ml of a-cyano-4-
hydroxycinnamic acid (Sigma) and directly spotted on a MALDI
sample plate (Applied Biosystems). MALDI-TOF measurements were
then performed on a Voyager-DE STR mass spectrometer (Applied
Biosystems). The resulting spectra where analyzed with the MascotTM
Software (Matrix Science) using the NCBInr Protein Database.
COIMMUNOPRECIPITATION AND F2H ASSAY
GFP fusion pulldowns with the GFP-trap and the F2H assay were
performed as described [Meilinger et al., 2009]. For detection of
ubiquitinated proteins by immunoprecipitation, cells were lysed in
buffer containing 150mMKCl, 50mMTris–HCl (pH7.4), 5mMMgCl2,
1% Triton X-100, 5% Glycerol, 2mM phenylmethyl sulphonyl
ﬂuoride and 2mM Mercaptoethanol and 5mM NEM. After brief
sonication cell lysates were cleared by centrifugation at 48C for
10min and supernatants were incubated with GFP-trap beads
(Chromotek) for 2 h at 48C with gentle rotation. The beads were
then washed three times with lysis buffer and resuspended in SDS–
PAGE sample buffer. The anti-HA mouse monoclonal antibody
12CA5 was used for detection of ubiquitinated proteins. Ch-Usp7 was
detected with either an afﬁnity puriﬁed polyconal antibody speciﬁc
for human USP7 (a gift fromGrigory Dianov, University of Oxford) or
anti-red monoclonal antibody (Chromotek) [Rottach et al., 2008].
Rabbit antisera used for detection of Dnmt1 and Uhrf1 have been
described [Li et al., 1992; Citterio et al., 2004]. The goat anti-Lamin B1
antibody was from Santa Cruz Biotechnology. Horseradish perox-
idase-conjugated secondary antibodies (Sigma) and ECL Plus reagent
(GE Healthcare) were used for chemiluminescent detection.
RESULTS
Usp7 INTERACTS WITH Dnmt1 AND Uhrf1
To identify Dnmt1 interaction partners we established dnmt1/
embryonic stem cell (ESC) lines stably expressing GFP-tagged
Dnmt1 (GFP-Dnmt1). A clone expressing steady state levels of
GFP-Dnmt1 similar to those of the endogenous Dnmt1 in wild-type
ESCs was selected for afﬁnity puriﬁcation of GFP-Dnmt1 using the
GFP-trap [Rothbauer et al., 2008]. Bound proteins were separated by
SDS–PAGE and Usp7 was identiﬁed by MALDI-TOF mass spectro-
metry (Fig. 1A). This was conﬁrmed by immunoprecipition of
GFP-Dnmt1 from the same clone of stably complemented dnmt1/
ESCs and probing of the blot with an anti-USP7 antibody (Fig. 1B).
To test for unspeciﬁc interaction of Usp7 with the GFP tag we
transiently co-expressed GFP or GFP-Dnmt1 with Cherry-tagged
Usp7 (Ch-Usp7) in HEK293T cells and immunoprecipitated protein
complexes with the GFP-trap. Ch-Usp7 coimmunoprecipitated
with GFP-Dnmt1 but not with GFP (Fig. 1C). In addition, we could
not detect interaction of Ch-Usp7 with GFP fusions of the de novo
methyltransferases Dnmt3a and Dnmt3b, further supporting
the speciﬁcity of the interaction between Usp7 and Dnmt1 (Suppl.
Fig. 1).
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Uhrf1 (also known as Np95 in the mouse and ICBP90 in human)
interacts with Dnmt1 and is a crucial cofactor for maintaining
genomic methylation [Bostick et al., 2007; Sharif et al., 2007].
To investigate whether Usp7 interacts also with Uhrf1 we
immunoprecipitated a Uhrf1-GFP fusion from lysates of cells
coexpressing Ch-Usp7. The latter clearly coprecipitated with Uhrf1-
GFP, indicating that Usp7 forms complexes with both Dnmt1 and
Uhrf1 (Fig. 1D).
MAPPING OF THE INTERACTION BETWEEN Dnmt1 AND Usp7
To deﬁne the domains that are responsible for the interaction
between Dnmt1 and Usp7, we generated several domain and
deletion constructs for both GFP-Dnmt1 and Ch-Usp7 and tested
their interaction by co-immunoprecipitation from transfected cells
and ﬂuorescent two hybrid assay (F2H). In the latter assay a GFP-
tagged bait protein is anchored to a lac operator array inserted in
the genome of BHK cells, so that the array is visible as a spot of
enriched GFP ﬂuorescence in the nucleus. Accumulation of Cherry-
tagged prey proteins at this spot reﬂects the interaction between
prey and bait [Fellinger et al., 2009; Meilinger et al., 2009].
Both methods showed that only the C-terminal region (amino acids
561–1,103) of Usp7, containing four ubiquitin like domains,
strongly interacted with GFP-Dnmt1 and that deletion of the same
region abolished the interaction (Suppl. Fig. 2). In contrast,
individual deletion of several domains in Dnmt1 did not overtly
disrupt the interaction with Usp7, only the deletion of the highly
conserved central part of the TS domain [Fellinger et al., 2009]
resulting in a substantially weaker interaction (Suppl. Fig. 3).
However, the strong interaction detected with the full length Dnmt1
construct was not preserved with any of several Dnmt1 fragments,
including the entire N-terminal region and C-terminal catalytic
domain (Suppl. Fig. 4). These major parts of Dnmt1 are known to
engage in intramolecular interaction required for catalytic activity
[Margot et al., 2000; Fatemi et al., 2001; Pradhan and Esteve, 2003].
Therefore, we tested whether mutation of the (KG)7 linker between
the N-terminal region and the C-terminal catalytic domain of Dnmt1
affects the interaction with Usp7. Substitution of all lysines in the
(KG)7 linker with glutamine residues generating a neutrally charged
(QG)7 linker completely abrogated the interaction with Usp7
(Suppl. Fig. 3). These data suggest that the (KG)7 linker contributes
to the interaction with Usp7 either directly or indirectly, by
mediating a speciﬁc conformation of Dnmt1.
Usp7 REGULATES THE UBIQUITINATION STATUS OF Dnmt1 AND
Uhrf1
DNMT1 was shown to be ubiquitinated in human cell lines [Agoston
et al., 2005]. To determine whether Usp7 affects the ubiqutination
levels of Dnmt1, GFP-Dnmt1 was coexpressed with either
HA-tagged ubiquitin or both HA-ubiquitin and Ch-Usp7 in
HEK293T cells. GFP-Dnmt1 was then immunoprecipitated with
the GFP-trap and its ubiquitination was probed with anti-HA
antibody. In the absence of Ch-Usp7 the ubiquitinated GFP-Dnmt1
appeared as a smear reﬂecting relatively broad size heterogeneity
(Fig. 2A). Overexpression of Ch-Usp7 resulted in both reduced signal
strength and altered migration of ubiquitinated GFP-Dnmt1, which
appeared as a sharp band comigrating with the lowest part of the
smear obtained in the absence of Ch-Usp7 (Fig. 2A). In contrast,
overexpression of Ch-Usp7C224S, a catalytically inactive point
mutant [Li et al., 2002], led to an apparent increase in the
ubiquitination levels of GFP-Dnmt1. Using the same assay and
mutation analysis we could map the ubiquitination sites of Dnmt1
within amino acids 524–629, corresponding to the C-terminal part
of the TS domain (Suppl. Fig. 5).
Uhrf1 contains a Ring domain endowed with E3 ubiquitin ligase
activity and has been shown to ubiquitinate itself as well as core
histones both in vitro and upon overexpression in HEK293T cells
[Citterio et al., 2004; Karagianni et al., 2008]. As we showed that
Usp7 also interacts with Uhrf1 we used the same immunoprecipita-
tion assay as described above to determine whether Usp7 affects the
ubiquitination levels of Uhrf1. The levels of ubiquitinated GFP-
Uhrf1 were clearly reduced by coexpression of Ch-USP7 (Fig. 2B).
Thus, our results suggest that ubiquitination status of both Dnmt1
and Uhrf1 is regulated by Usp7.
Uhrf1 ENHANCES UBIQUITINATION OF Dnmt1 IN VIVO
The E3 ubiquitin ligases responsible for ubiquitination of Dnmt1 are
unknown. As the Ring domain of Uhrf1 has E3 ubiquitin ligase
activity, we explored the possibility that Uhrf1 ubiquitinates Dnmt1.
Fig. 1. Usp7 interacts with Dnmt1 and Uhrf1. A: GFP-trap pulldowns from
dnmt1/ ESCs and a clone of the same cells stably expressing GFP-Dnmt1. A
colloidal Coomassie blue stained SDS–PAGE of bound fractions is shown and
the position of Usp7 as identiﬁed by mass spectrometry is shown. B: GFP-trap
pulldowns as in A were probed with an afﬁnity puriﬁed anti-USP7 antibody. C:
GFP-trap pulldowns from HEK293T cells coexpressing Ch-Usp7 and either GFP
or GFP-Dnmt1. D: GFP-trap pulldowns from HEK293T cells coexpressing Ch-
Usp7 and GFP-Uhrf1. The blots in C and D were probed with the anti-red
monoclonal antibody that recognizes several red ﬂuorescent proteins including
Cherry. I, input; B, bound fractions.
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GFP-Dnmt1 was coexpressed with either HA-ubiquitin or both
HA-ubiquitin and Uhrf1-Cherry in HEK293T cells (Fig. 3). The
latter condition generated a clear increase in size of ubiquitinated
GFP-Dnmt1, indicating that Uhrf1 is able to ubiquitinate Dnmt1 in
vivo.
USP7 CONTROLS Dnmt1 STABILITY
As Usp7 dependent deubiquitination is known to stabilize both
p53 and Mdm2 we asked whether Usp7 affects Dnmt1 protein
stability. To this aim we over-expressed either Cherry or Ch-Usp7 in
HEK293T cells and treated themwith cycloheximide to block protein
synthesis. With prolonged cycloheximide treatment endogenous
Dnmt1 levels steadily decreased in cells overexpressing Cherry,
showing a half-life of about 5 h, while they remained unaltered in
cells overexpressing Ch-Usp7 (Fig. 4). This result clearly supports the
idea that deubiquitination by Usp7 increases Dnmt1 stability.
DISCUSSION
Here we show that the DUB Usp7 interacts with both Dnmt1 and
Uhrf1, two factors crucial for maintenance of genomic methylation
patterns. We provide evidence that ubiquitination of Dnmt1 is
controlled by the Uhrf1 and Usp7 and that deubiquitination by the
latter stabilizes Dnmt1. In addition several Ring domain E3 ubiquitin
Fig. 2. Usp7 deubiquitinates both Dnmt1 and Uhrf1. GFP-trap pulldowns from HEK293T cells expressing the indicated combinations of HA-ubiquitin, Ch-Usp7, Ch-
Usp7C224S, and either GFP-Dnmt1 (A) or GFP-Uhrf1 were probed with an anti-HA antibody to detect ubiquitinated proteins and either anti-Dnmt1 (A) or anti-Uhrf1 (B)
antibodies as loading controls.
Fig. 3. Uhrf1 ubiquitinates Dnmt1. GFP-trap pulldowns from HEK293T cells
expressing the indicated combinations of HA-ubiquitin, GFP-Dnmt1 and
Uhrf1-Ch were probed with anti-HA and anti-Uhrf1 antibodies as in Figure 2B.
Fig. 4. USP7 stabilizes Dnmt1. HEK293T cells expressing either Cherry or Ch-
Usp7 were treated with cycloheximide (CHX) for the indicated time periods
before harvesting. A: Endogenous Dnmt1 levels were detected with an anti-
Dnmt1 antibody, while anti-Lamin B1 and anti-Usp7 blots served as loading
controls. B: shows quantiﬁcation of the blots in (A).
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ligases were shown to regulate their own stability by autoubiqui-
tination. Here we conﬁrm that Uhrf1 ubiquitinates itself and
show that in turn it is deubiquitinated by Usp7. Our data are
consistent with a very recent report [Du et al., 2010] in supporting a
network of ubiquitination mediated feedback loops that ultimately
ﬁne tune the levels of two central effectors of DNA methylation
maintenance. Interestingly, two other types of PTM have been
proposed to modulate Dnmt1 stability, namely phosphorylation and
methylation [Sun et al., 2007; Esteve et al., 2009; Wang et al., 2009].
This observation raises the question as to whether these PTMs are
part of distinct mechanisms that mediate the control of Dnmt1
stability independently or belong to a common pathway. In any
case, Dnmt1 stability seems to be under control of a complex system
of mechanisms that likely reﬂects the necessity for tight regulation
of Dnmt1 levels, as altered Dnmt1 expression has been associated to
several pathologic states ranging from cancer [Gaudet et al., 2003]
to major psychoses [Costa et al., 2007].
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Supplementary Figure 1. Usp7 does not interact with de novo DNA methyltransferases 
Dnmt3a and 3b. GFP-trap pulldowns from HEK293T cells transiently coexpressing 
Ch-Usp7 and either GFP-Dnmt3a or GFP-Dnmt3b were probed with the anti-red 
monoclonal antibody that recognizes several red fluorescent proteins including Cherry. 
I=input and B=bound fractions. 
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Supplementary Figure 2. Mapping of the Usp7 domain responsible for the interaction 
with Dnmt1. (A) Schematic representation of Ch-Usp7 constructs used for the mapping. 
(B) GFP-trap pulldowns from HEK293T cells transiently coexpressing GFP-Dnmt1 and 
the indicated Ch-Usp7 constructs as shown in A. The blot was probed with probed with 
the anti-red monoclonal antibody. I=input and B=bound fractions. (C) F2H assays 
(Zolghadr et al., 2008, Mol Cell Proteomics 7:2279) using GFP-Dnmt1 as bait and the 
Ch-Usp7 constructs shown in A as preys. 
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Supplementary Figure 3. Mapping of the Dnmt1 domain responsible for the interaction 
with Usp7. (A) Schematic representation of GFP-Dnmt1 constructs used for the mapping. 
(B) GFP-trap pulldowns from HEK293T cells transiently coexpressing Ch-Usp7 and the 
indicated GFP-Dnmt1 constructs as shown in A. the blot was probed with probed with an 
anti-Usp7 antibody. I=input and B=bound fractions. (C) F2H assays (Zolghadr et al., 
2008, Mol Cell Proteomics 7:2279) using GFP-Dnmt1 constructs shown in A as baits and 
Ch-Usp7 as prey. 
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Supplementary Figure 4. Further mapping of the Dnmt1 domain responsible for the 
interaction with Usp7. (A) Schematic representation of GFP-Dnmt1 constructs used for 
the mapping. (B) GFP-trap pulldowns from HEK293T cells transiently coexpressing 
Ch-Usp7 and the indicated of GFP-Dnmt1 constructs as shown in A. The blot was probed 
with probed with the anti-red monoclonal antibody. I=input and B=bound fractions. (C) 
F2H assays (Zolghadr et al., 2008, Mol Cell Proteomics 7:2279) using GFP-Dnmt1 
constructs shown in A as baits and Ch-Usp7 as prey. 
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Supplementary Figure 5. Mapping of the ubiquitinated domain in Dnmt1. (A) 
Schematic representation of the GFP-Dnmt1 fragment constructs used for the mapping. 
(B) GFP-trap pulldowns from HEK293T cells transiently coexpressing HA-ubiquitin and 
the indicated GFP-Dnmt1 constructs as shown in A. The blot was probed with probed 
with an anti-HA antibody to detect ubiquitinated proteins. I=input and B=bound 
fractions. Amino acids 524-629 corresponding to the C-terminal part of the TS domain 
harbor the ubiquitinated sites. Some additional ubiquitinated sites may be present in the 
C-terminal catalytic domain. 
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Different Binding Properties and Function of CXXC Zinc
Finger Domains in Dnmt1 and Tet1
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Abstract
Several mammalian proteins involved in chromatin and DNA modification contain CXXC zinc finger domains. We compared
the structure and function of the CXXC domains in the DNA methyltransferase Dnmt1 and the methylcytosine dioxygenase
Tet1. Sequence alignment showed that both CXXC domains have a very similar framework but differ in the central tip region.
Based on the known structure of a similar MLL1 domain we developed homology models and designed expression constructs
for the isolated CXXC domains of Dnmt1 and Tet1 accordingly. We show that the CXXC domain of Tet1 has no DNA binding
activity and is dispensable for catalytic activity in vivo. In contrast, the CXXC domain of Dnmt1 selectively binds DNA substrates
containing unmethylated CpG sites. Surprisingly, a Dnmt1 mutant construct lacking the CXXC domain formed covalent
complexes with cytosine bases both in vitro and in vivo and rescued DNA methylation patterns in dnmt12/2 embryonic stem
cells (ESCs) just as efficiently as wild type Dnmt1. Interestingly, neither wild type nor DCXXC Dnmt1 re-methylated imprinted
CpG sites of the H19a promoter in dnmt12/2 ESCs, arguing against a role of the CXXC domain in restraining Dnmt1
methyltransferase activity on unmethylated CpG sites.
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Introduction
In mammals DNA methylation is restricted to cytosine residues
and mainly involves CpG dinucleotides. CpG methylation is
widespread across mammalian genomes, including gene bodies
regardless of their transcriptional activity [1–4]. However, highly
CpG-rich regions (CpG islands) are refractory to methylation and
mostly coincide with promoters of constitutively active genes. The
methylation state of other regulatory sequences with moderate to
low CpG density, including promoters and enhancers, shows
developmental and/or tissue-specific variations and positively
correlates with a transcriptionally silent state [1,3–8]. Dense
methylation of repetitive sequences is also thought to maintain
these elements in a silent state and thus contribute to genome
stability [9–11]. In mammals cytosine methylation is catalyzed by
a family of DNA methyltransferases (Dnmts) [12]. Dnmt3a and
Dnmt3b establish methylation patterns during embryonic devel-
opment of somatic as well as germ cell lineages and, consistently,
show developmental stage and tissue specific expression patterns.
In contrast, Dnmt1 is ubiquitous and generally the most abundant
DNA methyltransferase in mammalian tissues, where it associates
with the replication machinery and restores symmetrical methyl-
ation at hemimethylated CpG sites generated by the semi-
conservative DNA replication process [13]. Thus, Dnmt1
maintains methylation patterns with high fidelity and is essential
for embryonic development and genome integrity [9,14,15].
Dnmt1 is a large enzyme with a complex domain structure that
likely evolved by fusion of at least three genes [16]. It comprises a
regulatory N-terminal region and a C-terminal catalytic domain
connected by a linker of seven glycine-lysine repeats (Figure 1A)[17].
The N-terminal part contains a PCNA binding domain (PBD), a
heterochromatin targeting sequence (TS), a CXXC-type zinc finger
domain and two Bromo-Adjacent Homology domains (BAH1 and
BAH2). The C-terminal domains of mammalian Dnmts contain all ten
catalytic motifs identified in bacterial DNA (cytosine-5) methyltrans-
ferases [12]. Thus, prokaryotic and mammalian cytosine methyltrans-
ferases are thought to adopt the same catalytic mechanism. However,
the C-terminal domain of Dnmt1 is the only DNA methyltransferase
domain in Dnmts that is not catalytically active when expressed
separately. Indeed, interaction with the N-terminal part is required for
allosteric activation of the enzyme [18]. Remarkably, the first 580
amino acids (aa) of human DNMT1 are dispensable for both
enzymatic activity and substrate recognition, whereas deletion of the
first 672 aa results in an inactive enzyme [19]. Interestingly, this
truncation eliminates part of the CXXC domain, suggesting an
involvement of this domain in allosteric activation. However, addition
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of an N-terminal fragment containing the isolated CXXC domain to
the catalytic domain was not sufficient for catalytic activation [20].
CXXC-type zinc finger domains are found in several other
proteins with functions related to DNA or chromatin modification,
including the histone H3 lysine 4 (H3K4) methyltransferases mixed-
lineage leukaemia (MLL) proteins 1 and 4, the CpG-binding protein
(CGBP, also known as Cfp1 or CXXC1), the methyl-CpG binding
domain protein 1 (MBD1), the H3 lysine 36 (H3K36) demethylases
KDM2A and B (also known as JHD1A/FBXL11 and JHD1B/
FBXL10) and the MLL1 fusion partner TET1 (Figure 1A) [21–28].
The CXXC domains of some of these proteins were shown to
mediate specific binding to double stranded DNA templates
containing unmethylated CpG sites [21,22,29,30]. A region of
Dnmt1 which mainly includes the CXXC domain (aa 628–753) was
also shown to bind Zn ions and DNA [20,31,32]. However, available
data on the selectivity of this DNA binding activity are conflicting.
Whereas a fragment including aa 613–748 of mouse Dnmt1 was
shown to bind DNA with a slight preference for hemimethylated
CpG sites [20], aa 645–737 of human DNMT1 were shown to
selectively bind unmethylated DNA [32]. As these studies used
different constructs and species, the selectivity of DNA binding by
the CXXC domain of Dnmt1 with regard to CpG methylation state
and the role of the CXXC domain in allosteric activation and
substrate discrimination remain to be firmly established.
Notably, not all CXXC domains show DNA binding activity, as
exemplified by the fact that only one out of three CXXC domains
in MBD1 binds DNA [29]. Interestingly, TET1 was recently
shown to be a 2 oxoglutarate- and Fe(II)-dependent dioxygenase
responsible for converting genomic 5-methylcytosine (mC) to 5-
hydroxymethylcytosine (hmC) [33,34]. However, it is not known
whether the CXXC domain of TET1 is involved in recognition of
methylated DNA substrates.
Here we report a functional study and characterization of the
DNA binding activity for the CXXC domains of mouse Dnmt1
and Tet1 proteins. We generated isolated CXXC domain and
deletion constructs based on structural homology models to
minimize structural alterations. We show that the CXXC domain
of Dnmt1 preferentially binds DNA substrates containing
unmethylated CpG sites, but does not contribute significantly to
the DNA binding properties of the full length enzyme and is
dispensable for its catalytic activity in vitro and in vivo. In addition,
we found that the CXXC domain of Tet1 does not bind DNA in
vitro and is also dispensable for catalytic activity of Tet1 in vivo.
Results
Sequence homology and structural modeling identify
distinct CXXC domain subtypes
Dnmt1 contains a zinc finger domain of the CXXC type, which
is present in several mammalian proteins including MLL1
(Figure 1A–C) and is highly conserved among Dnmt1 sequences
from various animal species (Figure S1 in File S1). The primary
structure of CXXC domains spans two clusters of 6 and 2 cysteine
residues separated by a stretch of variable sequence and length.
Sequence alignment and homology tree construction identified
three distinct groups of CXXC domains (Figure 1B and C). The
sequence between the two cysteine clusters in the CXXC domains
of Dnmt1, CGBP/Cfp1, Fbxl19, Mll1, Mll2 and Kdm2 proteins
and CXXC domain 3 of Mbd1 is highly conserved and contains a
KFGG motif. The two other homology groups, including the
CXXC domains 1 and 2 of Mbd1 on one side and those of Tet1,
Cxxc4/Idax, Cxxc5/RINF and Cxxc10 on the other side, lack the
KFGG motif and diverge from the first group and from each other
in the sequence between the cysteine clusters. We generated
structural homology models for the CXXC domains of mouse
Dnmt1 and Tet1 using the NMR structure of the MLL1 CXXC
domain as a template (Figure 1D and E)[35]. The CXXC domains
of these proteins adopt an extended crescent-like structure that
incorporates two Zn2+ ions each coordinated by four cysteine
residues. The peptide of the MLL1 CXXC domain predicted to
insert into the major groove of the DNA double helix (cyan in
Fig. 1E) is located on one face of the structure and is contiguous to
the KFGG motif [35]. The predicted structure of the Tet1 CXXC
domain lacks the short 310 helix (g1 in Figure 1E) formed by
residues PKF and partially overlapping the KFGG motif, but is
similar to the MLL1 CXXC domain in the region of the DNA-
contacting peptide. However, each of the two predicted b-strands
in Tet1 carries three positive charges, whereas there is only one or
no charged residue in the C-terminal strands of the CXXC
domains in MLL1 and Dnmt1. Depending on the orientation of
the positively charged side chains, it cannot be excluded that the
charge density prevents strand pairing in the Tet1 CXXC domain.
The Dnmt1 CXXC domain binds unmethylated DNA
To investigate the binding properties of the Dnmt1 CXXC
domain, we generated a GFP fusion construct including aa 652–699
(GFP-CXXCDnmt1). According to our homology model the ends of
this fragment form an antiparallel b-sheet that structurally delimits
the domain as in MLL1. We first compared the localization and
mobility of GFP-CXXCDnmt1 and GFP in mouse C2C12
myoblasts. While GFP was diffusely distributed in both nucleus
and cytoplasm, GFP-CXXCDnmt1 was exclusively nuclear with a
punctuated pattern throughout the nucleoplasm and was enriched
in nucleoli, a pattern independent of cell cycle stage (Figure 2A and
Figure S2 in File S1). Enrichment in the nucleus and nucleoli is
frequently observed with constructs containing stretches with high
density of basic residues. After photobleaching half of the nuclear
volume we observed a slower fluorescence recovery rate for GFP-
CXXCDnmt1 than for GFP (Figure 2B). To rule out a contribution of
nucleolar interactions to the slower kinetics of GFP-CXXCDnmt1,
Figure 1. Sequence and predicted structural homology of CXXC domains. (A) Schematic representation of the domain structure in Dnmt1 and
Tet1. The catalytic domain and the N-terminal region of Dnmt1 are connected by seven lysine-glycine repeats [(KG)7]. PBD: PCNA binding domain; TS:
targeting sequence; CXXC: CXXC-type zinc finger domain; BAH1 and 2: bromo-adjacent homology domain; NLS: nuclear localization signal; Cys-rich:
cysteine rich region. (B) Alignment of mammalian CXXC domains. Numbers on the right side indicate the position of the last amino acid in the
corresponding protein. The Mbd1a isoform contains three CXXC motifs (Mbd1_1-3). Absolutely conserved residues, including the eight cysteines
involved in zinc ion coordination are highlighted in red and the conserved KFGG motif is in red bold face. Positions with residues in red face share 70%
similarity as calculated with the Risler algorithm [66]. At the top residues of MLL1 involved in b sheets b1 and b2 (black arrows), a helices a1 and a2 and
strict a turns (TTT) are indicated. All sequences are from M. musculus. Accession numbers (for GenBank unless otherwise stated): Dnmt1, NP_034196;
Mll1, NP_001074518; Mll4, O08550 (SwissProt); CGBP, NP_083144; Kdm2a, NP_001001984; Kdm2b, NP_001003953; Fbxl19, NP_766336; Mbd1,
NP_038622; CXXC4/Idax, NP_001004367; CXXC5, NP_598448; CXXC10 (see Materials and Methods). (C) A homology tree was generated from the
alignment in (B). The three subgroups of CXXC domains identified are in different colors. Average distances between the sequences are indicated. (D–E)
Homology models of the mouse Dnmt1 (D; red) and Tet1 (E; blue) CXXC domains superimposed to the CXXC domain of MLL1 (green; [35]). MLL1
residues that were described to contact DNA according to chemical shift measurements [35] are cyan in (E), while cysteines involved in coordination of
the two zinc ions are yellow. Arrows point to the KFGG motif in MLL1 and Dnmt1. The locations of a helices and b sheets are indicated as in (B).
doi:10.1371/journal.pone.0016627.g001
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we separately bleached nucleoplasmic and nucleolar regions and
found that GFP-CXXCDnmt1 has even faster kinetics within the
nucleolus (Figure S3 in File S1). These results are consistent with a
binding activity of GFP-CXXCDnmt1 in the nucleus and very
transient, unspecific binding in the nucleolus. To investigate
whether the CXXC domain of Dnmt1 binds DNA and its possible
selectivity with respect to CpG methylation we used a recently
developed fluorescent DNA binding assay [36,37]. GFP-
CXXCDnmt1 was transiently expressed in HEK293T cells, im-
munopurified with the GFP-trap (Figure S4 in File S1) and
incubated with fluorescent DNA substrates containing either no
CpG site or one central un-, hemi- or fully methylated CpG site in
direct competition. As shown in Figure 2C, GFP-CXXCDnmt1
displayed a significant preference for the substrate containing one
unmethylated CpG site, which increased substantially with a five-
fold higher concentration of the DNA substrates (Figure S5 in File
S1). These results are consistent with the reported binding pre-
ference of the CXXC domains in human DNMT1 and other factors
belonging to the same CXXC homology group [21,22,29,32].
Notably, the CXXC domains 1 and 2 of Mbd1 lack the KFGG
motif and do not bind DNA, while mutation of this motif prevented
DNA binding by the CXXC domain of MLL1 [29,38]. Therefore,
we generated a GFP-CXXCDnmt1 construct where the KFGG motif
was mutated to AAGG (GFP-CXXCDnmt1KF/AA, Figure S4 in File
S1) to test the requirement of the KFGG motif for binding by the
CXXC domain of Dnmt1. The mutant domain showed signifi-
cantly decreased binding to all DNA substrates and complete loss of
preferential binding to the unmethylated substrate in vitro
(Figure 2B). In addition, GFP-CXXCDnmt1KF/AA showed faster
recovery after photobleaching (FRAP) in vivo compared to the
corresponding wild type construct (Figure 2C). These results further
support the importance of the KFGG motif for DNA binding by
CXXC domains.
The CXXC domain of Tet1 shows no specific DNA binding
activity and is dispensable for enzymatic activity in vivo
It was recently shown that Tet1 oxidizes genomic mC to hmC.
However, the mechanism by which Tet1 is targeted to genomic
mC is not known. Our model for the structure of the Tet1 CXXC
domain diverged from the structure of the MLL1 CXXC domain
with respect to the KFGG motif but not to the DNA-contacting
peptide, suggesting that the Tet1 CXXC domain may still bind
DNA. To test this we generated a GFP-tagged Tet1 CXXC
Figure 2. Properties of isolated Dnmt1 and Tet1 CXXC domains. (A–B) Subcellular localization (A) and binding kinetics (B) of GFP-CXXCDnmt1,
GFP-CXXCDnmt1KF/AA, GFP-CXXCTet1 and GFP in mouse C2C12 myoblasts. Localization and binding kinetics were independent from the cell cycle stage
(Figures S2 and S5 in File S1). Arrowheads in (A) point to nucleoli. Scale bar: 5 mm. Binding kinetics were analyzed by FRAP. (C) DNA binding specificity
of the Dnmt1 and Tet1 CXXC domains. GFP, GFP-CXXCDnmt1, GFP-CXXCDnmt1KF/AA and GFP-CXXCTet1 were pulled down from extracts of transiently
transfected HEK293T cells and incubated with fluorescent DNA substrates containing no CpG site or one central un-, hemi- or fully methylated CpG
site in direct competition (noCGB, UMB, HMB, FMB, respectively). Shown are the mean DNA/protein ratios and corresponding standard errors from 5
(GFP), 4 (GFP-CXXCDnmt1 and GFP-CXXCDnmt1KF/AA) and 2 (GFP-CXXCTet1) independent experiments. * P=0.01; ** P=0.007; ***P= 0.001.
doi:10.1371/journal.pone.0016627.g002
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construct (GFP-CXXCTet1) following the same criteria as for GFP-
CXXCDnmt1 and investigated its cellular localization, in vivo
binding kinetics and in vitro DNA binding activity. GFP-CXXCTet1
was prevalently nuclear with a homogeneous distribution includ-
ing nucleoli that was independent of cell cycle stage (Figure 2A and
Figure S6 in File S1). After photobleaching GFP-CXXCTet1
showed very fast recovery kinetics similar to GFP (Figure 2B) and
its DNA binding activity in vitro was also similar to the background
levels of the GFP control (Figure 2C). We conclude that the
isolated CXXC domain of Tet1 has no specific DNA binding
activity. Together with the observation that the CXXC domains 1
and 2 of Mbd1 also lack the KFGG motif and do not bind DNA
[29] and that mutation of this motif reduced DNA binding by the
CXXC domains of both Dnmt1 (Figure 2C) and MLL1 [38], this
result indicates that the KFGG motif is a major determinant for
DNA binding by CXXC domains.
To assess whether the CXXC domain is required for catalytic
activity of Tet1 we generated a GFP-Tet1 fusion construct and a
corresponding mutant lacking the CXXC domain (GFP-
Tet1DCXXC). In C2C12 myoblasts GFP-Tet1 and GFP-
Tet1DCXXC showed punctuated nuclear patterns that did not
depend on the cell cycle stage (Figure 3A and data not shown).
The same constructs were transfected in HEK293T cells and
global levels of genomic hmC were measured using a recently
described hmC glucosylation assay [39]. Overexpression of GFP-
Tet1 and GFP-Tet1DCXXC determined a similar 5-fold increase of
genomic hmC levels relative to control samples overexpressing
GFP (Figure 3B), indicating that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Deletion of the CXXC domain does not affect the activity
of Dnmt1 in vitro
To explore the role of the CXXC domain in Dnmt1 function
we generated GFP-Dnmt1 fusion constructs where the CXXC
domain, as defined by our homology model, was deleted. We
reasoned that precise deletion of the entire structure delimited by
the antiparallel b-sheet (Figure 1D) would have the highest
chances to preserve native folding of the rest of the protein. We
introduced this deletion in GFP fusion constructs encoding either
the full length Dnmt1 or the isolated N-terminal region (GFP-
Dnmt1DCXXC and GFP-NTRDCXXC, respectively; Figure 4A and
Figure S4 in File S1). We then compared DNA binding properties,
catalytic activity and interaction between N-terminal region and
C-terminal catalytic domain of DCXXC and corresponding wild
type constructs. Competitive DNA binding assays with the same
set of substrates as used for the experiments with GFP-
CXXCDnmt1 and GFP-CXXCTet1 reported above (Figure 2C)
showed that both GFP-Dnmt1 and GFP-Dnmt1DCXXC bind DNA
independently of the presence and methylation state of a CpG site
(Figure 4B). As the isolated CXXC domain preferentially bound
the substrate containing an unmethylated CpG site, the result with
GFP-Dnmt1 and GFP-Dnmt1DCXXC indicates that the CXXC
domain contributes negligibly to the DNA binding specificity of
the full-length enzyme.
Several groups reported that interaction between the N-
terminal region and the C-terminal catalytic domain of Dnmt1
leads to allosteric activation of Dnmt1 [16,18–20,40]. To test
whether the CXXC domain is involved in this intramolecular
interaction, we co-expressed either GFP-tagged N-terminal region
(GFP-NTR) or GFP-NTRDCXXC constructs with a Cherry- and
His-tagged C-terminal domain (Ch-CTD-His) in HEK293T cells
and performed co-immunoprecipitation experiments. Ch-CTD-
His co-precipitated both GFP-NTR and GFP-NTRDCXXC,
indicating that the CXXC domain is dispensable for the
interaction between the N-terminal region and the C-terminal
domain of Dnmt1 (Figure 4C).
To investigate whether the CXXC domain is needed for
enzymatic activity or substrate recognition, we tested formation of
the covalent complex with cytosine and transfer of the methyl
group for GFP-Dnmt1 and GFP-Dnmt1DCXXC. We first employed
an assay to monitor covalent complex formation that exploits the
formation of an irreversible covalent bond between the enzyme
and the mechanism-based inhibitor 5-aza-2-deoxycytosine (5-aza-
dC). This results in permanent trapping of the enzyme by DNA
substrates containing 5-aza-dC, as opposed to the reversible
complex formed with substrates containing the natural substrate 2-
deoxycytosine (dC) [36]. GFP-Dnmt1 and GFP-Dnmt1DCXXC
were incubated with fluorescent DNA substrates containing either
dC (binding) or 5-aza-dC (trapping) at a single CpG site in direct
competition. DNA-protein complexes were then isolated by GFP
pulldown and molar DNA/protein ratios were calculated from
fluorescence measurements (Figure 4D). Covalent complex
Figure 3. Cellular localization and in vivo catalytic activity of GFP-Tet1 and GFP-Tet1DCXXC. (A) Live images of C2C12 myoblasts expressing
GFP-Tet1. Scale bar: 5 mm. (B) Genomic hmC content in HEK293T cells overexpressing GFP, GFP-Tet1 and GFP-Tet1DCXXC. Shown are mean values and
standard deviation of hmC percentage over total cytosine for three measurements from one transfection.
doi:10.1371/journal.pone.0016627.g003
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formation was then estimated by comparing trapping and binding
activities. GFP-Dnmt1 and GFP-Dnmt1DCXXC showed compara-
ble covalent complex formation rates (trapping/binding ratios),
which were about 15- and 12-fold higher for hemi- than un-
methylated substrates, respectively (Figure 4E). Together with the
data from binding experiments (Fig. 4B), this result indicates that
the preference of Dnmt1 for hemimethylated substrates is
determined at the covalent complex formation step rather than
upon DNA binding. Furthermore, the CXXC domain clearly does
not play a major role in determining either the efficiency or the
methylation state-specificity of covalent complex formation.
Next, we tested whether deletion of the CXXC domain affects
the ability of Dnmt1 to transfer [3H]methyl groups from the donor
S-adenosylmethionine (SAM) to a poly(dI?dC)-poly(dI?dC) sub-
strate, a standard DNA methyltransferase activity assay. This
showed that in vitro GFP-Dnmt1 and GFP-Dnmt1DCXXC are equally
active methyltransferases (Figure S7 in File S1). This result is in
contrast with a previous report showing that deletion of aa 647–690
in human DNMT1 encompassing the CXXC domain resulted in a
drastic loss of catalytic activity [32]. However, according to our
homology model the deletion by Pradhan et al. would eliminate the
predicted N-terminal b-strand (b1 in Figure 1) preventing the
formation of the antiparallel b-sheet and potentially distort the
folding of the rest of the protein. This is in contrast with our GFP-
Dnmt1DCXXC mutant that was designed to retain the b-sheet
structure. To test whether this may account for the observed
discrepancy, we generated GFP fusion constructs of wild type
human DNMT1 and the same deletion as reported by Pradhan et al.
and tested covalent complex formation with 5-aza-dC containing
DNA substrates as described above. While the human wild type
construct showed the same preference for hemimethylated over
unmethylated trapping substrates as the mouse constructs, this
preference was clearly reduced for the human CXXC deletion
mutant (Figure S8 in File S1). This result is consistent with the loss of
enzymatic activity shown by Pradhan et al. for this mutant and
together with the retention of trapping and catalytic activity by the
different deletion in GFP-Dnmt1DCXXC suggests that disruption of
the antiparallel b-sheet delimiting the CXXC domain results in
further distortion and loss of activity of the enzyme.
In conclusion, we showed that, in vitro, deletion of the CXXC
domain does not affect the interaction between N-terminal region
and C-terminal domain, DNA binding, the preference for
hemimethylated substrates upon covalent complex formation
and the methyltransferase activity of Dnmt1. Together, these
data strongly argue against an involvement of the CXXC domain
in allosteric activation of Dnmt1.
Figure 4. DNA binding specificity, intramolecular interaction and trapping of wild-type Dnmt1 and CXXC deletion constructs in
vitro. (A) Schematic representation of Dnmt1 expression constructs. (B) DNA binding specificity of GFP-Dnmt1 and GFP-Dnmt1DCXXC were assayed as
described in Figure 2C. (C) Co-immunoprecipitation of the C-terminal domain of Dnmt1 (Ch-CTD-His) and the N-terminal region with and without
deletion of the CXXC domain (GFP-NTR and GFP-NTRDCXXC, respectively). GFP fusions were detected using an anti-GFP antibody, while the C-terminal
domain construct was detected using an anti-His antibody. GFP was used as negative control. I = input, B = bound. (D) Comparison of binding and
trapping activities for GFP-Dnmt1 and GFP-Dnmt1DCXXC to monitor irreversible covalent complex formation with hemimethylated substrates. (E)
Relative covalent complex formation rate of GFP-Dnmt1 and GFP-Dnmt1DCXXC on substrates containing one un- (UMT) or hemi-methylated CpG site
(HMT) in direct competition. The trapping ratio for GFP-Dnmt1 on unmethylated substrate was set to 1. In (D) and (E) the means and corresponding
standard deviations of triplicate samples from three independent experiments are shown. GFP was used as negative control.
doi:10.1371/journal.pone.0016627.g004
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Deletion of the CXXC domain does not affect Dnmt1
activity in vivo
We then undertook a functional characterization of the GFP-
Dnmt1DCXXC construct in vivo. We first compared localization and
binding kinetics of GFP-Dnmt1 or GFP-Dnmt1DCXXC in mouse
C2C12 myoblasts co-transfected with RFP-PCNA, which served
as S-phase marker [41]. GFP-Dnmt1DCXXC showed the same cell-
cycle dependent nuclear localization pattern as previously shown
for GFP-Dnmt1 and endogenous Dnmt1 (Figure 5A)[42,43].
Interaction with PCNA via the PBD directs Dnmt1 to replication
foci throughout S-phase. In addition, in late S-phase and G2
Dnmt1 is enriched at chromocenters, clusters of pericentric
heterochromatin (PH) that are observed as discrete domains
densely stained by DNA dyes in mouse interphase cells.
Association of Dnmt1 with PH at these stages is mediated by
the TS domain [42]. Thus, the CXXC domain clearly does not
contribute to the subnuclear localization of Dnmt1 at this level of
resolution.
We also compared the mobility of GFP-Dnmt1 and GFP-
Dnmt1DCXXC in living C2C12 myoblasts by FRAP analysis
(Figure 5B). These experiments revealed that the kinetics of
Dnmt1 is not significantly affected by deletion of the CXXC
domain in early-mid as well as late S-phase.
To test covalent complex formation in living cells, we used a
previously established trapping assay [44]. Mouse C2C12
myoblasts were co-transfected with RFP-PCNA and either GFP-
Dnmt1 or GFP-Dnmt1DCXXC and treated with 5-aza-dC.
Immobilization of the Dnmt1 constructs at the site of action was
then measured by FRAP analysis (Figure 5C). GFP-Dnmt1 and
GFP-Dnmt1DCXXC showed very similar trapping kinetics, the
immobile enzyme fraction reaching nearly 100% after 20 and 40
minutes in early-mid and late S-phase, respectively. This result
clearly shows that the CXXC domain is dispensable for covalent
complex formation also in vivo.
Finally, we compared the ability of GFP-Dnmt1 and GFP-
Dnmt1DCXXC to restore DNA methylation patterns in mouse
dnmt12/2 ESCs. Cells transiently expressing either GFP-Dnmt1 or
GFP-Dnmt1DCXXC were FACS sorted 48 h after transfection.
Isolated genomic DNA was then bisulfite treated and fragments
corresponding to major satellite repeats, intracisternal type A
particle (IAP) interspersed repeats, skeletal a-actin and H19a
promoters were amplified and subjected to pyrosequencing
(Figure 6). As shown previously [43], under these conditions
GFP-Dnmt1 partially restored methylation of major satellite and
IAP repeats and the skeletal a-actin promoter, but not of the
imprinted H19a promoter, as establishment of the methylation
imprint requires passage through the germ line [45]. Methylation
patterns of all these sequences in cells expressing GFP-
Dnmt1DCXXC were very similar to those in GFP-Dnmt1
expressing cells, including the lack of (re-) methylation at the
H19a promoter. These results suggest that the CXXC domain is
not required for maintenance of DNA methylation patterns by
Dnmt1 and does not restrain the DNA methyltransferase activity
of Dnmt1 on unmethylated CpG sites. Thus, the CXXC domain
does not play a major role in subcellular localization, it does not
contribute to the global binding kinetics of Dnmt1 and, consistent
with the in vitro data reported above, is dispensable for maintaining
DNA methylation patterns in living cells.
Figure 5. Cell cycle dependant cellular localization, protein mobility and trapping of wild-type Dnmt1 and CXXC deletion
constructs in mouse C2C12 myoblasts. (A) Cell cycle dependent localization of GFP-Dnmt1 and GFP-Dnmt1DCXXC constructs. Scale bar: 5 mm. (B)
Analysis of binding kinetics of GFP-Dnmt1 and GFP-Dnmt1DCXXC in early and late S-phase cells by FRAP. The recovery curve for GFP is shown for
comparison. (C) In vivo trapping by FRAP analysis in cells treated with 5-aza-dC. The trapped enzyme fraction is plotted over time for early and late S-
phase cells. For each construct three to six cells in early-mid and late S phase were analysed per time point. Shown are mean values 6 SEM. In (A–C)
RFP-PCNA was cotransfected to identify cell cycle stages in living cells.
doi:10.1371/journal.pone.0016627.g005
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Discussion
We generated homology models based on the reported structure
of the MLL1 CXXC domain to design isolated CXXC domain
constructs and CXXC domain deletion mutants for Dnmt1 and
Tet1 with minimal probability of structural alteration. According
to these models CXXC domains are delimited by an antiparallel
b-sheet, a discrete structural element. Our data show that the
CXXC domain of mouse Dnmt1 preferentially binds DNA
substrates containing unmethylated CpG sites as previously shown
for CXXC domains of human DNMT1 and other mammalian
proteins. We note that sequences C-terminal to the corresponding
peptide in CGBP/Cfp1 were reported to be required for DNA
binding in vitro [22] and that only a significantly larger peptide
spanning the CXXC-3 domain of Mbd1a was tested for DNA
binding. However, sequences C-terminal to CXXC domains are
not conserved (Figure 1B) and our data show that they are not
required for DNA binding by the CXXC domain of Dnmt1.
Nevertheless, all the CXXC domains reported to selectively bind
unmethylated CpG sites cluster in a distinct homology group and
contain the KFGG motif. The latter was shown to be crucial for
DNA binding by the CXXC domain of MLL1 [38] and here we
extend this observation to the CXXC domain of Dnmt1.
Sequence alignment reveals two distinct CXXC domain homology
groups that lack the KFGG motif (Figure 1A). Consistent with a
role of this motif in DNA binding, members of these groups such
as CXXC-1/2 of Mbd1 [29] and the CXXC domain of Tet1 (this
study) show no DNA binding activity. While no specific function is
known for CXXC-1/2 of Mbd1, the CXXC domain of Tet1 is
closely related to those in CXXC4/Idax and CXXC5/RINF that
were shown to mediate protein-protein interactions [46–48]. This
suggests that the CXXC domain of Tet1, rather than mediating
DNA binding, may function as a protein-protein interaction
domain. However, our data do not rule out the possibility that the
DNA binding properties of the CXXC domain within the context
of full length Tet1 may be different from those of the isolated
domain. Nevertheless, we show that the CXXC domain is not
required for enzymatic activity of Tet1 in vivo.
Although we observed a clear DNA binding activity by the
isolated CXXC domain of Dnmt1, we found that, within the
context of the full length enzyme, this domain is dispensable for
overall DNA binding properties, preference for hemimethylated
substrates upon covalent complex formation, methyltransferase
activity and allosteric activation as well as for the ability to restore
methylation of representative sequences in dnmt1 null ESCs.
Consistent with our data, a recent report showed a preference of
the CXXC domain of human DNMT1 for substrates containing
unmethylated CpG sites [32]. However, the same report showed
that deletion of the CXXC domain from the human enzyme
results in a significant decrease in methyltransferase activity on
hemimethylated substrates in vitro and 25% lower methylation at
rDNA repeats upon overexpression in HEK293 cells, suggesting a
dominant negative effect of the deletion construct. These
discrepancies may be due to the fact that the fragment deleted
by Pradhan et al. includes the N-terminal strand of the predicted
antiparallel b-sheet, potentially leading to disruption of native
folding, to species-specific differences and/or to the analysis of
non-physiological expression levels in HEK293 cells. In our
trapping assay the same human deletion mutant showed reduced
covalent complex formation, consistent with loss of enzymatic
activity. The report from Pradhan et al. also showed that mutation
of cysteine 667 to glycine within the CXXC domain of human
Figure 6. The CXXC deletion construct of Dnmt1 restores methylation in dnmt1 null cells. Mouse dnmt12/2 ESCs transiently expressing
GFP-Dnmt1 or GFP-Dnmt1DCXXC were isolated by FACS-sorting 48 h after transfection and CpG methylation levels within the indicated sequences
were analyzed by bisulfite treatment, PCR amplification and direct pyrosequencing. Methylation levels of untransfected wild type and dnmt12/2 ESCs
are shown for comparison.
doi:10.1371/journal.pone.0016627.g006
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DNMT1 disrupts DNA binding and enzymatic activity. However,
as this point mutation involves one of the zinc coordinating
residues it is not unlikely to alter peptide folding with negative
consequences potentially extending beyond the CXXC domain
and including reduced enzymatic activity. In this respect the
dominant negative effect observed upon overexpression of this
mutant may be explained by the prevalent occurrence of Dnmt1
as a dimer [49]. These observations, together with preserved
ability for covalent complex formation and catalytic activity of our
CXXC domain deletion, support the validity of our homology
model-driven approach for functional characterization of the
CXXC domain. In addition, our genetic complementation
approach constitutes a rather physiologic functional assay.
However, due to the transient approach and the analysis of
genomic methylation at only a few representative sequences, subtle
or highly sequence specific effects of deletion of the CXXC
domain cannot be excluded.
It was recently shown that binding of Cfp1/CGBP and
KDM2A to CpG islands through their CXXC domains leads to
local enrichment and depletion of H3K4 and H3K36 methylation,
respectively [26,30]. Analogously, Dnmt1 may bind CpG islands
through its CXXC domain. However, this interaction would not
lead to a straightforward functional interpretation as CpG islands
with high CpG density are generally refractive to DNA
methylation and a function of Dnmt1 as a de novo DNA
methyltransferase is not well established. It could be envisaged
that binding to unmethylated CpG sites/islands by the CXXC
domain may have a negative effect on the enzymatic activity of
Dnmt1 and restrain its function as a de novo DNA methyltrans-
ferase. However, we show that in dnmt1 null ESCs methylation of
the imprinted H19a promoter is not restored upon expression of
either wild type or DCXXC Dnmt1 constructs, arguing against a
negative regulatory function of the CXXC domain.
Notably, binding of unmethylated CpG sites by KFGG motif-
containing CXXC domains does not exclude a role in protein-
protein interaction as the CXXC domain of MLL1 was reported
to interact with both DNA and Polycomb Repressive Complex 1
components HPC2/CBX4 and BMI-1 [21,50]. Therefore, it is
possible that the CXXC domain of Dnmt1 has regulatory
functions in specific cell types or developmental stages that may
involve DNA binding and/or interaction with other proteins. The
generation of dedicated animal models may be instrumental for
testing these possibilities.
Materials and Methods
Bioinformatic methods
Alignments were performed using the ClustalW2 software [51].
The CXXC domain homology tree (Figure 1C) was generated
from the alignment in Figure 1B with Jalview 2.4 by unweighted
pair group method with arithmetic mean (UPGMA). The
neighbor-joining method gave the same result. Average distances
between the sequences were calculated using the BLOSSUM62
matrix. The human CXXC10 coding sequence [52] was
determined by assembling ESTs AI438961, BX114363,
BX492895, BU633058.1, AW207644.1 and the genomic sequence
AC073046.7. The putative translational start site is located
16308 bp upstream of the annotated transcriptional start site of
TET3. A partial coding sequence of murine Cxxc10 containing
the CXXC domain was identified by aligning the human
CXXC10 protein sequence to the ORFs present in
NT_039353.7 upstream of the tet3 gene from position 35663306
to 35808487). A very high match was found 13266 nt upstream of
tet3 at positions 35676374-35676572 of NT_039353.7. To build
homology models for the CXXC domains of Dnmt1 (aa 645–696)
and Tet1 (aa 561–614), we submitted the respective sequences to
the HHpred server [53]. The best template was the CXXC
domain of MLL1 (PDB-ID: 2J2S). The 49 residues of the CXXC
domain in Dnmt1 can be aligned to this domain with 45%
sequence identity and only a single amino acid gap after residue
661 (Figure 1B). 3D models were calculated with the homology
modeling software MODELLER [54] (version 9.5) using this
alignment. Distance restraints were given to MODELLER to
enforce a distance of 2.360.1 A˚ between the eight sulphurs in the
Zn-coordinating cysteines and the Zn2+ ions. TM-align [55] was
used to superpose the model structure with the template domain.
Images were generated using the PyMol Molecular Graphics
System (Version 1.3, Schro¨dinger, LLC). The quality of the
models and the underlying alignments were checked with DOPE
[56] and Verify3D [57] and results for both models were found to
be comparable to the MLL1 template structure (2J2S).
Expression constructs
Fusion constructs were generated using enhanced green
fluorescent protein, monomeric red fluorescent protein or
monomeric cherry and are here referred to as GFP, RFP and
Cherry fusions, respectively. Mammalian expression constructs for
GFP, mouse GFP-Dnmt1, GFP-NTR and human RFP-PCNA
were described previously [42,44,49,58]. The deletion construct
GFP-Dnmt1DCXXC was obtained by replacing the sequence
coding for aa 655–696 with three alanine codons in the GFP-
Dnmt1 construct as described [59]. The GFP-DNMT1DCXXC
construct was generated by subcloning the sequence coding for
human DNMT1DCXXC from the homonymous construct by
Pradhan et al. [32] in the pEGFP-C2 vector (Clonetech). To
generate GFP-Tet1 three partially overlapping fragments span-
ning the Tet1 coding sequence were amplified using E14 ESCs
cDNA as template. The fragments were then joined by overlap
extension PCR and inserted into the pCAG-GFP-IB vector [43].
To generate GFP-Tet1DCXXC aa 569-621 of murine Tet1 were
deleted from GFP-Tet1 using a type IIs restriction endonuclease
approach as described [60]. To generate GFP-CXXCDnmt1 and
GFP-CXXCTet1 sequences coding for the respective CXXC
domains (aa 643-700 for Dnmt1 and 561-614 for Tet1) were
amplified by PCR using the GFP-Dnmt1 expression construct and
cDNA from E14 ESCs as templates, respectively. PCR fragments
were then inserted into the pCAG-GFP-IB vector. GFP-
NTRDCXXC was obtained by replacing the BglII-XhoI fragment
of GFP-NTR with the same fragment of GFP-Dnmt1DCXXC. Ch-
CTD-His was generated by replacing the GFP coding sequence in
a GFP-CTD construct [49] with the Cherry coding sequence. All
constructs were confirmed by sequencing.
Cell culture, transfection and cell sorting
HEK293T cells [61] and mouse C2C12 myoblasts [62] were
cultured in DMEM supplemented with 50 mg/ml gentamicin and
10% and 20% fetal calf serum, respectively. For expression of
fusion proteins HEK293T cells were transfected with polyethy-
lenimine (Sigma). For live cell imaging, C2C12 cells were grown
to 40% confluence on Lab-Tek chambers (Nunc) or m-slides
(Ibidi) and transfected with TransFectin transfection reagent
(BioRad) according to the manufacturer’s instructions. Mouse
ESCs were cultured as described [63] and transfected with
FuGENE HD (Roche) according to the manufacturer’s instruc-
tions. ESCs were sorted with a FACS Aria II instrument (Becton
Dickinson). The dnmt12/2 J1 ESCs used in this study are
homozygous for the c allele [14].
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In vitro DNA binding and trapping assays
In vitro DNA binding and trapping assays were performed as
described previously [36,37] with the following modifications.
DNA substrates labeled with four different ATTO fluorophores
(Tables S1 and S2 in File S1) were used at a final concentration of
125 nM each in the pull-down assay with immobilized GFP
fusions. After removal of unbound substrate, the amounts of
protein and DNA were determined by fluorescence intensity
measurements with a Tecan Infinite M1000 plate reader using
calibration curves from purified GFP or DNA coupled ATTO
fluorophores, respectively. The following excitation/emission 6
detection bandwidth settings were used: 490/511610 nm for
GFP, 550/580615 nm for ATTO550, 600/630615 nm for
ATTO590, 650/670610 nm for ATTO647N and 700/
720610 nm for ATTO700. Cross detection of GFP and different
ATTO dyes was negligible with these settings. Binding and
trapping ratios were calculated dividing the concentration of
bound DNA substrate by the concentration of GFP fusion on
the beads.
In vivo mC hydroxylation assay
Genomic DNA was isolated from HEK293T cells 24 h after
transfection with the GFP-Tet1 and GFP-Tet1DCXXC constructs
and global hmC levels were measured using the in vitro
glucosylation assay as previously described [63], except that
100 nM b-glucosyltransferase and only UDP-[3H]glucose donor
(0.43 mM) were used.
Co-immunoprecipitation
Co-immunoprecipitation was performed as described previously
[49,64]. Shortly, HEK293T cells were transiently co-transfected
with expression plasmids for GFP fusions and the Ch-CTD-His
construct, harvested and lysed. GFP fusions were pulled down
using the GFP-Trap [65] (Chromotek) and subjected to western
blotting using anti-GFP (Roche or Chromotek) and anti-His
(Invitrogen) monoclonal antibodies.
Live cell microscopy, FRAP analysis and live cell trapping
assay
Live cell imaging and FRAP experiments were performed as
described previously [43]. For each construct 6-15 nuclei were
averaged and the mean values as well as the standard errors were
calculated. For presentation, we used linear contrast enhancement
on entire images. The DNA methyltransferase trapping assay was
described previously [44]. Briefly, transfected cells were incubated
with 30 mM 5-aza-dC (Sigma) for the indicated periods of time
before photobleaching experiments. FRAP analysis was performed
with a confocal laser scanning microscope (TCS SP5, Leica)
equipped with a 636/1.4 NA Plan-Apochromat oil immersion
objective. Microscope settings were as described except that a
smaller region of interest (3 mm63 mm) was selected for photo-
bleaching. Mean fluorescence intensities of the bleached region
were corrected for background and for total loss of nuclear
fluorescence over the time course, and normalized by the mean of
the last 10 prebleach values.
DNA Methylation Analysis
Genomic DNA was isolated with the QIAmp DNA Mini Kit
(Qiagen) and 1.5 mg were bisulfite converted using the EZ DNA
Methylation-Gold Kit (Zymo research) according to the manu-
facturer’s instructions. Primer sets and PCR conditions for IAP-
LTR, skeletal a-actin and H19 promoters were as described [43].
Primer sequences for major satellites were AAAATGAGAAA-
CATCCACTTG (forward primer) and CCATGATTTT-
CAGTTTTCTT (reverse primer). For amplification we used
Qiagen Hot Start Polymerase in 1x Qiagen Hot Start Polymerase
buffer supplemented with 0.2 mM dNTPs, 0.2 mM forward
primer, 0.2 mM reverse primer, 1.3 mM betaine (Sigma) and
60 mM tetramethylammonium-chloride (TMAC, Sigma). Pro-
moter regions and IAP-LTR were amplified with two subsequent
(nested) PCR reactions and major satellite repeats were amplified
with a single amplification reaction. Pyrosequencing reactions
were carried out by Varionostic GmbH (Ulm, Germany).
Pyrosequencing primers are listed in Table S3 in File S1.
Supporting Information
File S1 Tables S1–S3, Figures S1–S8 and Supplemental
methods.
(PDF)
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Table S1. Sequences of DNA oligonucleotides used for preparation of double stranded DNA 
substrates. M: 5-methylcytosine. 
Name Sequence 
CG-up 5’- CTCAACAACTAACTACCATCCGGACCAGAAGAGTCATCATGG -3’ 
MG-up  5’- CTCAACAACTAACTACCATCMGGACCAGAAGAGTCATCATGG -3’ 
noCG-up 5’- CTCAACAACTAACTACCATCTGGACCAGAAGAGTCATCATGG -3’ 
Fill-In-550 5’- ATTO550-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-590 5’- ATTO590-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-647N 5’- ATTO647N-CCATGATGACTCTTCTGGTC -3’ 
Fill-In-700 5’- ATTO700-CCATGATGACTCTTCTGGTC -3’ 
 
Table S2. DNA substrates used for the in vitro DNA binding and trapping assays. 
Name CpG site Label Oligo I Oligo II dCTP reaction  Purpose 
noCGB 700 no CpG site 700 noCG-up Fill-In-700 dCTP Binding 
UMB 550 
unmethylated 
550 
CG-up 
Fill-In-550 
dCTP Binding 
UMB 590 590 Fill-In-590 
UMB 647N 647N Fill-In-647N 
UMB 700 700 Fill-In-700 
UMT 550 550 Fill-In-550 5-aza-dCTP Trapping
HMB 590 
hemimethylated 
590 
MG-up 
Fill-In-590 
dCTP Binding 
HMB 647N 647N Fill-In-647N 
HMT 550 550 Fill-In-550 
5-aza-dCTP Trapping
HMT 647N 647N Fill-In-647N 
FMB 647N fully methylated 647N MG-up Fill-In-647N 5methyl dCTP Binding 
 
Table S3. Primers used for pyrosequencing. Each primer is biotinylated at the 5’ end. 
Name Sequence 
skeletal α-actin-1 5’- AGTTGGGGATATTTTTTATA -3’ 
skeletal α-actin-1b  5’- TTTTGGTTAGTGTAGGAGAT -3’ 
skeletal α-actin-2 5’- TGGGAAGGGTAGTAATATTT -3’ 
H19-1 5’- ATAGTTATTGTTTATAGTTT -3’ 
H19-2 5’- AGGAATATGTTATATTTAT -3’ 
IAP LTR-1 5’- CCCTAATTAACTACAACCCA -3’ 
IAP LTR-2 5’- TGTAGTTAATTAGGGAGTGA -3’ 
Major Satellite-1 5’- AAAATGAGAAATATTTATTTG -3’ 
Major Satellite-2 5’- GAGAAATATATACTTTAGGA -3’ 
Frauer et al.  Supplemental Information File 
3 
 
 
 
 
 
 
Figure S1. Dnmt1 domain structure and alignment of Dnmt1 CXXC domains from different 
species. Numbers on the right side indicate the position of the last amino acid in each 
sequence. PBD: PCNA binding domain; TS: targeting sequence; CXXC: CXXC-type zinc 
finger domain; BAH1 and 2: bromo-adjacent homology domain; (KG)7: seven lysine-glycine 
repeats. Absolutely conserved residues are highlighted in red. Positions with residues in red 
face share 70% similarity as calculated with the Risler algorithm {Mohseni-Zadeh, 2004 
#133}. The alignment was generated with ClustalW2 and displayed with ESPript 2.2. 
GenBank accession numbers are: Mus musculus: NP_034196; Homo sapiens: 
NP_001124295; Bos taurus: NP_872592; Monodelphis domestica: NP_001028141; Gallus 
gallus: NP_996835; Xenopus laevis: NP_001084021; Danio rerio: NP_571264; 
Paracentrotus lividus: Q27746 (Swiss Prot); Apis mellifera: NP_001164522 (Dnmt1a); 
Bombyx mori: NP_001036980. 
Frauer et al.  Supplemental Information File 
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Figure S2. The cellular localization of GFP-CXXCDnmt1 is independent of cell cycle stage. 
Live images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCDnmt1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S3. Differential mobility of GFP-CXXCDnmt1 in nucleoli and nucleoplasm of mouse 
C2C12 myoblasts measured by FRAP analysis. Identical regions of interest over the 
nucleoplasm or nucleoli (as exemplified in the inset) were bleached and recovery curves were 
recorded over 30 seconds. GFP-CXXCDnmt1 kinetics is faster in nucleoli than in the nucleus, 
which indicates more transient (possibly unspecific) binding in the former than in the latter. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S4. GFP fusion pulldowns from transiently transfected HEK293T cells using the 
GFP-trap. Shown is a SDS polyacrylamide gel stained with coomassie blue. I = input (1%); B 
= bound (10%). 
Frauer et al.  Supplemental Information File 
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Figure S5. The CXXC domain of Dnmt1 preferentially binds unmethylated CpG sites. GFP 
and GFP-CXXCDnmt1 purified from transiently transfected HEK293T cells with the GFP trap 
were challenged with fluorescent DNA substrates containing no CpG site or one central un-, 
hemi- or fully methylated CpG site in direct competition (noCGB, UMB, HMB and FMB, 
respectively) as in Figure 2C, except that a five-fold higher concentration (625 nM) of each 
substrate was used. 
Frauer et al.  Supplemental Information File 
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Figure S6. The cellular localization of GFP-CXXCTet1 is independent of cell cycle stage. Live 
images of C2C12 mouse myoblasts cotransfected with expression constructs for 
GFP-CXXCTet1 and RFP PCNA. The latter served for identification of the cell cycle stage. 
Scale bar: 5 µm. 
Frauer et al.  Supplemental Information File 
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Figure S7. Radioactive methyltransferase activity assay for GFP Dnmt1 and 
GFP-Dnmt1∆CXXC. The transfer of [3H]-methyl groups to poly(dI•dC)-poly(dI•dC) substrate 
was measured for increasing volumes of GFP fusion proteins immunopurified from 
transiently transfected HEK293T cells. Counts per minute (cpm) were normalized to the 
relative protein concentration as determined by SDS-PAGE analysis. GFP was used as 
negative control. Numbers above the bars indicate the volume (µl) of protein solution added. 
Frauer et al.  Supplemental Information File 
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Figure S8. Competitive DNA binding and trapping assays for human GFP-DNMT1 and 
GFP-DNMT1∆CXXC. GFP, GFP-DNMT1 and GFP-DNMT1∆CXXC were purified from 
transfected HEK293T cells using the GFP-trap and incubated with fluorescent DNA 
substrates containing one central unmethylated (UM) or hemimethylated (HM) CpG site in 
direct competition. Both substrates contained either dC (binding) or 5 aza dC (trapping) on the 
strand opposite to the differentially methylated one. The comparison of binding and trapping 
ratios reflects irreversible covalent complex formation. Note the reduction in trapping of 
GFP-DNMT1∆CXXC relative to GFP-DNMT1 by the hemimethylated substrate. Shown are 
mean values and standard deviation of DNA/protein ratios from two independent 
experiments. 
Frauer et al.  Supplemental Information File 
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SUPPLEMENTARY METHODS 
 
In vitro methyltransferase activity assay 
Eight milligrams of His-tagged GFP-binding protein (GBP; Chromotek) were coupled to 1ml 
Ni-NTA agarose beads (Qiagen) by incubating for 2 h at 4°C in PBS and unbound protein 
was washed out twice with PBS. Extracts of HEK293T cells expressing GFP or a GFP fusions 
were prepared in 200 µl lysis buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM 
imidazole, 0.5 % Tween-20, 2 mM MgCl2, 1 mg/ml DNaseI, 2 mM PMSF, 1X mammalian 
protease inhibitor mix). After centrifugation, supernatants were diluted to 500 µl with 
immunoprecipitation buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole, 
0.05 % Tween-20) and precleared by incubation with 25 µl of equilibrated Ni-NTA agarose 
beads for 30 min at 4°C followed by centrifugation. Precleared extracts were then incubated 
with 40 µg of His-tagged GFP-trap coupled to Ni-NTA beads for 2 h at 4°C with constant 
mixing. GFP or GFP fusions were pulled down by centrifugation at 540 g. After washing 
twice with wash buffer II (50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.05 
% Tween-20), complexes were eluted with 60 µl of elution buffer (10 mM Tris pH 7.5, 100 
mM KCl, 1 mM EDTA, 1 mM DTT, 250 mM imidazole) for 10 min at 25°C with constant 
mixing. 10 µl aliquots of all eluates were subjected to western blot analysis using mouse or rat 
monoclonal antibodies to GFP (Roche and Chromotek, respectively) and quantified by 
densitometry. Indicated volumes of eluate were incubated with 1 µg of poly(dI·dC)- 
poly(dI·dC) substrate (Sigma), 0.5 µg/µl of BSA and 1 µCi of S-adenosyl-[3H-
methyl]-methionine in 50 µl of trapping buffer (10 mM Tris pH 7.5, 100 mM KCl, 1 mM 
EDTA, 1 mM DTT) for 60 min at 37°C. 15 µl of each sample were spotted onto blotting 
paper and the DNA was precipitated with ice cold 5 % TCA. After washing twice with 5% 
TCA and once with cold 70 % ethanol, paper filters were air dried and analyzed by 
scintillation in 4 ml scintillation cocktail (Rotiszint® eco plus, Roth) for 5 min. 
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2.3. UHRF1 PLAYS MULTIPLE ROLES IN THE REGULATION OF DNA 
METHYLTRANSFERASE 1 
RESULT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
Qin et al., 2011  
 
Uhrf1 plays multiple roles in the regulation of DNA methyltransferase 1 
 
Weihua Qin, Karin Fellinger, Henrike Klinker, Garwin Pichler, Carina Frauer, 
Fabio Spada* and Heinrich Leonhardt* 
 
Ludwig Maximilians University and Center for Integrated Protein Science Munich (CIPSM), 
Department of Biology II, Großhaderner Str. 2, 82152 Planegg-Martinsried, Germany. 
 
 
 
Corresponding authors: FS: f.spada@lmu.de; Fax +49 89 2180-74236; Tel. +49 89 2180-
74230 
HL: h.leonhardt@lmu.de; Fax +49 89 2180-74236; Tel. +49 89 2180-74232 
 
 
 
 
 
 
 
 
 
Key words: Uhrf1; ubiquitination; DNA methylation; Dnmt1 
 
 1
Qin et al., 2011  
 
Abstract 
In mammals Dnmt1 is the major DNA methyltransferase responsible for maintaining 
genomic methylation patterns after DNA replication. Uhrf1, a crucial cofactor of Dnmt1, was 
suggested to recruit Dnmt1 to hemimethylated CpG sites. In this study, we show that the 
interaction of Dnmt1 with Uhrf1 is essential but not sufficient for maintenance of DNA 
methylation and that the PHD and Ring domains of Uhrf1 are involved in Dnmt1 recruitment. 
A deletion mutant of Dnmt1 lacking amino acids (aa 459-501) essential for the interaction 
with Uhrf1 is enzymatically active in vitro. Interestingly, this mutant is unable to methylate 
naked hemimethylated DNA when cell extracts were added to the methylation reaction, 
suggesting that activation and inhibition of Dnmt1 occur in vivo. Uhrf1 did inhibit 
maintenance of DNA methylation by competitively binding hemimethylated CpG sites in 
vitro. These results suggest that Uhrf1 plays multiple roles in the maintenance of DNA 
methylation. We propose that in vivo maintenance of DNA methylation by Dnmt1 might 
involve three steps: recruitment, access and enzymatic activation.  
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Introduction 
Vertebrate genomes are modified by DNA methylation at the C5 position of cytosine residues, 
mostly within cytosine-guanine dinucleotides (CpG). DNA methylation is involved with 
imprinting, X-chromosome inactivation, stable transcriptional repression, genome stability 
and tumorigenesis (Bird, 2002). Establishment of DNA methylation patterns is mediated by 
de novo methyltransferases Dnmt3a and Dnmt3b during gametogenesis and early 
development, and is maintained by maintenance methyltransferase Dnmt1 after DNA 
replication. 
Dnmt1 is a relatively large protein comprising a N-terminal regulatory region, which covers 
two thirds of the molecule, and a C-terminal catalytic domain which contains all essential 
motifs of active C5 DNA methyltransferases. The N-terminal domain mediates the 
subcellular distribution of Dnmt1 during the cell cycle and controls enzymatic activity. 
Dnmt1 associates with proliferating cell nuclear antigen (PCNA) at replication sites via 
PCNA binding domain (PBD; Chuang et al., 1997; Leonhardt et al., 1992). The association of 
Dnmt1 with the replication machinery enhances methylation efficiency, but is not strictly 
required for postreplicative maintenance of DNA methylation (Schermelleh et al., 2007; 
Spada et al., 2007). A targeting sequence (TS domain) mediates Dnmt1 dimerization 
(Fellinger et al., 2009) and targets Dnmt1 to pericentric heterochromatin (Easwaran et al., 
2004). A recent crystal structure shows that the TS domain inserts into the DNA binding 
pocket of the catalytic domain, suggesting a role in autoinhibition in the regulation of Dnmt1 
activity (Syeda et al., 2011; Takeshita et al., 2011). The CXXC-type zinc finger domain of 
Dnmt1 preferentially binds to unmethylated DNA (Frauer et al., 2011). Another recent crystal 
structure of Dnmt1 incomplete with unmethylated DNA suggests that the linker between 
CXXC and the bromo-adjacent homology 1 (BAH1) domain inhibits de novo activity of 
Dnmt1 by blocking the catalytic center (Song et al., 2011).  
Uhrf1, also known as Np95 (mouse) or ICBP90 (human), is involved in maintenance of DNA 
methylation by Dnmt1. Mice lacking uhrf1 show a similar phenotype to that observed in 
dnmt1 null mice, which is genomic hypomethylation and developmental arrest at embryonic 
day 9.5 (Bostick et al., 2007; Sharif et al., 2007). Uhrf1 shows a preferential binding to 
hemimethylated DNA and histone H3 tail containing trimethylated lysine 9 (Rottach et al., 
2010). In addition, Uhrf1 harbors a Ring domain and endows ubiquitin E3 ligase activity in 
vitro, which is required for the growth regulation of tumor cells (Jenkinis et al., 2005; Citterio 
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et al., 2004). Recently we reported that the ubiquitination state and stability of Dnmt1 
controlled by Uhrf1 and the ubiquitin specific protease Usp7 (Qin et al., 2011). 
Here we aimed at elucidating the role of Uhrf1 in controlling maintenance of DNA 
methylation by Dnmt1. The interaction of Dnmt1 with Uhrf1 was mapped to the TS domain. 
Moreover, a Dnmt1 mutant lacking part of the TS domain, Dnmt1∆TS, failed to restore DNA 
methylation patterns in dnmt1-/- embryonic stem cells (ESCs). Similarly, two Uhrf1 mutants 
with single amino acid substitution in the PHD and Ring domains, H346G and H730A, 
respectively, could not rescue DNA methylation patterns in uhrf1-/- ESCs. These data suggest 
that the interaction between Dnmt1 and Uhrf1 is necessary but not sufficient for propagation 
of DNA methylation. Interestingly, we showed that Dnmt1∆TS is enzymatically inactive when 
cell extracts were added to methylation reaction, implicating that the effect on DNA 
methylation is not only due to a failure in recruiting Dnmt1, but also a lack of enzymatic 
activation. In vitro Uhrf1 inhibits DNA methylation by competitively binding 
hemimethylated CpG sites. These results suggest that Uhrf1 plays multiple roles in 
maintenance of DNA methylation by Dnmt1. Thus, we propose that in vivo maintenance of 
DNA methylation might involve three steps: recruitment, access and enzymatic activation. 
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Result 
TS domain of Dnmt1 is required for the interaction with Uhrf1 
Uhrf1 was suggested to target Dnmt1 to hemimethylated CpG sites. To investigate the 
mechanism of recruitment, we first mapped the domains involved in the interaction of Dnmt1 
with Uhrf1 by co-immunoprecipitation (Fig. 1B and D). Our data showed that the N-terminal 
part, but not the C-terminal catalytic domain of Dnmt1, interacts with Uhrf1. Furthermore, 
the association with Uhrf1 was narrowed down to the conserved TS domain (Fig. 1B and 2B). 
Consistently, the Dnmt1 deletion construct lacking conserved region (aa 459-501, Dnmt1∆TS) 
did not interact with Uhrf1 (data not shown). Notably, an in vitro radioactive 
methyltransferase assay showed that Dnmt1∆TS is able to transfer the methyl group from 
donor of S-Adenosyl-L-Methionine (AdoMet) to poly(dI•dC)-poly(dI•dC) substrate (Fig. 2C). 
This data suggest that the catalytic activity of Dnmt1 is not affected by deletion of amino 
acids 459 to 501 in vitro. Similarly, the Ubl domain of Uhrf1 was found to mediate the 
interaction with Dnmt1 (Fig. 1D). 
 
Dnmt1∆TS cannot reestablish DNA methylation patterns in dnmt1-/- ESCs 
To test if the interaction of Dnmt1 with Uhrf1 is indeed required for maintenance of DNA 
methylation, embryonic stem cells (ESCs) where expression of endogenous Dnmt1 is 
abolished by genetic deletion (dnmt1-/-, C/C) were stably transfected with constructs for the 
expression of GFP fusion with either wild type Dnmt1 (Dnmt1wt) or Dnmt1∆TS. The resulting 
ESC lines express GFP-Dnmt1wt and GFP-Dnmt1∆TS as the only Dnmt1 protein.  In contrast 
to Dnmt1wt, Dnmt1∆TS did not colocalize with Uhrf1 and showed a dispersed distribution in 
the nucleus (Fig. 3A), suggesting that the interaction with Uhrf1 is essential for cellular 
localization of Dnmt1. The activity of Dnmt1wt and Dnmt1∆TS in living cells further was also 
tested by using an in vivo trapping assay developed by Schermelleh (Schermelleh et al., 2005). 
In this assay, cytosine analogue 5-aza-2’-deoxycytidine (5-aza-dC) is used. 5-aza-dC can 
form a covalent complex with the C6 position of the cytosine residue, if incorporated into 
DNA, which is in contrast to cytosine irreversible. Dnmt1 is therefore trapped at DNA 
replication foci. Trapped Dnmt1 fraction increases overtime and reflects enzymatic activity of 
Dnmt1. In ESCs stably expressing either GFP-Dnmt1wt or mutant GFP-Dnmt1∆TS, foci of 
immobilized GFP-Dnmt1wt emerged within 20 min (Fig. 3B). GFP-Dnmt1∆TS did not 
accumulate at replication foci even after 2 hours, suggesting that GFP-Dnmt1∆TS is unable to 
methylate DNA in the context of living cells. We next analyzed both global DNA 
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methylation levels and methylation patterns of specific sequence. Our data showed that GFP-
Dnmt1∆TS cannot reestablish the DNA methylation patterns in contrast to Dnmt1wt. 
Consistently the rescue experiment was also carried out in p53 and dnmt1 knockout somatic 
cells. After expression of GFP-Dnmt1∆TS the global DNA methylation level is similar to that 
observed in dnmt1-/- ESCs (Fig. S2). Moreover the re-methylation of specific genes 
sequences, like major satellites and skeletal α-actin promoters, did not occur (Fig. 3C and S1).  
In summary, GFP-Dnmt1∆TS does not interact with Uhrf1 and is able to methylate DNA 
substrate in vitro. However, GFP-Dnmt1∆TS cannot restore the DNA methylation patterns in 
dnmt1-/- ESCs, suggesting that the association of Dnmt1 with Uhrf1 is required to maintain 
DNA methylation in living cells. 
 
The PHD and Ring domains of Uhrf1 are functionally required for maintenance methylation 
To elucidate the functional mechanism of Dnmt1 recruitment by Uhrf1, we introduced point 
mutations in the PHD and Ring domain, (Uhrf1H346G and Uhrf1H730A, respectively). These 
mutations are expected to prevent coordination of zinc ions by zinc finger motifs. The 
preferential binding of Uhrf1 to hemimethylated DNA and trimethylated H3K9 was not 
affected by these mutations (Fig. S3 and S4). Also we tested whether the point mutations 
introduced in the PHD and Ring domains influence the interaction with Dnmt1. By co-
immunoprecipitation, Dnmt1 complex was precipitated by using RFP binder (Chromotek, 
Germany) from the cell lysate which transiently expressed RFP tagged Dnmt1 in combination 
with GFP-tagged wild type Uhrf1, or Uhrf1H346G or Uhrf1H730A. Co-precipitated Uhrf1 was 
visualized with a GFP antibody in all bound fractions, showing that both mutants still interact 
with Dnmt1 (Fig. 4A). Consistently the interactions were confirmed by a modified method of 
a recently developed fluorescent two-hybrid assay (F2H; Zolghadr et al., 2008). Uhrf1-GFP 
fusion constructs were used as baits by tethering them to a lac operator array present in BHK 
cells, so that the array was visible as a distinct nuclear spot of enriched GFP fluorescence. 
The RFP-Dnmt1 fusion (prey) accumulated at this spot when Uhrf1wt, Uhrf1H346G or 
Uhrf1H730A were used (Fig. 4B). Additionally, the data showed that the ubiquitin ligase 
activity of Uhrf1 was abolished by substitution of histidine 730 to alanine (Fig. S5). 
In order to clarify the role of the PHD and Ring domains in maintenance of DNA methylation, 
we stably expressed GFP tagged Uhrf1wt, or Uhrf1H346G or Uhrf1H730A in uhrf1-/- ESCs, 
respectively. In these ESCs, Uhrf1H346G-GFP and Uhrf1H730A-GFP showed a normal cellular 
localization and accumulate at heterochromatin comparable to Uhrf1wt-GFP (Fig. 4C). Thus, 
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the mutations do not affect localization of Uhrf1. Interestingly, Dnmt1 did not colocalize with 
Uhrf1H346G or Uhrf1H730A in contrast to Uhrf1wt and showed a dispersed distribution in 
nucleus. This observation is consistent with the result done by visualization of the 
colocalization between the mutants and the endogenous Dnmt1 (Fig. 4D). Similarly, we also 
analyzed DNA methylation level at specific loci. Indeed, our data showed that both 
Uhrf1H346G and Uhrf1H730A cannot rescue DNA methylation patterns in uhrf1-/- ESCs in 
contrast to Uhrf1wt (Fig. 4E).  
In summary, the interaction of Dnmt1 with Uhrf1 is essential but not sufficient for 
maintenance of DNA methylation, suggesting that the PHD and Ring domains are involved in 
recruiting Dnmt1 to hemimethylated CpG sites. 
 
Uhrf1 inhibits methylation of naked DNA and nucleosomal substrate by Dnmt1 
Since the PHD domain of Uhrf1 is involved in large-scale chromocenter reorganization, it 
can be speculated that Uhrf1 might modulate chromatin accessibility for Dnmt1. To test this 
hypothesis, an assay was established to test Dnmt1 activity on nucleosomal substrates in the 
presence or absence of Uhrf1. To generate the nucleosomal substrates, 200 base pairs of 
nucleosome positioning sequence (601 sequence; Fig. S6A; Lowary et al., 1998), that was 
un- or hemimethylated at CpG sites, was reconstituted with recombinant core histones by salt 
dialysis (Fig. S6B). These nucleosomal substrates and the corresponding naked DNA 
substrates were incubated with ESCs extracts stably expressing GFP-Dnmt1wt or GFP-
Dnmt1∆TS and methylation of the substrates was analyzed. In hemimethylated nucleosomal 
substrates only the linker DNA was methylated by extracts containing GFP-Dnmt1wt (Fig. 5A 
and 5B), suggesting that an enzymatic activation of Dnmt1 in vivo is required. To clarify the 
role of Uhrf1 at local chromatin sites, transiently expressed GFP fusion proteins were 
immunoprecipitated from HEK293T cell lysates and incubated with the same DNA and 
nucleosomal substrates as above. Methylation analysis showed that GFP-Dnmt1wt methylated 
the naked hemimethylated DNA (Fig. 6A). As the same with cell lysates, GFP-Dnmt1wt 
preferentially methylated the hemimethylated CpG in linker DNA, but not in the sequence 
wrapped with the histone octamer. Interestingly, a reduction of DNA methylation in the 
presence of Uhrf1 was observed (Fig. 6B). This effect is likely due to competitive binding of 
Uhrf1 to hemimethylated CpG sites, as deletion of the SRA domain abolished this influence 
on DNA methylation (Fig. 6C). Consistently, a time course experiment confirmed the 
inhibitory effect of Uhrf1 on DNA methylation by Dnmt1 (Fig. 6D). 
 7
Qin et al., 2011  
 
 8
Usp7 has an activating effect on the enzymatic activity of Dnmt1 
As the results above suggested that an activation of Dnmt1 is required in vivo, Uhrf1 however 
has an inhibitory function in maintenance of DNA methylation in vitro. Therefore, we next 
aimed to identify the proteins involved in the activation of Dnmt1. Since Usp7 was reported 
as a novel interacting protein with Dnmt1 in our previous study, the role of Usp7 was 
investigated by in vitro trapping assay (Frauer et al., 2009). In this approach, transiently 
expressed GFP fusion proteins were immunoprecipitated from HEK293T cell lysates and 
incubated with fluorescently labeled DNA substrates. Dnmt1 activity could be reflected by 
fluorescence intensity ratios of bound probe/bound GFP fusion. Notably, Dnmt1 activity on 
hemimethylated substrates was increased two-fold in the presence of GFP-Usp7 (Fig. 7), 
suggesting that Usp7 is an activator of Dnmt1.  
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Discussion 
Here we showed that the interaction of Dnmt1 with Uhrf1 is required for enrichment of 
Dnmt1 at DNA target sites in vivo. The PHD and Ring domains of Uhrf1 are involved in 
Dnmt1 recruitment. Importantly, these domains are not involved in the interaction of Uhrf1 
with either hemimethylated CpG sites (SRA domain) or Dnmt1 (Ubl domain). To clarify the 
mechanism of Dnmt1 recruitment, we tested Dnmt1 activity on nucleosomal substrates with 
or without Uhrf1. We showed that in hemimethylated nucleosomal substrates only the linker 
DNA was methylated and that Uhrf1 acts as a competitive inhibitor of Dnmt1 on naked DNA 
and mononucleosomal substrates. The mononucleosomal substrates in this study likely do not 
reflect the complexity of chromatin in vitro. We could not gain deeper insights into the 
mechanism by which Uhrf1 allows Dnmt1 to maintain DNA methylation. However, 
altogether our results strongly indicate that the role of Uhrf1 is far more complex than 
recruitment of Dnmt1 to hemimethylated CpG sites. The PHD domains have been reported to 
bind histone modifications and it might mediate Uhrf1 binding to another histone 
modifications in addition to trimethylated H3K9 (tandem Tudor domain). Recognition of 
“bivalent histone modification marks” by Uhrf1 might be required for Dnmt1 targeting to 
chromatin substrate in vivo. Therefore, histone modifications should be considered when 
making the chromatin substrates and the polynucleosomal substrates should be used. 
Additionally, in this study we observed that the Ring domain of Uhrf1 was also involved in 
maintenance of DNA methylation. In previous studies, Uhrf1 was shown to ubiquitinate core 
histones in vitro (Citterio et al., 2004). Ubiquitination of core histones by Uhrf1 might also 
modulate the accessibility of chromatin for the recruitment of Dnmt1. Mapping the 
ubiquitination sites of histones catalyzed by Uhrf1 might likely allow us to understand the 
mechanism of Dnmt1 targeting in vivo.  
A recent crystal structure shows that the TS domain plays an autoinhibition role by insertion 
into the catalytic DNA binding pocket of Dnmt1 (Takeshita et al., 2011), suggesting that an 
activation of Dnmt1 might be required. Here, we showed an opposite role of Uhrf1 and Usp7 
in the regulation of Dnmt1 activity. In our previous study we reported that the interaction 
between Dnmt1 and Usp7 was abolished by substitution of all lysine in the GK linker, 
suggesting a function of Usp7 in modulating the folding of Dnmt1, or in controlling the 
Dnmt1 activity by affecting the intra-molecular interaction of Dnmt1. Additionally, Uhrf1 
and Usp7 coordinately control the ubiquitination state of Dnmt1. Therefore, it is interesting to 
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investigate whether the inhibition and activation of Dnmt1 by Uhrf1 and Usp7, respectively, 
are ubiquitination dependent or independent. 
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Materials and Methods 
Expression constructs 
Expression construct for GFP-Dnmt1wt was described previously (Easwaran et al., 2004; 
Schermelleh et al., 2007). Different fragments of Dnmt1, named as GFP-Dnmt11-1111, GFP-
Dnmt11124-1620, GFP-Dnmt11-309, GFP-Dnmt1310-629 and GFP-Dnmt1630-1111 were cloned into 
pcDNA3-GFP by PCR amplification. Uhrf1wt-GFP, Uhrf1H346G-GFP and Uhrf1H730A-GFP 
constructs for expression were cloned into pCAG-GFP-IRES-IP vector. The expression 
construct for HA-tagged ubiquitin was kindly provided by Stefan Jentsch (MPI Biochemistry, 
Germany). All constructs were verified by DNA sequencing. 
 
Cell culture and transfection  
Human embryonic kidney (HEK) 293T cells and baby hamster kidney (BHK) cells were 
cultured in DMEM supplemented with 10% fetal calf serum and 50 µg/ml gentamycine (PAA, 
Germany). The embryonic stem cells (ESCs) here used, including wild type J1, dnmt1-/-, E14 
and uhrf1-/- cultured without feeder cells in gelatinized flasks as described (Schermelleh et al., 
2005). The dnmt1-/- ESCs used in this study are homozygous for the c allele (Lei et al., 1996). 
Mouse ESCs were transfected with FuGENE HD (Roche) according to the manufacturer’s 
instructions and sorted with a FACS Aria II instrument (Becton Dikinson). HEK293T cells 
and BHK cells were transfected using polyethylenimine as transfection reagent (Sigma, 
Germany) according to the manufacturer’s instructions. Cell fixation and microscopy were 
carried out as described by Zolghadr et al. (2008).  
 
Co-immunoprecipitation and Western blotting 
Extracts from HEK293T cells were prepared in lysis buffer (20 mM Tris–HCl (pH 7.5), 0.5 
mM EDTA, 1 μg/μl DNase I, 2 mM MgCl2, 2 mM phenylmethyl sulphonyl fluoride and 
0.5% NP40) containing 150 mM NaCl and diluted with lysis buffer without NP40. GFP trap 
(Rothbauer et al, 2008) was used for immunoprecipitation of GFP fusion proteins. GFP trap 
was washed twice with dilution buffer containing 300 mM NaCl and re-suspended in SDS–
PAGE sample buffer.  
Rabbit antisera were used for detection of Dnmt1 and Uhrf1 (Grohmann et al, 2005; Citterio 
et al., 2004). Horseradish peroxidase-conjugated rabbit anti-mouse or goat anti-rabbit 
secondary antibodies (Sigma) and ECL Plus reagent (GE Healthcare, Munich, Germany) 
were used for detection. 
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DNA methylation assay 
Genomic DNA was isolated with the QIAmp DNA Mini Kit (Qiagen) and was bisulfate 
converted using the EZ DNA Methylation-Gold Kit (Zymo research) according to the 
manufacturer’s instructions. 
For in vitro methylation, GFP-Dnmt1 was purified by immunoprecipitation from HEK293T 
cells over-expressed GFP-Dnmt1. The concentration of GFP-Dnmt1 in bound fraction is 
measured by TECAN reader. Incubate 3 μg of GFP-Dnmt1 with 88 ng of DNA template in 
the methylation buffer containing 160 μM of SAM, 100 ng/μl of BSA at 37°C for 3 hours. 
After inactivation of reaction at 65°C for 30 min, the DNA was isolated with Nucleospin 
PCR cleaning kit (Macherey-Nagel) and bisulfate treated with EZ DNA Methylation-Gold 
Kit (Zymo research). Primer sequences for 601 DNA were TGTATGTATTGAATAG 
(forward primer) and TACACAAAATATATATATC (reverse primer). For amplification we 
used Qiagen Hot Start Polymerase in 1x Qiagen Hot Start Polymerase buffer supplemented 
with 0.2 mM dNTPs, 0.2 µM forward primer, 0.2 µM reverse primer, 1.3 mM betaine (Sigma) 
and 60 mM tetramethylammonium-chloride (TMAC, Sigma). Pyrosequencing reactions were 
carried out by Varionostic GmbH (Ulm, Germany). 
To measurement of total DNA methylation level, a slot blot assay was used. In this assay, a 
series amount of genomic DNA, including 150, 300 and 600 ng, were loaded into nylon 
membrane. 5mC antibody is used to detect the methylation level and anti single strand DNA 
was used to normalization (IBL, Japan). 
 
Preparation of reconstituted mononucleosomes 
601 DNA was kindly provided by Peter Becker’s group. In order to get enough unmodified 
DNA templates, the 601 DNA sequences were amplified with primers: 
TGCATGTATTGAACAG (forward) and TGCACAGGATGTATATATC (reverse).  
To prepare the hemimethylated DNA, an efficient method for preparation of long 
heteroduplex DNA was used as described (Thomas et al., 2002). In this strategy, one pairs of 
modified PCR primers were synthesized, which are labeled with phosphate at 5’-end, like 5‘-
phosphorylated-TGCATGTATTGAACAG-3’ and 5‘-phosphorylated-
TGCACAGGATGTATATATC-3’. To get single and up-strand DNA, the DNA was 
amplified with the reverse primer labeled with phosphate at 5’-end, following a lambda-
nuclease digestion (NEB). The same procedure is required for making low-strand DNA. 
However, in order to prepare the methylated low-strand DNA, one more step, in vitro 
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methylation by bacterial methyltransferase M.SssI (NEB), is required before treatment with 
lambda-nuclease. In the end, the equal amount of up and low strand DNA were mixed and 
incubated at 95°C for 5 min, followed annealing. 
To get rid of contamination from double strand DNA after lambda-nuclease treatment, the 
hydroxyapatite chromatography was carried out. Hydroxyapatite column was packaged 
according to the manufacturer’s instructions (Sigma) and the single strand DNA was eluted 
by elution buffer containing 150 mM sodium phosphate.  
 
Histone ubiquitination assay 
HEK293T cells were transfected with HA-ubiquitin alone or in combination with Uhrf1wt-
GFP and Uhrf1H730A-GFP. Histone core particles then were isolated as described (Shechter et 
al., 2007). Ubiquitinated histones were visualized by HA antibody.  
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Figure legend 
 
Figure 1. Mapping the interaction of Dnmt1 with Uhrf1 
(A) Schematic representation of Dnmt1 and its fragments. Dnmt1 is a relative large protein 
comprising a N-terminal regulatory domain and a catalytic domain. The N-terminal 
regulatory domain harbors several functional subdomains: a PCNA binding domain (PBD), a 
targeting sequence (TS) domain, a zinc finger domain (ZnF) and two bromo-adjacent 
homology domains (BAH1 and BAH2). 
(B) The N-terminal domain, but not the C-terminal catalytic domain of Dnmt1, is responsible 
for the interaction with Uhrf1. HEK293T cells were transiently transfected with constructs 
expressing for Uhrf1-his in combination with GFP-Dnmt1wt, or GFP-Dnmt11-1111, or GFP-
Dnmt11-309, or GFP-Dnmt1310-629, GFP-Dnmt1630-1111 or GFP-Dnmt11124-1620. GFP fusion 
proteins were immunoprecipitated with GFP trap. Bound fraction was separated by SDS-
PAGE and detected by anti-his antibody.  
(C) Schematic representation of Uhrf1 and its fragments. Uhrf1 harbors several functional 
domains, an ubiquitin-like domain (Ubl), a plant and homeodomain (PHD), a set and ring 
associated domain (SRA) and a really interesting new gene (Ring). 
(D) Ubl domain is required for the interaction between Dnmt1 and Uhrf1. 
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Figure 2. The amino acids of 459 to 501 are essential for the interaction between the TS 
domain and Uhrf1.  
(A) Dnmt1 structure and alignment of the TS domain from amino acids 459 to 501 in various 
species. Several conserved amino acids in all species were highlighted in gray. NCBI 
accession numbers of Dnmt1 from different species are as follows: M. musculus, NP_034196; 
B. Taurus, NP_872592.2; R. norvegicus, NP_001003959.1; O. sativa, B1Q3J6.1; C. 
familiaris, XP_533919; M. domestica, NP_001028141.1; H.sapiens, NP_008823.1; D. rerio, 
NP_571264.1; X. helleri, AAF73200; X. laevis, NP_001084021.1; G. gallus, NP_996835.1; 
P. lividus, CAA90563.1; B. mori, NP_001036980.1; A. thaliana, NP_199727.1; Z. mays, 
NP_001105186.1; O. aries, NP_001009473.1; D. carota, AAC39356.1. 
(B) The amino acids 459-501 in the TS domain are required for the interaction between the 
TS domain and Uhrf1. His tagged Uhrf1 was transiently expressed in HEK293T cells with 
GFP-TS310-629, GFP-TS∆459-501 or GFP-TSG474E. GFP fusion proteins were precipitated by 
GFP trap and Uhrf1 proteins were detected by anti-his antibody in bound fraction.  
(C) GFP-Dnmt1∆TS shows enzymatic activity in an in vitro radioactive methyltransferase 
assay. The transfer of [3H]-methyl groups to poly(dI•dC)-poly(dI•dC) substrate was 
measured for increasing volumes of GFP fusion proteins immunopurified from transiently 
transfected HEK293T cells. Counts per minute (cpm) were normalized to the relative protein 
concentration as determined by SDS-PAGE analysis. GFP was used as negative control.  
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Figure 3. Dnmt1∆TS failed to rescue DNA methylation in dnmt1 knockout ESCs. 
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(A) RFP-Uhrf1 was transiently overexpressed in dnmt1 knockout ESCs stably expressing 
GFP-Dnmt1wt or GFP-Dnmt1∆TS. GFP-Dnmt1∆TS shows a dispersed distribution in the 
nucleus and not colocalizes with Uhrf1 at heterochromatin in contrast to GFP-Dnmt1wt. The 
scale bar stands for 5 μm. 
(B) Enzymatic activity of GFP-Dnmt1wt and GFP-Dnmt1∆TS in living cells was analyzed by 
in vivo trapping assay. Dnmt1 knockout ESCs stably expressing either GFP-Dnmt1wt or GFP-
Dnmt1∆TS were incubated with 10 μM of cytosine analogue of 5-aza-deoxycytosine. Trapped 
GFP-Dnmt1∆TS fraction did not emerge at DNA replication foci in contrast to GFP-Dnmt1wt, 
reflecting GFP-Dnmt1∆TS is unable to rescue DNA methylation in dnmt1 knockout ESCs. The 
scale bar stands for 20 μm. 
(C) Genomic DNA was isolated from dnmt1 knockout (C/C) ESCs stably expressing GFP-
Dnmt1wt or GFP-Dnmt1∆TS and was bisulfite-treated. The promoter sequences of major 
satellite and skeletal α-actin were amplified by PCR and methylation level of these sequences 
was analyzed by pyrosequencing. C/C ESCs show hypomethylation compared with wild type 
ESCs (WT). In contrast to GFP-Dnmt1wt, GFP-Dnmt1∆TS cannot rescue DNA methylation at 
promoter regions of major satellites and partially rescue the skeletal α-actin. 
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Figure 4. The PHD and Ring domains are involved in maintenance of DNA methylation 
(A) The mutants of Uhrf1H346G-GFP and Uhrf1H730A-GFP still interact with Dnmt1 by 
coimmunoprecipitation. RFP-Dnmt1 was transiently overexpressed in HEK293T cells in 
combination with Uhrf1wt-GFP, Uhrf1H346G-GFP or Uhrf1H730A-GFP. RFP-Dnmt1 was 
precipitated by RFP-trap and bound fractions were separated by SDS-PAGE. Uhrf1 proteins 
in bound fraction were detected by an anti-GFP antibody.  
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(B) The mutants of Uhrf1H346G-GFP and Uhrf1H730A-GFP still interact with Dnmt1 by a 
modified F2H assay. Uhrf1-GFP fusion constructs were used as baits by tethering them to a 
lac operator array present in BHK cells, so that the array was visible as a distinct nuclear spot 
of enriched GFP fluorescence. The RFP-Dnmt1 fusion (prey) accumulated at this spot when 
Uhrf1wt, Uhrf1H346G or Uhrf1H730A were used. 
(C) RFP-Dnmt1 was transiently expressed in uhrf1-/- ESCs stably expressing Uhrf1wt-GFP, 
Uhrf1H346G-GFP or Uhrf1H730A-GFP, respectively. RFP-Dnmt1 accumulates at 
heterochromatin and overlaps with Uhrf1wt-GFP, whereas it does not colocalize with Uhrf1 
mutants, although Uhrf1H346G-GFP and Uhrf1H730A-GFP show a normal cellular distribution. 
The scale bar stands for 5 μm. 
(D) Endogenous Dnmt1 was stained by using a rat antibody against Dnmt1. Dnmt1 
colocalizes with Uhrf1wt-GFP at heterochromatin, but not with the mutants, Uhrf1H346G-GFP 
and Uhrf1H730A-GFP. The scale bar stands for 20 μm. 
(E) Uhrf1H346G-GFP and Uhrf1H730A-GFP can partially rescue DNA methylation in uhrf1-/- 
ESCs compared with Uhrf1wt-GFP. With pyrosequencing, the DNA methylation levels were 
analyzed at promoter regions of major satellite and skeletal α-actin. The uhrf1-/- ESCs (Uhrf1 
ko) show hypomethylation at promoter regions of both genes compared to wild type E14 
ESCs.  
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Figure 5. Dnmt1∆TS is unable to methylate naked hemimethylated DNA when cell lysate was 
added to the methylation reaction.  
(A) Cell lysates of ESCs stably expressing GFP-Dnmt1wt were incubated with DNA subsates, 
either un- or hemimethylated mononucleosomal DNA and the corresponding naked DNA 
substrates. Methylation level of these sequences was measured by pyrosequencing. GFP-
Dnmt1wt showed methylation activity on the naked hemimethylated DNA and the linker part 
of hemimethylated mononucleosomal DNA, but not on the sequence wrapped with core 
histones. 
(B) Cell lysates of ESCs stably expressing GFP-Dnmt1∆TS were incubated with DNA 
subsates, either un- or hemimethylated mononucleosomal DNA and the corresponding naked 
DNA substrates. The DNA methylation level of these sequences was analyzed by 
pyrosequencing. No methylation activity of GFP-Dnmt1∆TS was observed on all DNA 
substrates used in this study.  
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Figure 6. Uhrf1 has inhibitory function in DNA methylation by competitively binding to 
hemimethylated cytosine. 
(A) Transiently expressed GFP-Dnmt1wt were immunoprecipitated from HEK293T cells and 
incubated with mononucleosomal substrates and corresponding naked DNA. The methylation 
level of these DNA substrates was analyzed by pyrosequencing. GFP-Dnmt1wt can methylate 
naked hemimethylated DNA substrates. In hemimethylated mononucleosomal DNA 
substrates, only linker DNA was methylated. 
(B and C) DNA methylation level was dropped after addition of Uhrf1-GFP into methylation 
reaction. However, the effect was abolished by deletion of SRA domain.  
(D) Time course of DNA methylation by Dnmt1 in presence of Uhrf1 and deletion mutant. 
The naked hemimethylated DNA substrates were incubated with GFP-Dnmt1 in the presence 
or absence of Uhrf1 or its deletion mutant. DNA methylation of these DNA sequence was 
analyzed at different time points. Notably, Uhrf1 seems to inhibit maintenance DNA 
methylation by competitive binding of hemimethylated CpG sites.  
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Figure 7. Usp7 stimulates Dnmt1 activity on hemimethylated DNA 
(A) Trapping assays were carried out using fluorescently labeled double stranded 
oligonucleotide probes. The oligonucleotides have the same sequence except for containing 
one central CpG site with either 5-methylcytosine or cytosine. Shown are fluorescence 
intensity ratios of bound probe/bound GFP fusion, reflecting Dnmt1 activity. GFP was used 
as a control. Dnmt1 activity on hemimethylated DNA was increased two-fold in the presence 
of flag-Usp7.  
(B) Coomassie blue staining gel showing proteins immunoprecipitated from overexpressing 
HEK293T cells that were used in (A). 
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Figure S1. Additional methylation of IAP and XIST at their promoter region was analyzed 
by pyrosequencing.  
The rescue experiments were carried out in both dnmt1 knockout ESCs (C/C) and p53/dnmt1 
double knockout MEF cells (PM). The DNA methylation level was measured at the promoter 
region of the intracisternal A-particle (IAP), major satellites, skeletal α-actin and XIST (X-
inactive specific transcript). Dnmt1wt can rescue DNA methylation similar to wild type ESCs 
levels (WT), but Dnmt1∆TS cannot. In MEF cells, Dnmt1wt is also able to rescue the DNA 
methylation level up to ~60% of p53 knockout cells (P), but Dnmt1∆TS cannot. 
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Figure S2. Measurement of global DNA methylation level in genomic DNA 
The rescue experiments were carried out in both dnmt1 knockout ESCs (C/C) and p53/dnmt1 
double knockout MEF cells (PM). Genomic DNA was isolated from different clones and 
loaded into nylon membrane. Methylated cytosine was detected by an anti-5mC antibody. 
The detection of single strand DNA here was used as an internal control.  
The quantification was done by Image J. GFP-Dnmt1∆TS cannot restore the DNA methylation 
patterns in both dnmt1 knockout ESCs and PM MEF cells in contrast to GFP-Dnmt1wt (A and 
B). WT and P mean the wild type ESCs and p53 knockout MEF cells, respectively.  
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Figure S3. In vitro DNA binding properties of Uhrf1 and its mutants 
Binding assays were carried out using two fluorescently labeled double stranded 
oligonucleotide probes in direct competition. The oligonucleotides have the same sequence 
except for containing one central either un- or hemimethylated CpG site. Shown are 
fluorescence intensity ratios of bound probe/bound GFP fusion. GFP was used as a control. 
The DNA binding properties of Uhrf1 was not affected by single amino acid substitution of 
histidine 730 to alanine and histidine 346 to glycine, respectively.  
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Figure S4. Failure of Uhrf1H346G-GFP and Uhrf1H730A-GFP to remethylate uhrf1-/- ESCs is 
independent of binding trimethylated histone H3K9 and H4K20. The trimethylated 
H3K9me3 and H4K20me3 were detected by anti-H3K9me3 and H4K20me3 antibodies, 
respectively. Uhrf1 colocalizes with heterochromatin marks, H3K9me3 and H4K20me3, 
reflecting that Uhrf1H346G-GFP and Uhrf1H730A-GFP still possess histone binding ability. The 
scale bar stands for 5 μm. 
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Figure S5. Substitution of histidine 730 to alanine abolished the ubiquitin ligase activity of 
Uhrf1. 
HEK293T cells were transiently transfected with HA-ubiquitin alone or in combination with 
Uhrf1wt-GFP or Uhrf1H730A-GFP. Histone core particles were isolated and separated by SDS-
PAGE. Ubiquitinated histones were visualized with a HA antibody. Ponceau staining here is 
used as a loading control.  
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Figure S6. Reconstitution of mononucleosomes in vitro 
(A) The 601 DNA sequence is used for reconstitution of mononucleosomes in vitro. This 
sequence contains 18 of CpG sites, 13 of them in the nucleosome position (highlighted in 
yellow) and 5 of them in the linker part. 
(B) Titration of histone octamer and DNA to make reconstituted mononucleosome. The 
reconstituted mononucleosomes were checked by running polyacrylamide gel and were 
stained by ethidium bromide. The ratios of histone octamer/unmethylated or hemimethylated 
DNA are 0.75:1, 1:1 and 1.25:1, respectively. The ratio 1.25:1 of histone octamer/DNA is the 
best condition for making pure mononucleosomes. 
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Abstract 
DNA methylation plays a central role in the epigenetic regulation of gene expression during 
development and disease. Remarkably, the complex and changing patterns of genomic DNA 
methylation are established and maintained by only three DNA methyltransferases. Here we focus on 
DNMT1, the major and ubiquitously expressed DNA methyltransferase in vertebrates, to outline 
possible regulatory mechanisms. A list of all protein interactions and post-translational modifications 
reported for DNMT1 clearly shows that DNMT1 and by extension also DNA methylation in general are 
functionally linked with several other epigenetic pathways and cellular processes. General themes of 
these interactions and modifications include the activation, stabilization and recruitment of DNMT1 at 
specific sites and heterochromatin regions. For a comprehensive understanding of the regulation of 
DNA methylation it is now necessary to systematically quantify these interactions and modifications, to 
elucidate their function at the molecular level and to integrate these data at the cellular level.  
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Introduction 
Multicellular organisms contain a variety of highly specialized cells that albeit their morphological and 
functional differences contain the same genetic information. During development different sets of 
genes are activated and repressed to generate the cell type-specific functionality. It becomes more 
and more clear that cell type-specific gene expression patterns are established and maintained by a 
complex interplay of transcriptions factors and epigenetic regulators. In particular, DNA and histone 
modifications control the composition, structure and dynamics of chromatin and thereby regulate gene 
expression.1-3  
DNA methylation was the first identified epigenetic modification and has been intensively studied for 
half a century. DNA methylation is the post-replicative addition of methyl groups to the C5 position of 
cytosines catalyzed by a family of DNA methyltransferases (Dnmts). All C5 Dnmts share the same 
conserved motifs involved in the complex molecular mechanism of methyl group transfer best studied 
in the prokaryotic Dnmt M.HhaI (Fig. 1A).4 The mechanism involves Dnmt binding to the DNA, flipping 
the target cytosine out of the DNA double helix, covalent bond formation of a conserved cysteine 
nucleophile with the cytosine C6, transfer of a methyl group from S-adenosyl-L-methionine to the 
activated cytosine C5 and Dnmt release by β-elimination.4, 5  
In vertebrates, there are five members of the Dnmt family known that differ in structure and function 
and apart for DNMT2 all Dnmts compromise an N-terminal, regulatory domain in addition to the C-
terminal, catalytic domain (Fig. 1A). The Dnmt3 subfamily, comprising DNMT3a and DNMT3b, shows 
activity towards unmethylated DNA and establishes de novo DNA methylation patterns during 
gametogenesis and embryogenesis.6-8 The cofactor DNMT3L9 specifically recognizes unmethylated 
histone H3K410 and stimulates the activity of DNMT3a and DNMT3b11 but by itself lacks enzymatic 
activity.12 Established DNA methylation patterns are maintained during DNA replication and DNA 
repair by the ubiquitously expressed DNMT113, 14 that displays a strong preference for hemimethylated 
CpG sites, the substrate of maintenance DNA methylation.15 The fifth member of the Dnmt family, 
DNMT2, shows very weak activity towards DNA and was instead shown to methylate cytoplasmic 
tRNAAsp.16, 17  
Despite their common catalytic mechanism all three active eukaryotic Dnmts have distinct and non 
redundant functions which are likely mediated by their diverse regulatory domains (Fig. 1A). In 
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contrast to prokaryotic Dnmts, the tissue-specific de novo Dnmts, DNMT3a and DNMT3b are only 
active on a subset of target CpG sites18 reflecting a selective control imposed by the N-terminal, 
regulatory domain. The ubiquitously expressed DNMT1 preferentially methylates hemimethylated CpG 
sites and thereby maintains DNA methylation patterns after DNA replication and DNA repair.13-15 
Remarkably, the catalytic domain of DNMT1 – although possessing all conserved motifs – is by itself 
not catalytically active and requires allosteric activation by the N-terminal, regulatory domain.19-21 In 
this review we will focus on a detailed description of DNMT1 regulation to illustrate the extremely 
complex and interconnected regulation of DNA methylation.  
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Structure and function of DNMT1 
Bioinformatic analysis suggested that mammalian DNMT1 evolved by fusion of at least three ancestral 
genes.20 The N-terminal domain of DNMT1 harbors a proliferating cell nuclear antigen (PCNA) binding 
domain (PBD), a targeting sequence (TS domain), a zinc finger domain (CXXC) and two bromo-
adjacent homology domains (BAH1/2) and is connected to the C-terminal, catalytic domain by seven 
lysyl-glycyl dipeptide repeats.22, 23 The PBD domain has been shown to mediate the interaction with 
PCNA leading to the association of DNMT1 with the replication machinery.13, 24, 25 The TS domain 
mediates association with heterochromatin and may lead to dimerization of DNMT1.13, 25, 26 The CXXC 
domain of DNMT1 binds to unmethylated DNA but its deletion did not alter the activity and specificity 
of DNMT1.27 Interestingly, the isolated C-terminal, catalytic domain of DNMT1, although harboring all 
conserved Dnmt motifs, requires an additional large part of the N-terminal domain for enzymatic 
activity.19-21 Fusion of this N-terminal region of DNMT1 to the prokaryotic Dnmt M.HhaI induced a 
preference for hemimethylated DNA.28 Cleavage between the regulatory and the catalytic domain 
stimulated the initial velocity of methylation of unmethylated DNA without substantial change in the 
rate of methylation of hemimethylated DNA.29 These findings illustrate the role of the N-terminal 
domain in the selective activation of the catalytic domain to ensure faithful maintenance of DNA 
methylation patterns.  
First insights into the molecular mechanism of DNMT1 regulation were provided by two recently 
published crystal structures comprising either a large fragment of mouse DNMT1 (aa 291-1620) (PDB 
ID code 3AV4) or a shorter fragment (aa 650-1602) in complex with unmethylated DNA (PDB ID code 
3PT6).30, 31 Notably, the overall structure of the eukaryotic catalytic domain is highly similar to the 
prokaryotic M.HhaI (PDB ID code 5mht) (Fig 1B/C).32 In addition, both structures showed an 
interaction of N-terminal, regulatory domain with the C-terminal, catalytic domain30, 31 which is 
consistent with prior genetic and biochemical studies.19, 33 Remarkably, the TS domain was found 
deeply inserted into the catalytic pocket and would in this conformation prevent DNMT1 binding to 
hemimethylated DNA, the substrate for maintenance DNA methylation.31 These structural insights 
indicate that DNMT1 most likely undergoes several conformational changes during the methylation 
reaction. Activation of DNMT1 requires displacement of the TS domain from the DNA binding pocket 
to allow substrate binding. Indeed, deletion of the TS domain lowered the activation energy32 and 
addition of purified TS domain inhibit DNMT1 methylation activity in vitro34 clearly pointing to an auto-
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inhibitory function of the TS domain. These findings suggest that interacting proteins may modulate 
the interactions of the N-terminal domain with the catalytic domain and thereby regulate the activity of 
DNMT1 in vivo.  
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Regulation of DNMT1 activity by interacting factors 
Over the last two decades, a large variety of proteins was found to interact with DNMT1 ranging from 
DNA methyltransferases, DNA binding proteins, chromatin modifiers and chromatin binding proteins to 
tumor suppressors, cell-cycle regulators and transcriptional regulators (Fig. 2 and Table 1). 
The discrepancy between the high processivity of DNA replication (~ 0.035 seconds per nucleotide)35 
and the low turnover rates (70-450 seconds per methyl group) of recombinant DNMT136 in vitro 
suggests that additional mechanisms increase the activity of DNMT1 in vivo. Indeed, DNMT1 
associates with the replication machinery13 by direct binding to PCNA, a homotrimeric ring serving as 
a common loading platform for replication factors.24, 37-39 Binding of DNMT1 to PCNA enhances the 
methylation activity about twofold, but is not strictly required for maintaining DNA methylation in vivo. 
40, 41 Thus, the transient association between DNMT1 and PCNA alone cannot bridge the gap between 
the slow in vitro kinetics of DNMT1 and the fast progression of the replication fork in vivo. 
Although DNMT1 can bind hemimethlytated CpG sites by itself it also interacts with methyl-CpG 
binding proteins like MeCP242, MBD2/343 and the UHRF family.23, 44 MeCP2 binds DNA, induces 
chromatin compaction45, 46 and interacts with DNMT1 via its transcription repressor domain (TRD).42 
MeCP2 and MBD2, that specifically recognize fully methylated CpG sites47 and MBD3 also form 
complexes with histone deactelyases HDAC1 and HDAC2 which in turn interact with DNMT1.42, 48-51 
This set of interactions explain the correlation between DNA hypermethylation with histone 
hypoacetylation at transcriptional inactive regions52 suggesting a role in transcriptional repression.53 
This complex may also comprise the DNMT1 association protein (DMAP1)51, 54 and the transcriptional 
co-regulator Daxx55 mediating repression in an HDAC-independent manner.51, 54 In addition, the 
interaction with methyl-CpG binding proteins and HDACs may enrich DNMT1 in highly methylated 
heterochromatic regions to increase local methylation efficiency and/or enhance heterochromatin 
formation at these highly methylated regions. 
Recently, UHRF1 has emerged as an essential co-factor for maintenance DNA methylation. The 
genetic ablation of uhrf1 in embryonic stem cells (ESCs) leads to genomic hypomethylation similar to 
dnmt1 -/- ESCs. 56, 57 UHRF1 co-localizes and interacts with DNMT1 throughout S-phase and 
preferentially binds hemimethylated DNA via a SET and Ring associated (SRA) domain and the 
H3K9me3 heterochromatin mark via a tandem Tudor domain.58-62 The crystal structure of the SRA 
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domain in complex with hemimethylated DNA revealed that the 5-methylcytosine is flipped out of the 
DNA double helix, a configuration that would stabilize the UHRF1-DNA interaction.58-62 These results 
suggest that DNMT1 does not directly bind its substrate, the hemimethylated DNA, but is rather 
recruited by UHRF1. Recently, also the second member of the UHRF family, UHRF2, was shown to 
interact with DNMT1 and repressive epigenetic marks. 63 The similar but slightly different structure and 
function of UHRF1 and UHRF2 on one hand and their opposite expression pattern on the other hand 
suggest non-redundant functions during development.63 In addition, UHRF1, UHRF2 as well as 
DNMT1 bind to the de novo Dnmts DNMT3a and DNMT3b.63-68 These results demonstrate a complex 
interplay between methyl-CpG binding proteins and Dnmts in establishing genomic DNA methylation 
patterns.  
Besides the interaction with methyl-CpG binding proteins, DNMT1 also associates with a number of 
proteins involved in establishment and maintenance of heterochromatin structure. DNMT1 interacts 
with the major eukaryotic histone methyltransferases Suv39H169 and EHMT270-73 (also known as G9a) 
that are essential for H3K9 methylation.66, 74 Genetic ablation of ehmt274, 75 and suv39h66 in mouse 
ESCs leads to DNA hypomethylation at specific loci in genomic DNA and altered DNA methylation of 
pericentric satellite repeats, respectively. Interestingly, also the H3K9me3 binding heterochromatin 
protein HP1β was shown to interact with DNMT169 but localization of DNMT1 at late replicating 
chromocenters seemed to be independent of SUV39H1/2 and HP1β.25 In addition, DNMT1 interacts 
with Polycomb group (PcG) proteins EZH276, 77 and EED76 that are subunits of the PRC2/EED-EZH2 
complex, which methylates H3K27. EZH2 was shown to recruit DNMT1 to target genes and thereby 
mediates promoter methylation.76  
In addition to the histone modifying enzymes, also chromatin remodeling ATPases like LSH are 
required for maintaining DNA methylation in mammals. LSH is related to the SNF2 family of 
chromatin-remodeling ATPases and forms a complex with DNMT1, DNMT3b and HDACs suggesting 
a role in transcriptional repression.78, 79 Similarly, BAZ2A (also known as TIP5), the large subunit of the 
nucleolar remodeling complex (NoRC), forms a complex with DNMT1, DNMT3s, HDACs and hSNF2H 
mediating recruitment to rDNA80. One component of this complex, the chromatin remodeler hSNF2H, 
increases the binding affinity of DNMT1 to mononucleosomes.81 The interaction with these chromatin 
remodeling factors may help DNMT1 accessing substrate sites in heterochromatic regions.  
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Besides indirect connections to transcriptional regulation, also direct interactions of DNMT1 with 
transcription regulators and factors have been described. CXXC1 (CFP1), a component of the 
SetD1A/B methyltransferase complex, binds to DNMT1 and Cxxc1-deficient ESCs display reduced 
levels of global DNA methylation.82 Moreover, DNMT1 was shown to interact with the transcription 
factors SP183, SP383 and STAT3.84 A STAT3-DNMT1-HDAC1 complex binds to the promoter of shp1, 
encoding a negative regulator of cell signaling, inducing cell transformation.84 Also RIP140, a co-
repressor for nuclear receptors, interacts with DNMT1 and DNMT3s in gene repression.85  
Additional DNMT1 interactions have been reported with various tumor suppressor genes including 
WT177, Rb50, 86, p5387 and hNaa10p.88 The Wilms tumor suppressor protein (WT1) recruits DNMT1 to 
the Pax2 promoter resulting in DNA hypermethylation.77 The retinoblastoma (Rb) tumor supressor 
gene product associates with DNMT1 and the transcription factor E2F1 resulting in transcriptional 
repression of E2F1-responsive promoters.50 The interaction with p53 stimulates DNMT1 activity 
leading to hypermethylation.87 Finally, the tumor suppressor hNaa10p recruits DNMT1 to promoters of 
tumor suppressor genes and increases the DNA binding affinity of DNMT1.88 Besides a role in normal 
gene regulation also connections with deregulated gene expression in cancer were reported. The 
leukemia-promoting PML-RAR fusion recruits DNMT1 to target promoters inducing gene 
hypermethylation, an early step of carcinogenesis.89  
For the sake of completeness, the following DNMT1 interacting proteins should be mentioned even 
though the function of these interactions is still unclear. The first described interaction partners of 
DNMT1 were Annexin V90 and the molecular chaperone p2391. Also the function of DNMT1 
interactions with RGS6, a protein negatively regulating the heterotrimeric G protein signalling92, with 
PARP-193, 94 and with HESX195 remain elusive. The diversity of proteins reported to interact with 
DNMT1 provides a first insight into the complexity of the epigenetic network and illustrates the central 
role of DNMT1 in these regulatory pathways.   
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Regulation of DNMT1 activity by modifications 
While most of the interacting factors regulate DNMT1 activity by recruitment to specific DNA 
sequences and target genes some of them have been described to modulate DNMT1 activity by post-
translational modifications (Fig. 3). Recent publications described different post-translational 
modifications that influence the stability, abundance and activity of DNMT1. 
DNMT1 was shown to undergo cell cycle dependent changes in acetylation and ubiquitination. 96-98 On 
the one hand, DNMT1 is acetylated by KAT5 and subsequently ubiquitinated by the E3 ubiquitin ligase 
UHRF1 marking DNMT1 for proteolytic degradation.97 On the other hand, DNMT1 is deubiquitinated 
by USP7 (also known as Herpes virus-associated ubiquitin-specific protease Hausp) and deacetylated 
by HDAC1 protecting DNMT1 from proteolytic degradation.97, 98  
Actually, the first post-translation modification described was the phosphorylation of Dnmt1 at Ser515 
(DNMT1 Ser509)99 (Fig 3A) that was suggested to modulate the interaction between the regulatory 
and catalytic domain.100 In addition, Dnmt1 is phosphorylated at Ser146 (unique for mouse) by the 
casein kinase 1δ/ε decreasing the DNA binding affinity101 and at not further mapped sites in the 
regulatory domain by the family of PKCs.102 Notably, it has been reported that the phosphorylation of 
DNMT1 disrupts the DNMT1/PCNA/UHRF1 interaction promoting global DNA hypomethylation in 
human gliomas.103 Phosphorylation of Ser143 by AKT1 during early and mid-S phase has been 
described to stabilize DNMT1.104 S143 phosphorylation in turn blocks methylation of the adjacent 
Lys142 by SETD7 that marks DNMT1 for proteolytic degradation during late S-phase and G2.104, 105  
Besides Lys142, SET7/9 can also methylate Lys1096 of Dnmt1 (Lys1094 of DNMT1), which 
destabilizes the enzyme. The corresponding demethylation by KDM1A (also known as lysine specific 
demethylase LSD1 and AOF2) in turn increases the stability of Dnmt1.106 Consistently, the genetic 
ablation of kdm1a in ESCs led to progressive loss of DNA methylation106 and caused cellular 
differentiation.107 Finally, DNMT1 is also sumoylated by the ubiquitin-conjugating enzyme UBC9 
leading to increased catalytic activity on genomic DNA in vitro.108 
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Perspective 
This ever-increasing list of interacting factors and post-translational modifications reported for Dnmt1 
impressively illustrates the complexity of the regulation of DNA methylation in vivo. As many of these 
interactions and modifications were identified in different cells and species using different and mostly 
qualitative methods, it is now essential to systematically and quantitatively analyze which of them 
occur in which combination, in which phase of the cell cycle, at what stage of cellular differentiation, in 
which cell types and in which fraction of the cellular DNMT1 protein pool. Clearly, the availability of first 
structural data on DNMT1 helps to elucidate the function of these interactions and modifications in the 
regulation of DNMT1 at the molecular level.30, 31, 109 The hardest part, however, is the integration of all 
these data to comprehend DNMT1 regulation in the context of living cells taking into account the 
complexity and dynamics of its natural substrate, the chromatin, as well as the competition or 
cooperation with countless other cellular proteins and processes.  
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Figure Legends 
Figure 1.  
Structural insights into the DNA methyltransferase 1 (DNMT1). A. Schematic outline of the domain 
architecture of mammalian Dnmts in comparison to the prokaryotic Dnmt M.HhaI. All Dnmts harbor 
highly conserved motifs (I-X) in the C-terminal, catalytic domain. In addition, DNMT1 harbors a 
proliferating cell nuclear antigen (PCNA) binding domain (PBD) followed by the targeting sequence 
(TS domain), a zinc finger domain (CXXC), two bromo-adjacent homology domains (BAH1/2). 
DNMT3a and DNMT3b comprise a PWWP domain and a PHD domain that is also found in DNMT3L. 
B. Crystal structure of the prokaryotic cytosine-(C5) methyltransferases M.HhaI in complex with 
hemimethylated DNA (PDB ID code 5mht).32 C. Crystal structure of the large fragment (291-1620) of 
mouse DNMT1 (PDB ID code 3AV4)31 in superimposition with the prokaryotic structure (B) showing 
the expected steric clash between the TS domain and DNA binding in the catalytic pocket. The single 
domains are color-coded as in (A). 
Figure 2. 
Overview of DNMT1 interacting proteins. Interacting proteins range from DNA methyltransferases, 
DNA binding proteins, chromatin modifiers and chromatin binding proteins to tumor suppressors, cell-
cycle regulators and transcriptional regulators. Proteins involved in the post-translation modification of 
DNMT1 are highlighted in green. 
Figure 3.  
Regulation of DNMT1 by post-translational modifications. A. Schematic outline of the domain 
architecture of DNMT1. The lysine residues K142 and K1094 are methylated and the serine residues 
S143 and S509 phosphorylated. In addition, the murine Dnmt1 is phosphorylated at S146. The 
conservation of known modified sites are shown in sequence logos by WebLogo110. The input to 
WebLogo was a ClustalW111 alignment of DNMT1 from different species (Homo sapiens P26358.2; 
Bos Taurus DAA27999.1; Mus musculus P13864.5; Rattus norvegicus Q9Z330.2; Gallus gallus 
Q92072.1; Paracentrotus lividus Q27746.1 and Danio rerio AAI63894.1). B. Crosstalk between 
DNMT1 and interacting proteins leading to post-translational modifications of DNMT1. Following 
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abbreviations are use: Ac = Acetylation; Ub = Ubiquitination; SUMO = Sumoylation; P = 
Phosphorylation; Me = Methylation. Dotted line indicates a hypothetical dephosphorylation.  
Table 1. 
Overview of DNMT1 interacting proteins. The function of proteins is according to the UniProt 
database112, 113 and the applied method is according to the BioGRID114 database apart from the 
fluorescent two-hybrid (F2H) assay.115 All protein names are according to the human nomenclature 
unless noted otherwise. Proteins involved in the post-translation modification of DNMT1 are 
highlighted in green. 
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Table 1 
Interacting Protein Function Method Reference 
Trancriptional regulator 
DMAP1 Involved in transcription 
repression and activation 
Component of the NuA4 
histone acetyltransferase 
(HAT) complex
Yeast 2-hybrid (Y2H) 
Affinity Capture-Western 
(AC/WB) 
Reconstituted Complex 
Rountree et al. 2000 
PML-RAR Transcriptional regulator 
of retinoic acid (RA) target 
genes; induces gene 
hypermethylation and 
silencing by recruiting 
Dnmt1 
AC/WB Di Croce et al., 2002 
HESX1 Required for the normal 
development of the 
forebrain, eyes and other 
anterior structures; 
Possible transcriptional 
repressor 
Y2H 
AC/WB 
Sajedi et al., 2008 
CXXC1 (CFP1) Transcriptional activator 
that exhibits a unique 
DNA binding specificity for 
[AC]CpG[AC] 
unmethylated CpG motifs 
AC/WB Butler et al., 2008 
SP1 Transcription factor AC/WB Esteve et al.; 2007 
SP3 Transcription factor AC/WB Esteve et al.; 2007 
STAT3 Transcription factor that 
binds to the interleukin-6 
(IL-6)-responsive 
elements 
AC/WB 
Co-localization 
Zhang et al.; 2005 
WT1 Transcription factor that 
plays an important role in 
cellular development and 
cell survival 
AC/WB Xu et al.; 2011 
RIP140 Modulates transcriptional 
activation and repression 
AC/WB Kiskinis et al.; 2007 
Chromatin modifier 
HDAC1/2 Deacetylation of lysine 
residues on the N-
terminal part of the core 
histones (H2A, H2B, H3 
and H4) 
AC/WB  
Co-fractionation 
Reconstituted Complex 
Y2H 
Fuks et al.,2000 
Rountree et al.; 2000 
Achour et al.;2008 
Kimura et al.; 2003  
Robertson et al.;2000 
Myant et al.; 2008; 
KDM1A (AOF2; LSD1) Histone demethylation of 
H3K4me and H3K9me; 
Demethylation of DNMT1 
AC/WB Wang et al., 2008 
SUV39H1 Histone methyltransferase 
that specifically 
trimethylates H3K9 
AC/WB Fuks et al., 2003 
EHMT2 (G9a) Histone methyltransferase 
that specifically mono- 
and dimethylates H3K9 
AC/WB Estève et al., 2006 
Kim et al.,2009 
Tachibana et al 2002; 
Peters et al., 2003 
EZH2 Polycomb group (PcG) 
protein. Catalytic subunit 
of the PRC2/EED-EZH2 
complex 
AC/WB  
Reconstituted complex 
Vire et al., 2006;  
Xu et al; 2011 
EED Polycomb group (PcG) 
protein. Component of the 
PRC2/EED-EZH2 
complex 
AC/WB  
Co-localization 
Vire et al., 2006 
SETD7 Histone methyltransferase 
that specifically 
monomethylates H3K9 
AC/WB  
Biochemical Activity 
Esteve et al.; 2009 
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KAT5 (TIP60) Catalytic subunit of the 
NuA4 histone 
acetyltransferase complex 
AC/WB Du et al.; 2010 
LSH Chromatin remodeling AC/WB Myant and Stancheva, 2008
SMARCA5 (SNF2H) Helicase that possesses 
intrinsic ATP-dependent 
nucleosome-remodeling 
activity 
AC/WB Robertson et al.; 2004 
 
BAZ2A (TIP5) Essential component of 
the NoRC (nucleolar 
remodeling complex) 
complex 
Reconstituted Complex Zhou et al.; 2005 
(Methyl) CpG binding proteins 
MeCP2 Methylated CpG binding 
protein 
AC/WB  
Reconstituted complex 
Kimura and Shiota, 2003 
MBD2/MBD3 Methylated CpG binding 
protein 
AC/WB Tatematsu et al., 2000 
UHRF1 Hemimethylated CpG 
binding protein; essential 
for maintenance DNA 
methylation 
Y2H 
AC/WB  
Reconstituted complex 
Co-localization 
 
Bostick et al., 2007  
Sharif et al., 2007 
Arita et al., 2008; 
Awakumov et al.; 2008; 
Qian et al., 2008 
Achour et al,; 2008 
Meilinger et al.; 2009 
UHRF2 E3 ubiquitin-protein ligase 
which mediates 
ubiquitination and 
subsequent proteasomal 
degradation of PCNP;  
Hemimethylated CpG 
binding protein 
AC/WB Pichler et al.; 2011 
Tumor suppressor 
p53 Tumor suppressor in 
many tumor types 
AC/WB Esteve et al., 2005 
hNaa10p Tumor suppressor 
Stimulate Dnmt1 activity 
AC/WB Lee et al., 2010 
DNA methyltransferase 
DNMT3a Required for genome 
wide de novo methylation 
and is essential for the 
establishment of DNA 
methylation patterns 
during development 
AC/WB  
Reconstituted Complex 
Fatemi et al., 2002 
Kim et al., 2002 
DNMT3b Required for genome 
wide de novo methylation 
and is essential for the 
establishment of DNA 
methylation patterns 
during development 
AC/WB  
Reconstituted Complex 
Rhee et al., 2002 
Kim et al., 2002 
Lehnertz et al.; 2003 
Geiman 2004 
Chromatin binding protein 
HP1β Recognizes and binds 
methylated H3K9 
Reconstituted Complex Fuks et al.; 2003 
CBX5 Recognizes and binds 
methylated H3K9 
AC/WB Lehnertz et al.; 2003 
Cell cycle regulator 
PCNA Targeting Dnmt1 to 
replication foci 
AC/WB  
Reconstituted Complex 
Co-localization 
Leonhardt et al.,1992 
Chuang et al.; 1997  
Rountree et al.; 2000 
RB1 Cell cycle regulator AC/WB  
Reconstituted Complex 
Co-fractionation 
Robertson et al., 2000 
Pradhan et al.; 2002 
E2F1 Transcription factor 
Play a role in controlling 
cell cycle entry 
Co-fractionation Robertson et al., 2000 
CHEK1 (CHK1) checkpoint mediated cell AC/WB Palii et al.;  2008 
25 
 
UNDER REVIEW 
 
26 
 
cycle arrest in response to 
DNA damage or the 
presence of unreplicated 
DNA 
Others 
RGS6 Regulator of G-protein 
signaling 
Reconstituted Complex Liu et al; 2004 
USP7 Hydrolase that 
deubiquitinates target 
proteins 
AC/Mass Spectrometry 
AC/WB  
F2H 
Sowa et al.; 2009 
Qin et al.; 2010 
Du et al.; 2010 
UBC9 E2 ubiquitin-conjugating 
enzyme  
AC/WB Lee et al.; 2009 
AKT1 RAC-alpha 
serine/threonine-protein 
kinase 
AC/WB  
Co-localization 
Esteve et al.; 2010 
PARP-1 Poly [ADP-ribose] 
polymerase 1 
AC/WB  
Reconstituted Complex 
Reale et al.; 2005 
Zampieri et al.; 2009 
p23 Molecular chaperone AC/WB  Zhang and Verdine 1996 
Daxx Adapter protein in a 
MDM2-DAXX-USP7 
complex  
AC/WB  
Co-localization 
Muromoto et al.; 2004 
Annexin V Anticoagulant protein AC/WB Ohsawa et al.; 1996 
PKCs Protein kinase C AC/WB  
Co-localization 
Lavoie et al.; 2011 
CK1 δ/ε Casein kinase 1δ/ε AC/WB Sugiyama et al.; 2010 
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3. Discussion 
3.1.  The regulation of Dnmt1 in living cells is still unclear 
3.1.1. Regulation of Dnmt1 by posttranslational modification during the cell cycle 
Over the past decades many interacting proteins were reported to regulate Dnmt1. In this 
thesis, the regulation of Dnmt1 function by its interacting partners Usp7 and Uhrf1 was 
investigated. We showed that Uhrf1 and Usp7 control the stability of Dnmt1 by controlling its 
ubiquitination state. At the same time Du et al described a mechanism for the control of 
DNMT1 stability involving destabilization of DNMT1 by Tip60-mediated acetylation and 
UHRF1-mediated ubiquitination as well as stabilization by HDAC1-mediated deacetylation 
and Usp7-mediated deubiquitination, thus confirming and extending our results (Du et al., 
2010).  
Tight control of Dnmt1 expression may be critical for preservation of normal DNA 
methylation levels and patterns. Low levels of Dnmt1 resulted in global hypomethylation, 
tumor formation and cell death (Gaudet et al., 2003; Eden et al., 2003; Yang et al., 2003). In 
contrast, the overexpression of dnmt1 leads to hypermethylation (Biniszkiewicz et al., 2002). 
Recently, Pradhan et al pointed out that the abundance of DNMT1 peaks in early S phase and 
decreases during mid and late S phase (Esteve et al, 2009). More recent work from the same 
group suggests that the abundance of DNMT1 during the cell cycle is regulated by 
posttranslational modifications (Esteve et al., 2010; Fig. 10). Although the ubiquitination of 
Dnmt1 by Uhrf1 was observed, it remains elusive whether this modification also participates 
in the regulation of Dnmt1 abundance during the cell cycle. 
The cell cycle dependant localization of Dnmt1 is mediated by its N-terminal regulatory 
domain. Immunostaining and coimmunoprecipitation experiments revealed that the PCNA-
binding domain (PBD) and the targeting sequence domain (TS) are responsible for targeting 
Dnmt1 to replication sites and pericentric heterochromatin, respectively (Leonhardt et al., 
1992; Easwaran et al., 2004, Schermelleh et al., 2007). Interestingly, we observed that the 
association of Dnmt1 with constitutive (pericentric) persists from the later part of mid S 
phase, when these sequences are replicated through to the G2 phase (Easwaran et al., 2004). 
This prolonged association of Dnmt1 with pericentric heterochromatin may be required to 
maintain the high levels of methylation of this genomic compartment, especially considering 
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the relatively low turnover rate of Dnmt1 as measured in vitro (Pradhan et al., 1999). 
However, the biological function and mechanism of this phenomenon is still not fully 
understood. A possibility is that the posttranslational modification of Dnmt1 might affect its 
localization as well as its stability during the cell cycle. 
 
Figure 10. Dnmt1 abundance is regulated by posttranslational modification throughout the cell cycle 
Dnmt1 protein levels peak in early S phase and drop after cells enter to mid S phase (green curve). Dnmt1 is 
modified by phosphorylation, methylation, acetylation, ubiquitination and sumoylation. However, so far cell 
cycle profiles of Dnmt1 posttranslational modification were investigated only for phosphorylation at Ser143 and 
methylation at Lys142. Phosphorylation of Dnmt1 at Ser143 occurs in early S phase (yellow curve), whereas 
Dnmt1 is methylated at Lys142 in late S phase to promote its degradation (blue curve). The ubiquitination of 
Dnmt1 is supposed to occur at late S phase.  
 
Therefore, several interesting questions remain to be investigated, including whether DNA 
methylation levels are affected either globally or at specific loci upon depletion of usp7, how 
control of Dnmt1 stability by ubiquitination/acetylation correlates with that imparted by the 
recently described methylation/phosphorylation switch at lysine 142/serine 143 (Esteve et al., 
2010), whether Dnmt1 acetylation and ubiquitination are cell cycle dependent, and where 
ubiquitination occurs. 
To investigate whether the regulation of Dnmt1 stability by ubiquitination is cell cycle stage 
dependent, I first checked the colocalization of Dnmt1 and Usp7 during DNA replication. My 
data showed that in mouse embryonic fibroblasts (MEF) Usp7 accumulates at pericentric 
heterochromatin at the time of its replication (later part of mid S phase) suggesting that Usp7 
might specifically protect Dnmt1 bound to constitutive heterochromatin to allow for 
maintenance of the heavily methylated repeats in this genomic compartment (Fig. 11). 
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However, this association of Usp7 with heterochromatin was not observed in ESCs (Fig. 12), 
suggesting that Usp7 might play different roles in undifferentiated pluripotent stem cells and 
differentiated cells. 
 
Figure 11. Colocalization of Dnmt1 and Usp7 during S phase in MEF cells 
The p53 and dnmt1 double knockout MEF cells stably expressing GFP tagged Dnmt1 were used in this study. 
The endogenous PCNA was stained using an anti-PCNA antibody to identify replication foci and to distinguish 
S phase stages. Nuclear staining was performed with 4’, 6-diamidino-2-phenylindole (DAPI) stain. GFP-Dnmt1 
accumulates at replication sites throughout S phase where it colocalizes with PCNA. In contrast, the endogenous 
Usp7 stained with an anti-Usp7 antibody shows a fully dispersed nuclear distribution in early and mid S phase 
stages, whereas in late S phase an association with heterochromatin is observed. The scale bar stands for 5 μm. 
 
Figure 12. Colocalization of Dnmt1 and Usp7 during S phase stages of the cell cycle in ESCs 
The dnmt1 knockout ESCs stably expressing GFP tagged Dnmt1 were used in this study. The endogenous 
PCNA was stained using an anti-PCNA antibody to identify replication foci and to distinguish S phase stages. 
Nuclear staining was performed with DAPI stain. GFP-Dnmt1 accumulates at replication sites throughout S 
phase where it colocalizes with PCNA. In contrast, the endogenous Usp7 stained with an anti-Usp7 antibody 
shows a fully dispersed nuclear distribution during S phase. The scale bar stands for 5 μm. 
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Interestingly, Du et al showed biochemical evidence from synchronized human colorectal 
cancer cells that Dnmt1 strongly associates with Usp7 during early and mid S phases and 
starts being degraded in late S phase when its association with Uhrf1 is highest (Du et al., 
2010). Thus, Usp7 associates with and stabilizes Dnmt1 till the end of pericentric 
heterochromatin replication. Starting around late S phase Usp7 dissociates with Dnmt1 and 
may be gradually replaced by Uhrf1, which drives Dnmt1 degradation by ubiquitinating it, 
possibly as methylation of pericentric DNA sequences is gradually completed. Therefore, my 
colocalization data actually complement the results of Du et al.  
3.1.2. Usp7, Uhrf1 and Dnmt1 form a dynamic complex 
Usp7 is identified as a novel interacting protein of Dnmt1 by co-immunoprecipitation in 
combination with mass spectrometry analysis. Due to the interaction between Dnmt1 and 
Uhrf1 was reported in 2007 (Achour et al., 2007; Bostick et al., 2007), I showed that Usp7 
also associates with Uhrf1, suggesting that a dynamic complex including Dnmt1, Uhrf1 and 
Usp7 might exist in mammalian cells. Using immunostaining to monitor protein localization 
in cells, the distribution of Uhrf1 in cell nucleus dynamically changes during the cell cycle, 
showing a colocalization with Dnmt1 at replication sites, especially at heterochromatin 
during mid and late S phases, whereas Usp7 shows a dispersed distribution in the nucleus 
during DNA replication, but concentrated at heterochromatin with Dnmt1 only at late S phase, 
suggesting that the complex of Dnmt1/Usp7 and Dnmt1/Uhrf1 might exist at early and mid S 
phases in vivo, and a complex of Dnmt1, Usp7 and Uhrf1 might be formed at late S phase. 
Uhrf1 and Usp7 were reported to modulate Dnmt1 stability by ubiquitination and 
deubiquitination, but it is still unknown whether Usp7 is also involved in maintenance of 
DNA methylation. 
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Figure 13. Structure and histone binding properties of GFP-Usp7 
a) Side view of the TRAF domain as surface representation in complex with trimethylated lysine 9 (green stick 
model). The image was generated with PyMOL. The crystal structure of TRAF domain (PDB 2FOJ) is available 
in the PBD database (Saridakis et al., 2005). The trimethylated lysine 9 could fix into the cage in the surface of 
TRAF domain. b) The binding specificity of GFP-Usp7 for histone H3 N-terminal peptides. The histone H3 
peptides containing either inactive chromatin marks trimethylated H3K9 or H3K27, or active marks acetylated 
H3K9 or H3K27 were tested in the binding specificity of GFP-Usp7. Y-axis presents fluorescence intensity 
ratios of bound probe to bound GFP fusion. GFP-Usp7 shows a preferential binding for trimethylated histone 
H3K9. 
 
With an in vitro peptide binding assay Usp7 showed a preferential binding to trimethylated 
histone H3K9 and weakly binds to trimethylated histone H3K27 (Fig. 13b) in contrast to 
active chromatin marks, acetylated H3K9 and H3K27. The association of Usp7 with histone 
peptide might depend on its TRAF domain, since the trimethylated lysine 9 could fix in the 
cage of TRAF (Fig. 13a). Additionally, Usp7 was observed to mediate the deubiquitination of 
histone H2A and H2B (van der Knaap et al., 2005). Therefore, a possible mechanism that 
Uhrf1 and Usp7 coordinately signal for Dnmt1 binding and release from heterochromatin 
might be speculated (Fig. 14). In this proposed mechanism, Uhrf1 might initially modify 
histones by ubiquitination at unknown lysine sites as a mark for down-stream molecular 
binding, which subsequently modulate the accessibility of chromatin. Dnmt1 thereby can 
access its target sites. Then Usp7 may activate the reverse process to catalyze the removal of 
ubiquitin moiety from histone, resulting in possible chromatin rearrangement. Usp7 could 
accumulate at heterochromatin via the Dnmt1-Uhrf1 complex, or its TRAF domain. 
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Figure 14. Proposed mechanism of Usp7 and Uhrf1 in recruiting Dnmt1 to chromatin 
Uhrf1 recognizes and binds to chromatin through its SRA and tandem Tudor domains. Uhrf1 could transfer 
ubiquitin moiety (U) to histone H3 (Citterio et al., 2004) that might be as a signal for recruiting Dnmt1 and 
Usp7 to DNA containing CpG sites. After methylating (m) the cytosine, Usp7 catalyzes the deubiquitination of 
histone H3 to activate chromatin reorganization that might allow Dnmt1 dissociation from chromatin.  
 
Uhrf1 is a chromatin binding protein and can tightly bind to chromatin containing 
trimethylated H3K9 and hemimethylated CpG sites. Due to a reduction of DNA methylation 
level was observed in uhrf1 knockout mice (Bostick et al., 2007 and Sharif et al., 2007), 
Uhrf1 is addressed as essential cofactor of Dnmt1 for maintenance of DNA methylation. 
Considering Usp7 is also involved in Dnmt1-Uhrf1 complex, it is reasonable to speculate that 
Usp7 plays a role not only in protein stability, but also in the regulation of Dnmt1 activity. By 
in vitro trapping assay, here Usp7 was shown to increase the trapping rate of Dnmt1 at 
hemimethylated DNA. These observations were complement to the results of Du’s. It was 
shown that global DNA methylation was not affected in usp7-/- human tumor cell lines. 
However, the DNA methylation level at imprinting gene H19 was decreased to 65% by 
disruption of usp7 (Du et al., 2010). Interestingly, in vitro Uhrf1 showed an inhibitory 
function in Dnmt1 activity resulting from its SRA domain, implicating that Uhrf1 might play 
multiple roles in the regulation of Dnmt1 activity. On one hand, Uhrf1 is essential for 
recruiting Dnmt1 to replication foci. But on the other hand, it plays a role in inhibition of 
Dnmt1 activity. Therefore, it could be interesting to clarify whether the opposite effect on 
DNA methylation by Usp7 and Uhrf1 is ubiquitination dependent or independent. 
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3.2. Uhrf1 ubiquitin activity and chromatin states 
Based on the preferential binding of both hemimethylated CpG and H3K9me3 (Rottach et al., 
2009), Uhrf1 was proposed to connect DNA methylation and histone modification. 
Additionally, Uhrf1 is a histone modifier, as it harbors a Ring domain which possesses 
ubiquitin E3 ligase activity. Thus, it might have function in modulating chromatin structure 
through its ubiquitin activity. In vitro, H2A, H2B and H3 were identified as substrates of 
Uhrf1 with similar efficiency (Citterio et al., 2004). Here, I confirmed that overexpression of 
Uhrf1 increases ubiquitination of histones in vivo, however it is still unclear which histones 
and which sites are modified. However, it was pointed out that the histone H3 could be the 
best substrate for Uhrf1 under conditions that more closely mimic the physiological 
conditions (Citterio et al., 2004). Interestingly, in this study I also showed that the 
ubiquitination activity of Uhrf1 was required for maintenance of DNA methylation by Dnmt1. 
Therefore, the ubiquitination of histone H3 by Uhrf1 might be required for maintaining DNA 
methylation. 
In contrast to ubiquitination of H2A and H2B, the H3 ubiquitination is little characterized. In 
mammalian cells, the ubiquitination of H3 was first reported in meiotic and postmeiotic germ 
cells of rat testes (Chen et al., 1998). It was speculated that the ubiquitination of H3 could 
contribute to induce nucleosomal replacement and depletion, and thereby may open up the 
higher order nucleosome structure to increase the chromatin accessibility for the transcription 
machinery. Further, E3Histone was characterized as a HECT domain E3 ligase in mammalian 
spermatids, which is responsible for the ubiquitination of histone H3 (Liu et al., 2005). 
Moreover, CUL4-DDB-ROC1 was also identified as a histone ubiquitin ligase of histone H3 
in human cells and the ubiquitylation of histone H3 is activated by UV irradiation, suggesting 
it participates in the cellular response to DNA damage (Wang et al., 2006). The RAG1 and 
RAG2 proteins are the only lymphoid specific factors. Recently, RAG1 was shown to 
preferentially interact with and promotes monoubiquitination of histone H3 by its Ring 
domain (Grazini et al., 2009). Monoubiquitination of histone H3 by RAG1 is involved in 
regulation the phase of chromosomal V(D)J recombination.  
Ubiquitination of histone might serve as signal for repression or activation of other histone 
modifications, such as histone methylation and acetylation. Uhrf1-mediated H3 
ubiquitination therefore might coordinate with other posttranslational histone modifications, 
like trimethylated histone H3K9 to modulate chromatin property. Also a cross-talk between 
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H3 ubiquitination and histone H4 acetylation might exist in cells, because depletion of Uhrf1 
results in an increase of histone H4 acetylation at lysine 5, 8, 12 and 16 at pericentromeric 
heterochromatin region (Papait et al., 2007). Indeed it was shown that acetylated histone H4 
contributes to open up condensed chromatin, suggesting that deacetylation of histone H4 is 
essential for maintaining chromatin compaction and silent state (Chen et al., 2000). In 
addition, it was found that Tip60 (a histone acetyltransferase with specificity toward lysine 5 
of histone H2A) and HDAC1 (a histone deacetylase 1) present in a complex with Uhrf1 
(Achour et al., 2009). Therefore, it can be speculated that a cross-talk between histone 
ubiquitination mediated by Uhrf1 and acetylation of histone exists in vivo and modulates the 
chromatin accessibility for subsequent chromatin modifiers, like DNA methyltransferases. To 
investigate this hypothesis, the exact site of ubiquitination in histone H3 need to be mapped 
to study its combination and the correlation of H3 ubiquitination and histone acetylation. An 
interesting question, how Dnmt1 access its target sites which are packaged into condensed 
chromatin, could be answered.  
In addition, a functional PHD domain resides in Uhrf1 between the tandem Tudor and the 
SRA domain, which has been proposed as a reader of histone modification and binds to 
chromatin. The binding preference for histone modifications, including the methylated or 
acetylated H3K4 and H3K9, were investigated by in vitro peptide binding assay. In contrast 
to previous studies (Karagianni et al., 2008), the PHD domain of Uhrf1 showed no binding to 
any peptides tested (unpublished data by Patricia Wolf). Moreover, the point mutant of Uhrf1 
substituted histidine at amino acid 346 to glycine failed to rescue DNA methylation patterns 
in uhrf1 -/- ESCs, suggesting that the PHD domain of Uhrf1 is also involved in maintenance 
of DNA methylation. Since the tandem Tudor domain contributes to the binding of Uhrf1 to 
trimethylated histone H3K9, the PHD and tandem Tudor domains might coordinately bind to 
“bivalent” histone modifications (Fig. 15), a still unknown histone modification and the 
trimethylated histone H3K9. Since the PHD domain of Uhrf1 was reported to be involved in 
large-scale reorganization of pericentromeric heterochromatin, it was proposed that PHD 
domain might also contribute to open up the chromatin structure (Papait et al., 2008). 
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Figure 15. Uhrf1 might modulate chromatin accessibility through the PHD and the Ring domain 
a) The tandem Tudor domain and the SRA domain recognize the histone H3K9me3 and the hemimethylated 
cytosines, respectively, that mediate Uhrf1 binding to chromatin. The Ring domain of Uhrf1 could modify 
histone H3 by ubiquitination (Citterio et al., 2004), which might be a signal for chromatin remodeling factor 
binding, to modulate chromatin accessibility. This histone modification and subsequent chromatin 
decondensation could help Dnmt1 access its target sites. b) The PHD domain of Uhrf1 might also be involved in 
modulating chromatin accessibility through recognizing an unknown histone modification. 
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3.3. Chromatin accessibility of Dnmt1 and histone modification 
In eukaryotic cells, DNA is assembled to the chromatin units of nucleosome, which contain in 
addition to 147 base-pairs (bp) of DNA also a histone octamer of H2A, H2B, H3 and H4 
proteins (Felsenfeld and Groudine, 2003). The linker DNA between two neighboring 
nucleosomes is ~70 bp in higher eukaryotes. DNA packaged in nucleosomes prevents 
transcription factors and DNA interacting proteins from access their target sites. However, the 
reduced accessibility of the target sites on nucleosomal DNA could be overcome by 
chromatin remodeling factors, which can reposition nucleosomes using energy generated 
from ATP hydrolysis.  
DNA methyltransferases were shown to methylate CpG sites in nucleosomal DNA in vitro 
(Takeshima et al., 2006; Gowher et al., 2005; Okuwaki and Verreault, 2004). Dnmt3a showed 
higher DNA methylation activity than Dnmt3b towards the naked DNA and the naked part of 
nucleosomal DNA. Dnmt3b can methylate the DNA within the nucleosomal core region 
although the activity is low, while Dnmt3a does not. The ability of DNMT1 to methylate 
nucleosomal DNA is highly dependent on the nature of DNA template (Okuwaki and 
Verreault, 2004). Here I also showed that Dnmt1 cannot methylate the hemimethylated CpG 
sites which are packaged into nucleosomes. Nucleosomes without any histone modifications 
protect DNA from DNA methylation by Dnmt1. Therefore, access of Dnmt1 to nucleosomal 
DNA substrate may require chromatin remodeling activities. For example, DNA methylation 
patterns of several highly repeated sequences including the rDNA arrays, a Y-specific satellite 
and subtelomeric repeats were changed by mutating the ATRX gene that encodes a component 
of ATP-dependent chromatin remodeling factor of the SWI2/SNF2 family (Gibbons et al., 
2000). Recently, it was reported that Snf2H can enhance Dnmt3a/3b activity on nucleosomal 
DNA by reposition of nucleosomes in the presence of ATP (Felle et al., 2011). Access of 
Dnmt1 to nucleosomal DNA templates may rely on chromatin remodeling factors, which 
recognize specific histone modification patterns. Therefore, it is reasonable to speculate that 
histone modification patterns may control access of Dnmt1 to nucleosomes. In addition, 
Dnmt1 may also directly read the histone modification. As first evidence, using a histone 
peptide binding approach we found that the isolated TS domain of Dnmt1 shows a 
preferentially binding to the heterochromatin mark, the trimethylated histone H3K9, in 
contrast to the acetylated H3K9 (unpublished data by Patricia Wolf). In addition, several 
proteins including HP1 and Uhrf1 were identified as adaptor proteins to link DNA 
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methylation to histone modification, suggesting an indirect way which targets Dnmt1 to 
nucleosomes. 
A series of epigenetic signals, including methylation, phosphorylation and acetylation at 
histone tails, influence higher order chromatin structure. The acetylation and deacetylation of 
histones dynamically change chromatin arrangement. By neutralizing negative charges, 
histone acetylation results in an opening of chromatin states (Gorisch et al., 2005), whereas 
deacetylation of histones catalyzed by HDAC is thought to generate a more compact 
chromatin state. Interestingly, it was shown that HDAC1 interacts with Dnmt1, suggesting 
that HDAC1 may link DNA methylation to histone deacetylation. In addition, a recent study 
indicates that DNA is more accessible in chromatin containing H3K4me and hyperacetylated 
H4K16, which localize at active promoters and gene rich areas (Bell et al., 2010). In contrast, 
DNA is hardly accessible when histone H3 is methylated at lysine 27 (H3K27me). Moreover, 
it was reported that nucleosomes with dimethylated H3K36 are refractory to nucleosome 
disassembly (Rao et al., 2005). In addition to histone modification, also the histone variants 
were shown to be involved in modulating chromatin accessibility (Raisner et al., 2005; Zhang 
et al., 2005).  
Although in the last two decades DNA methylation and histone modifications have been 
extensively characterized as two crucial epigenetic systems, little is known how Dnmt1 
access the genomic DNA when it is packaged into nucleosome in mammalian cells and which 
histone posttranslational modifications might be involved in this process. Therefore, to fully 
understand the mechanism of maintenance of DNA methylation, it is important to elucidate 
the binding preference of Dnmt1 toward nucleosomal templates that contain different histone 
modifications. To elucidate this question, it is necessary to generate hemimethylated DNA 
sequences. Gerasimaite et al engineered a hemimethylase M.HhaI that specifically recognize 
GCG sites (Gerasimaite et al., 2009) that can be applied to prepare the hemimethylated DNA 
sequences.  
To investigate this question, an alternative approach can be used, that is to precipitate the 
histones with Dnmt1 and analyze their modifications. For this purpose, I digested chromatin 
with micrococcal nuclease into mononucleosomes and thereby analyze mononucleosomes 
that would be coprecipitated with Dnmt1. For this aim, I used dnmt1 null embryonic ESCs, 
that stably expressing GFP tagged Dnmt1. My preliminary data showed that histones can be 
coprecipitated with Dnmt1, but their specific posttranslational modification signature will 
have to be identified by mass spectrometry (Fig. 16). 
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Figure 16. Isolation of histones associated with DNA methyltransferase 1 
Mononucleosomes isolated from an ES cell line stably expressing GFP tagged Dnmt1 in dnmt1 knockout cells 
(C/C+GFP-Dnmt1) were coprecipitated with Dnmt1 by using the GFP trap. The bound fraction was separated in 
a 5-12% of gradient gel and visualized by colloidal blue staining. Histone core particles were coprecipitated 
with Dnmt1 in C/C+GFP-Dnmt1 ESCs, but not in the negative control, the dnmt -/- ESCs (C/C). For preparation 
of mononucleosomes, nuclei are digested with 40 U/ml of micrococcal nuclease at 37°C for 5 min. 
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3.4. Dynamics of DNA methylation 
3.4.1. Tets, a novel protein family in epigenetics 
The Tet family includes three members: Tet1, Tet2 and Tet3. Tet enzymes are 2-oxoglutarate 
(2OG)-and Fe (II)-dependent dioxygenases with homology to JBP1/2 proteins and AlkB, 
which are enzymes responsible for hydroxylation of thymine in Trypanosomes and 
methyladenine in all kingdoms of life, respectively. Tet proteins modify 5mC to 5hmC. 
Tet1 protein is relative large protein harboring a CXXC-type zinc finger domain, a Cys-rich 
region and a catalytic domain. Surprisingly, the CXXC domain of Tet1 is highly similar to the 
zinc finger of Dnmt1. The isolated CXXC domain of Dnmt1 (aa 643-700) possesses DNA 
binding activity with a preference for unmethylated DNA by in vitro DNA binding assay. 
Deletion of the CXXC domain did not affect Dnmt1 activity and DNA binding properties, 
suggesting that it is dispensable for the catalytic activity of Dnmt1 (Frauer et al., 2011) and 
might play other roles, such as mediating protein-protein interaction. However, in contrast to 
our results, Pradhan et al showed that the CXXC domain of human Dnmt1 is necessary for 
enzymatic activity (Pradhan et al., 2008). A deletion of DNMT1 (aa 648-690) was 
characterized with a radioactive methyltransferase activity assay. The DNMT1∆CXXC activity 
on hemimethylated DNA was significantly reduced. Moreover, stable expression of 
DNMT1∆CXXC in COS-7 cell line resulted in a reduction of DNA methylation at rDNA repeat 
sequences (25%). Therefore, the authors proposed a dominant negative effect of 
DNMT1∆CXXC. The discrepancy with our results might be due to the differences in the 
construction of deletion mutants or to the use of Dnmt1 from different mammalian species. 
Basing on sequence comparison by mouse and human Dnmt1 sequences, the deletion of 
DNMT1 used by Pradhan group might affect the folding of surrounding protein sequences.  
The CXXC domain of Tet1 (aa 561-614) was constructed and tested whether it can bind to 
DNA. Interestingly, we found that the CXXC domain of Tet1 has no DNA binding affinity. 
Consistently, based on our structural model of CXXC domains, the CXXC domain of Tet1 is 
different from the structure of the Dnmt1 CXXC domain in the region of the KFGG motif. In 
contrast to our result, it was shown that the CXXC domain of TET1 (aa 528-674) can bind to 
both unmethylated and methylated CpG-rich DNA sequences (Zhang et al., 2011; Xu et al., 
2011). This discrepancy with our data might result from the use of different assay and DNA 
substrate or from the differences in the construction of CXXC fragments. Additionally, by 
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overexpression of CXXC deletion mutant of Tet1 in HEK293T cells, the 5hmC level is not 
affected, suggesting that the CXXC domain is dispensable for catalytic activity of Tet1 in 
vivo (Frauer et al., 2011). Thereby, further work is required to confirm and identify the 
region(s) of Tet proteins responsible for DNA binding.  
In mammalian zygotes, genomic methylation patterns are erased from the paternal genome 
even before the first replication cycle. Although the enzyme responsible for removal of 
methyl group from 5mC is so far not identified, it was proposed that the conversion of 5mC 
to 5hmC is one initial step for active DNA demethylation. Two recent studies detected high 
levels of 5hmC in the paternal genome from the one to the four cell stages (Iqbal et al., 2011; 
Wossidlo et al., 2011). In the same studies Tet3 transcripts were specifically detected in 
oocytes and zygotes, with a rapid decline already at the two cell stage. Thus, Tet3 is likely the 
enzyme responsible for converting 5mC to 5hmC in the paternal genome of zygotes (Iqbal et 
al., 2011; Wossidlo et al., 2011). The generation of specific antibodies against Tet proteins 
would help to investigate the expression pattern of Tet proteins during embryonic 
development and in adult tissues. 
In addition to elucidate the expression patterns, the regulation of Tet proteins could receive 
more attentions. To study the regulation of Tet proteins, it can be performed to identify the 
potential interaction partners. Several methods can be used to search for potential Tet 
interacting proteins, including the traditional yeast two-hybrid and affinity purification in 
combination with mass spectrometry.  
3.4.2. 5hmC, a novel DNA modification 
5mC and 5hmC are two modified cytosine bases. Whereas 5mC has been extensively studied 
for two decades, 5hmC has only recently been shown in mammalian genomes. The oxidation 
of 5mC to hmC catalyzed by Tet proteins is supposed to mediate gene reactivation. It was 
reported that catalytic mutations in Tet2 results in genomic hypermethylation in multiple 
myeloproliferative neoplasms (Tefferi et al., 2010), suggesting that Tet proteins might 
promote DNA demethylation. Moreover, overexpression of Tet proteins in HEK293T cells 
led to a reduction of 5mC content (Tahiliani et al., 2009). These observations suggest the 
possibility that 5hmC represents an intermediate of an active DNA demethylation process. 
Diverse methods were developed to monitor 5mC content and/or patterns, including 
procedures based on hydrolysis to single nucleotides/nucleosides and separation by thin-layer 
chromatography(TLC), high performance liquid chromatography (HPLC) or mass 
DISCUSSION 
 
151 
 
spectrometry (MS), COBRA (combined bisulfate restriction analysis), bisulfite sequencing, 
pyrosequencing after bisulfite treatment and 5mC antibody-dependent detection methods. 
Except for the methods based on physical separation (TLC, HPLC coupled to MS), these 
techniques cannot distinguish 5mC from 5hmC (Jin et al., 2010). Therefore, a major 
challenge is to develop methods that could accurately distinguish 5mC and 5hmC in the 
genomic context. Recently, several methods based on glucosylation of 5hmC by a specific 
glucosyltransferase were reported, and could be used to quantify and map the distribution of 
5hmC in mammalian genomic DNA (Szwagierczak et al., 2010; Robertson et al., 2011; 
Pastor et al., 2011; Song et al., 2011). Moreover, a sensitive mass spectrometry method for 
simultaneous quantification of DNA methylation and hydroxymethylation levels was 
developed (Le et al., 2011; Münzel et al., 2010). In addition, antibodies specific for 5hmC 
would allow genome-wide mapping of 5hmC by DNA immunoprecipitation followed by 
either microarray hybridization or high throughput parallel sequencing. 5mC occurs 
predominantly in the context of CpG dinucleotides. As methods that can discriminate 5hmC 
from 5mC at single base pair resolution are currently not available, it is not known whether 
5hmC is also predominantly found in CpG dinucleotides or present more frequently also in 
other sequence contexts. 
Although genomic 5hmC is proposed as an intermediate of active DNA demethylation, 
currently, its function is not clear. The identification of proteins that may specifically bind 
5hmC would be an important step towards understanding the role(s) of this modified 
nucleotide. The binding proteins of 5mC, including MBD1, MBD2, MBD3 and MeCP2 did 
not bind to 5mC when it was hydroxylated (Jin et al., 2010), suggesting that the 
hydroxylation of 5mC blocks MBD proteins binding, resulting in gene reactivation. To 
identify proteins that recognize 5hmC, cell extracts could be incubated with immobilized 
DNA oligonucleotides containing 5hmC as bait (Fig. 17a). I used this approach to test 
whether Uhrf1 binds DNA containing 5hmC. Preliminary results showed that Uhrf1 binds 
DNA oligonucleotides containing an asymmetrically hydroxymethylated CpG site and the 
binding is even less efficiently than the same oligonucleotide sequence without modification 
(Fig. 17b). This experiment was just conducted once and thereby has to been repeated. In 
addition, an internal normalization has to be considered to confirm this result. In contrast to 
this result, it was reported that Uhrf1 preferentially binds to hydroxymethylated cytosine 
(Frauer et al., 2011). The discrepancy might result from the use of different DNA substrate or 
different experimental set-ups, like uses complex extracts versus purified proteins. For the 
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understanding of Uhrf1 regulation and function it will be important to identify the molecular 
basis for this opposite binding properties.  
 
 
 
Figure 17. Strategy for identification of proteins which could recognize 5hmC 
a) Strategy for identifying proteins that specifically bind 5hmC. A biotin labeled bait DNA containing either un-, 
hemi- or hydroxyl-methylated cytosine is incubated with ESCs lysate. The proteins co-precipitated with bait 
DNA are identified by mass spectrometry. b) DNA oligonucleotides were incubated with cell lysate from 
HEK293T cells that transiently over-expressed Uhrf1-GFP. GFP fusion protein in bound fraction was measured 
with a fluorimeter and detected by western blotting using anti-GFP antibodies. Uhrf1 shows a preferential 
binding of hemi-methylated DNA over hydroxyl-methylated as well as unmethylated DNA. 
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4.2. Abbreviations 
2OGFeDO: 2-oxoglutarate and iron (II) dependent dioxygenase superfamily 
5-aza-dC: 5-aza-2´-deoxycytidine 
5hmC: 5 hydroxymethylcytosine 
5mC: 5-methylcytosine 
AdoMet: S-Adenosyl-LMethionine 
Akt1: threonine-protein kinase 
BAH: bromo adjacent homology domain 
BER: base excision repair 
CpG: cytosine-phosphatidyl-guanine 
C-Myc: Myc proto-oncogene protein 
CTD: catalytic domain 
DNA: deoxyribonucleic acid 
Dnmt: DNA methyltransferase 
DUB: de-ubiquitinase 
Dot1: histone H3 methyltransferase Dot1 
ESCs: embryonic stem cells 
E2F: transcription factor E2F 
Elp3: elongator complex protein 3 
E3: ubiquitin ligase 
GFP: green fluorescent protein 
Gadd45: growth arrest and DNA damage inducible protein 45α 
H3K9me: H3 lysine 9 methyltransferase 
HMTs: histone methyltransferases 
HDAC: histone deacetylase 
HP1: heterochromatin protein 1 
ICF: immunodeficiency, centromere instability, facial anomalies syndrome 
(KG)7: lysine-glycine repeats 
MBD: methyl-CpG binding domain protein 
MEF: Mouse Embryonic Fibroblast 
MLL: mixed lineage leukemia 
Np95: nuclear protein with 95 kilodalton 
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NTD: N-terminal domain 
NF-kB: nuclear factor kappa-light-chain-enhancer of activated B cells 
Oct4: octamer binding transcription factor 4 
PBD: PCNA binding domain 
PCNA: proliferating cell nuclear antigen 
PDB: protein data bank 
PHD: plant homeodomain 
PWWP: proline-tryptophan-proline motif 
PRC: polycomb repressive complex 
Ring: really interesting new gene 
SILAC: stable isotope labeling with amino acids in cell culture 
SAGA: Spt-Ada-Gcn5-Acetyltransferase complex 
S phase: synthesis phase 
SRA: SET and Ring associated 
TDG: thymidine glycosylase 
Tip60: histone acetyltransferase Tip60 
TKO: dnmt1, dnmt3a and dnmt3b knockout embryonic stem cells 
TRD: target recognition domain  
TS: targeting sequence 
Ubl: ubiquitin-like 
Uhrf1: ubiquitin-like, containing PHD and RING finger domains, 1 
ZnF: zinc finger 
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